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1. Summary 
 
Candida albicans is an opportunistic human fungal pathogen that causes a variety of 
infections, ranging from superficial mucosal to deep-seated systemic infections, especially in 
immunocompromised patients. Although the ability of C.albicans to cause disease largely 
depends on the immune status of the host, the fungus also exhibits specific characteristics that 
facilitate colonization, dissemination, and adaptation to different host niches and thereby turn 
C.albicans from a harmless commensal to an aggressive pathogen. In response to various 
environmental stimuli C.albicans switches from growth as a budding yeast to invasive 
filamentous growth, and this morphogenetic switch plays an important role in C.albicans 
pathogenesis. Nitrogen limitation is one of the signals that induce filamentous growth in 
C.albicans, and the control of the morphogenetic transition by nitrogen availability was 
studied in detail in the present work. 
Ammonium is a preferred nitrogen source for yeasts that is taken up into the cells by 
specific transporters. It was found in this study that C.albicans possesses two major 
ammonium transporters, encoded by the CaMEP1 and CaMEP2 genes, expression of which is 
induced by nitrogen starvation. Whereas ∆mep1 or ∆mep2 single mutants grew as well as the 
wild-type strain on limiting concentrations of ammonium, deletion of both transporters 
rendered C.albicans unable to grow at ammonium concentrations below 5 mM. In contrast to 
∆mep1 mutants, ∆mep2 mutants failed to filament and grew only in the yeast form under 
nitrogen starvation conditions, indicating that in addition to its role as an ammonium 
transporter CaMep2p also has a signaling function in the induction of filamentous growth. 
CaMep2p was found to be a less efficient ammonium transporter than CaMep1p and to be 
expressed at much higher levels, a distinguishing feature important for its signaling function. 
By the construction and analysis of serially truncated versions of CaMep2p, the C-terminal 
cytoplasmic tail of the protein was shown to be essential for signaling but dispensable for 
ammonium transport, demonstrating that these two functions of CaMep2p are separable. 
In C.albicans at least two signal transduction pathways, a MAP kinase cascade and a 
cAMP-dependent pathway ending in the transcriptional regulators Cph1p and Efg1p, 
respectively, control filamentous growth, and mutants defective in either one of these 
pathways are defective for filamentation under nitrogen starvation conditions. A hyperactive 
CaMEP2 allele rescued the filamentation defect of a ∆cph1 or a ∆efg1 mutant, but not of a 
∆cph1 ∆efg1 double mutant or a mutant deleted for RAS1, which acts upstream of and 
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activates both signaling pathways. Conversely, a dominant active RAS1 allele or addition of 
exogenous cAMP rescued the filamentation defect of  ∆mep2 mutants. These results suggest 
that CaMep2p activates both the MAP kinase and the cAMP pathway in a Ras1p dependent 
manner to promote filamentous growth under nitrogen starvation conditions. At sufficiently 
high concentrations, ammonium repressed filamentous growth even when the signaling 
pathways were artificially activated. Therefore, C.albicans has established a regulatory circuit 
in which a preferred nitrogen source, ammonium, serves as an inhibitor of morphogenesis that 
is taken up into the cell by the same transporter that induces filamentous growth in response 
to nitrogen starvation. 
Although a detailed understanding of virulence mechanisms of C.albicans may 
ultimately lead to novel approaches to combat infections caused by this pathogen, the 
identification and characterization of essential genes as potential targets for the development 
of antifungal drugs is a strategy favoured by most pharmaceutical companies. Therefore, 
C.albicans homologs of three genes that are essential in other fungi were selected in 
collaboration with an industrial partner and functionally characterized in this work. RAP1 
encodes the repressor/activator protein 1, a transcription factor and telomere binding protein 
that is essential for viability in the budding yeast Saccharomyces cerevisiae. However, 
deletion of the C.albicans RAP1 homolog did not affect viability or growth of the mutants, 
suggesting that it is not a promising target. CBF1 (centromere binding factor 1) is necessary 
for proper chromosome segregation and transcriptional activation of methionine biosynthesis 
genes in S.cerevisiae and is essential for viability in the related yeasts Kluyveromyces lactis 
and Candida glabrata. Deletion of CBF1 in C.albicans did not result in an increased 
frequency of chromosome loss, indicating that it has no role in chromosome segregation in 
this organism. However, the C.albicans ∆cbf1 mutants exhibited severe growth impairment, 
temperature sensitivity at 42°C, and auxotrophy for sulphur amino acids, suggesting that 
Cbf1p is a transcription factor that is important for normal growth of C.albicans. YIL19 is an 
essential gene in S.cerevisiae that is involved in 18S rRNA maturation. YIL19 was found to be 
an essential gene also in C.albicans. Conditional mutants in which the YIL19 gene could be 
excised from the genome by inducible, FLP-mediated recombination were non-viable and 
accumulated rRNA precursors, demonstrating that YIL19 is essential for this important 
cellular process and for viability of C.albicans and could serve as a target for the development 
of antifungal drugs. 
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1. Zusammenfassung 
 
Candida albicans ist ein opportunistisch pathogener Hefepilz, der sowohl 
oberflächliche Infektionen der Schleimhaut als auch lebensbedrohliche systemische 
Infektionen hervorrufen kann. Obwohl die Fähigkeit von C.albicans Infektionen auszulösen 
weitgehend vom Immunstatus des Wirts abhängt, besitzt der Pilz doch auch spezifische 
Eigenschaften, die eine Kolonisierung, Disseminierung und Anpassung an unterschiedliche 
Wirtsnischen ermöglichen und ihn vom harmlosen Kommensalen zum gefährlichen 
Krankheitsserreger werden lassen. Unter bestimmten Umweltbedingungen geht C.albicans 
vom Wachstum als sprossende Hefe zum invasiven, filamentösen Wachstum über, das eine 
wichtige Rolle in der Pathogenität des Pilzes spielt. Stickstoffmangel ist eines der Signale, die 
das filamentöse Wachstum in C.albicans induzieren, und die Kontrolle der Morphogenese 
durch die Verfügbarkeit von Stickstoff wurde in dieser Arbeit detailliert untersucht. 
Ammonium ist für Hefepilze eine bevorzugte Stickstoffquelle, die über spezifische 
Transporter in die Zelle aufgenommen wird. In der vorliegenden Arbeit konnte gezeigt 
werden, dass C.albicans zwei Ammoniumpermeasen besitzt, deren Expression durch 
Stickstoffmangel induziert wird. Während die Deletion von CaMEP1 oder CaMEP2 keinen 
Einfluss auf das Wachstum bei limitierenden Ammoniumkonzentrationen hatte, konnten 
∆mep1 ∆mep2 Doppelmutanten bei Ammoniumkonzentrationen unter 5 mM nicht mehr 
wachsen. Im Gegensatz zu ∆mep1 Mutanten bildeten ∆mep2 Mutanten unter Stickstoffmangel 
keine Hyphen mehr und wuchsen ausschließlich in der Hefeform. CaMep2p hat also nicht nur 
eine Funktion als Ammoniumtransporter, sondern spielt auch eine Rolle bei der Induktion des 
filamentösen Wachstums. Weitere Experimente zeigten, dass CaMep2p ein weniger 
effizienter Ammoniumtransporter als CaMep1p ist, dafür aber stärker exprimiert wird, und 
dass dieser Unterschied wichtig für die Signalfunktion von CaMep2p ist. Durch 
Deletionsanalysen konnte bewiesen werden, dass die C-terminale, cytoplasmatische Domäne 
von CaMep2p essentiell für die Induktion des Hyphenwachstums ist, für den 
Ammoniumtransport jedoch nicht benötigt wird, und diese beiden Funktionen von CaMep2p 
daher voneinander getrennt werden können. 
In C.albicans gibt es mindestens zwei Signalwege die das filamentöse Wachstum 
steuern, eine MAP-Kinase-Kaskade und einen cAMP-abhängigen Signalweg, die in den 
Transkriptionsfaktoren Cph1p bzw. Efg1p enden. Bei Inaktivierung des einen oder des 
anderen Signalwegs induziert Stickstoffmangel kein filamentöses Wachstum mehr. Ein 
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hyperaktives CaMEP2 Allel konnte den filamentösen Wachstumsdefekt sowohl von ∆cph1 
als auch ∆efg1 Mutanten aufheben, nicht jedoch den einer ∆cph1 ∆efg1 Doppelmutante oder 
einer Mutante, der das G-Protein Ras1p fehlte, das beide Signalwege aktiviert. Umgekehrt 
wurde der filamentöse Wachstumsdefekt von  ∆mep2 Mutanten durch ein dominant-aktives 
RAS1 Allel bzw. durch die Zugabe von cAMP aufgehoben. Diese Ergebnisse deuten darauf 
hin, dass CaMep2p bei Stickstoffmangel sowohl den MAP-Kinase- als auch den cAMP-
abhängigen Signalweg aktiviert, um filamentöses Wachstum zu induzieren. In genügend 
hohen Konzentrationen reprimierte Ammonium das filamentöse Wachstum selbst wenn die 
Signalwege artifiziell aktiviert waren. Die bevorzugte Stickstoffquelle Ammonium ist deshalb 
ein Inhibitor der Morphogenese, der durch denselben Transporter in die Zelle aufgenommen 
wird, der bei Stickstoffmangel das filamentöse Wachstum von C.albicans induziert. 
Obwohl ein genaues Verständnis der Virulenzmechanismen von C.albicans auch neue 
Ansätze zur Bekämpfung von Infektionen durch diesen Pilz liefern kann, ist doch die 
Identifizierung und Charakterisierung von essentiellen Genen als potentielle Ziele für die 
Entwicklung neuer Antimykotika eine Strategie, die von der pharmazeutischen Industrie 
favorisiert wird. Aus diesem Grund wurden in Zusammenarbeit mit einem Industriepartner 
drei Gene von C.albicans ausgewählt, die in anderen Pilzen als essentiell beschrieben wurden, 
und im Rahmen dieser Arbeit funktionell charakterisiert. RAP1 codiert für das 
Repressor/Aktivator Protein 1, ein Transkriptionsfaktor und Telomerbindeprotein, das in der 
Bäckerhefe Saccharomyces cerevisiae essentiell ist. Die Deletion des RAP1 Gens in 
C.albicans beeinträchtigte jedoch nicht die Lebensfähigkeit der Mutanten, so dass RAP1 kein 
vielversprechendes Ziel darstellt. CBF1 (centromere binding factor 1) ist in S.cerevisiae 
wichtig für die korrekte Chromosomenverteilung während der Mitose und außerdem auch für 
die transkriptionelle Aktivierung der Methioninbiosynthesegene; in den verwandten Hefen 
Kluyveromyces lactis und Candida glabrata ist CBF1 sogar essentiell. C.albicans ∆cbf1 
Mutanten wiesen jedoch keinen erhöhten Chromosomenverlust auf, so dass CBF1 hier 
offensichtlich keine Rolle bei der Chromosomensegregation spielt. Allerdings waren die 
Mutanten auxotroph für schwefelhaltige Aminosäuren und generell stark im Wachstum 
beeinträchtigt, was zeigte, dass Cbf1p für das normale Wachstum von C.albicans wichtig ist. 
YIL19 ist in S.cerevisiae ein essentielles Gen und hat eine Funktion bei der Reifung der 18S 
rRNA. YIL19 stellte sich auch in C.albicans als essentiell heraus. Konditionale Mutanten, in 
denen YIL19 durch induzierbare, FLP-vermittelte Rekombination aus dem Genom deletiert 
wurde, waren nicht lebensfähig und akkumulierten rRNA Vorstufen. Durch diese 
Untersuchungen konnte gezeigt werden, dass YIL19 essentiell für diesen wichtigen zellulären 
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Prozess und für die Lebensfähigkeit von C.albicans ist und sich möglicherweise als Ziel für 
die Entwicklung antifungaler Substanzen eignet. 
 
  Introduction 
 
 6 
2.  Introduction 
 
2.1. Candida albicans: an opportunistic human fungal pathogen 
The latter half of the twentieth century has seen enormous advancement in the field of 
medicine and surgery. This has led to the emergence of various forms of organ transplantation 
and cancer chemotherapy as essential medical treatment, automatically involving 
immunosuppression as part of the procedure. Although many health problems have been 
adequately addressed in this manner, the ceaseless development in modern medicine has led 
to the creation of “at risk individuals”, who are extremely susceptible to infections. The 
increasing number of immunodeficient individuals due to rapid increase in the incidence of 
AIDS has resulted in an epidemic of diseases caused by opportunistic fungal pathogens. Of 
particular interest is candidiasis, a disease caused by members of the Candida genus. The 
prevalent cause of candidiasis is Candida albicans, often regarded as the most common 
opportunistic fungal pathogen.  
There are several predisposing factors for C.albicans to alter from a state of a 
relatively quiescent commensalism to an aggressive pathogenic lifecycle. When immune 
systems are weak (for example, as a result of cancer chemotherapy, HIV infection or in 
neonates) or when the competing flora is eliminated (for example, after antibiotic treatment), 
C.albicans colonizes and invades host tissues. Although HIV patients frequently suffer from 
recurring oral candidiasis and sometimes die from advanced oesophageal colonization, 
infections of mucosal tissues such as thrush and vaginitis are usually not life threatening. 
However, if the organism gains access to the bloodstream (a condition known as 
candidaemia), by invasion of host tissues or by contamination of indwelling catheters, the 
infection can progress to the growth of fungal masses in the kidney, heart or brain. 
Current treatments for systemic fungal infections have toxic side effects and exhibit 
poor efficacy. Most commonly used antifungals inhibit the ergosterol biosynthetic pathway 
and chiefly include azoles, allylamines and morpholines. Others, such as polyenes and 5-FC, 
impair membrane barrier function and macromolecule synthesis respectively (Vanden 
Bossche, 1997). The incidence of C.albicans cells acquiring resistance to antifungals like 
azoles has increased considerably in recent years which has posed serious problems towards 
it’s successful chemotherapy (Cowen et al., 2000; Kakeya et al., 2000; White et al., 1998; 
Rex et al., 1995; Sternberg, 1994), probably due to rampant use of azole drugs on cancer and 
AIDS patients suffering from secondary fungal infections. Drug pressure leads to the 
generation of resistant cells with random mutations, or transient expression of genes which 
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can alter the phenotype of the cells (White et al., 1998). New antifungal agents targeting 
C.albicans and other opportunistic pathogens are therefore urgently needed. To develop such 
new therapies and treatments for candidiasis, it is essential to dissect the infectious process of 
C.albicans.  
Experimental work on C.albicans has long been hampered by its asexuality, its 
diploidy and its non-canonical codon usage (CUG encodes serine instead of leucine) (Scherer 
and Magee, 1990; Santos et al., 1996). Molecular genetic techniques have overcome these 
difficulties and today a number of host strains and transformation vectors are available and 
efficient gene-disruption protocols have been developed (Fonzi and Irwin, 1993; 
Morschhäuser et al., 1999; Wilson et al., 1999). New molecular methods to study gene 
functions in C.albicans have been designed (Theiss et al., 2002; Michel et al., 2002; Gerami-
Nejad et al., 2001; De Backer et al., 2001). Antibody based strategy has been employed to 
identify genes expressed during infection (Cheng et al., 2003). Reporter genes encoding ß-
galactosidase, luciferase, and green fluorescent protein (GFP) are available (Srikantha et al., 
1996; Cormack et al., 1997; Morschhäuser et al., 1998; Uhl and Johnson, 2001). The 
C.albicans genome sequence is currently completed at Stanford University (http://www-
sequence.stanford.edu/group/candida/), heralding new challenges in proteomic research and 
functional analysis of the gene products.  
Rapid advances of many basic biological processes in C.albicans have been made as a 
result of their similarity to well studied processes in Saccharomyces cerevisiae, which 
diverged from C.albicans many years ago. There is hope that recently developed techniques 
of manipulating C.albicans and the sequencing of its genome will lead to a thorough 
understanding of the virulence and biology of this fungal pathogen, thus offering the 
possibility of a knowledge-based approach to developing novel antifungal agents. 
 
 
2.2. Virulence determinants of C.albicans 
C.albicans needs to use several attributes which are potential pathogenicity factors to 
establish pathogenesis in the host. These include cell surface composition and phenotypic 
switching which is accompanied by changes in antigen expression, enzyme production, 
dimorphism, colony morphology, and tissue affinities (Calderone and Fonzi, 2001). 
C.albicans virulence is a function of multiple factors working jointly to overcome the host 
defence systems. A lack or debility in any of these factors will negatively affect its infectivity 
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and make it difficult for Candida to establish itself, particularly in a healthy individual 
(Ghannoum and Abu-Elteen, 1990). 
 
Lytic enzymes 
Like many other pathogenic organisms, C.albicans secretes extracellular enzymes 
such as hydrolases with relative broad specificities, including proteinases, phospholipases, 
lipases, and an acid phosphomonoesterase. These are involved in fungal invasion and 
destruction of host tissue. 
Phospholipases play a significant role in damaging cell membranes and invading host 
cells. High phospholipase production is correlated with an increased adherence and a higher 
mortality rate in animal models (Mayser et al., 1996). The secreted aspartyl proteinases are 
thought to contribute to virulence through their effects on adherence, invasion, and 
pathogenicity. So far, ten distinct SAP genes (SAP1 to SAP10) have been identified and recent 
studies by Hube, Sanglard and colleagues implicated the involvement of Sap proteins in 
virulence (Hube et al., 1997; Sanglard et al., 1997). 
 
Adherence 
            The C.albicans cell surface possesses several ligands, such as receptors for C3d, iC3b, 
fibrinogen, laminin, fibronectin, or fucose, that bind specifically and selectively to host 
components. The surface adhesins of C.albicans can either bind to the host Arg-Gly-Asp 
(RGD) sequences or to the sugar moiety of host membrane glycoproteins. Important adhesins 
reported from C.albicans are Als1p, Ala1p/Als5p and Hwp1p which are members of a class 
of proteins termed as glycosylphosphatidylinositol-dependent cell wall proteins (GPI-CWP). 
Another protein, Int1p, not belonging to this class is also involved in adhesion (Sundstrom, 
2002).  
 
 Dimorphism in Candida albicans 
One of the most remarkable aspects of C.albicans biology is its ability to assume a 
variety of cell morphologies. It is almost universally described as ‘dimorphic’, yet its cell 
morphology actually lies on a pleomorphic continuum from ovoid yeast cells to filamentous 
hyphae. Thus, the various cell morphologies exhibited in the organism range from yeast-like 
cells to a plethora of elongated growth forms, including a thread-like hyphal growth form, 
germ tubes and pseudohyphae, which vary in shape from attached strings of yeast-like cells to 
long filaments (Fig. 1) (Corner and Magee, 1997). The elongation of buds in pseudohyphae 
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can be so extreme that these filaments can superficially resemble hyphae. Because of this, it is 
often useful to refer pseudohyphae and hyphae collectively and the term ‘filamentous form’ 
has been used further here for this purpose. Another morphological form is the 
chlamydospore, which is thick-walled, relatively large round structure with condensed 
cytoplasm. It is considered a resistance form and is believed to be produced generally under 
unfavorable environmental conditions for the fungus (Odds, 1988). 
 
 
 
       A.                                            B.                                            C. 
 
 
 
 
 
 
Fig. 1. Scanning electron micrographs of different morphologies of Candida albicans. A.Yeast B. 
Pseudohyphae. C. Hyphae (adapted from Odds, 1988). 
 
 
Under in vitro conditions, the yeast or blastospore form is readily obtained following 
growth on most solid or liquid media. The transition into the hyphal (including pseudohyphal) 
form can occur under the influence of a variety of environmental factors such as changes in 
media composition, addition of serum, N-acetyl glucosamine (GlcNAc), or proline, growth 
under CO2 or semi-anaerobic conditions, or even a shift from acidic to neutral pH. With 
regard to morphogenesis, there is a long history of attempts to prove a relationship between 
the filamentous form of C.albicans and virulence (Odds, 1988). The ability to switch to 
filamentous growth has been shown to be important for virulence of C.albicans (Lo et al., 
1997; Saville et al., 2003; Zheng and Wang, 2004). As emphasized by numerous 
investigators, most lesions are populated by both morphological forms, suggesting that both 
have a role in the development and progression of the disease. The filamentous form may be 
required to evade the cells of the immune system, whereas the yeast form may be the mode of 
dissemination in the bloodstream. The filamentous forms might also be important for the 
colonization of organs, such as the kidney. The characterization of a filamentous state in the 
baker’s yeast S.cerevisiae has made it possible to use this as a model to compare regulation of 
filamentation in C.albicans and S.cerevisiae (Gimeno et al., 1992).  
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Signaling pathways and regulators involved in dimorphism of C.albicans 
Recent studies indicate that C.albicans uses a common set of conserved pathways to 
regulate dimorphism, mating and phenotypic switching. Major pathways known to regulate 
dimorphism include a MAP Kinase pathway via Cph1p and the cAMP-dependent protein 
kinase pathway through Efg1p (Fig. 2). Dimorphism of C.albicans is also under the control of 
Tup1p-mediated repression through Rfg1p and Nrg1p (Braun and Johnson, 1997; Braun et 
al., 2001; Murad et al., 2001a and b; Khalaf and Zitomer, 2001; Kadosh and Johnson, 2001). 
In addition, a pH response is mediated by a pathway that activates the Rim101p transcription 
factor (Porta et al., 1999; Ramon et al., 1999; Davis et al., 2000; El Barkani et al., 2000) and 
a response to embedding in a solid matrix is mediated by a pathway that activates the Czf1p 
transcription factor (Brown et al., 1999). A high proportion of the genes controlled by these 
signaling pathways contribute directly or indirectly to pathogenesis and virulence of 
C.albicans, therefore, virulence genes are co-regulated with cell morphogenesis (Liu, 2002). 
 
a) MAP Kinase Pathway 
            A mitogen-activated protein kinase (MAPK) pathway is involved in filamentation in 
C.albicans. The cascade consists of the kinases Cst20p (homologous to the p21-activated 
kinase [PAK] kinase Ste20p), CaSte7p/Hst7p (homologous to the MAP kinase kinase Ste7p), 
and Cek1p (homologous to the Fus3p and Kss1p MAP kinases) (Clark et al., 1995; Köhler 
and Fink, 1996; Leberer et al., 1996; Singh et al., 1997; Whiteway et al., 1992). A 
transcription factor, Cph1p, which is homologous to Ste12p that regulates mating and 
pseudohyphal growth in S.cerevisiae, has been identified (Liu et al., 1994). Null mutations in 
any of the genes in the MAP kinase cascade (Cst20p, Hst7p, or Cek1p) or the transcription 
factor Cph1p confer a hyphal defect on solid medium in response to many inducing 
conditions; however, all of these mutants filament normally in response to serum (Csank et 
al., 1998; Köhler and Fink, 1996; Leberer et al., 1996). 
In addition to these components, a MAP kinase phosphatase, Cpp1p, has been 
identified which regulates filamentous growth in C.albicans (Csank et al., 1997). Disruption 
of both alleles of the CPP1 gene derepresses hyphal production and results in a 
hyperfilamentous phenotype. This hyperfilamentation is suppressed by deletion of the MAP 
kinase CEK1 (Csank et al., 1997). The cpp1 mutant strains are also reduced for virulence in 
both systemic and localized models of candidiasis (Csank et al., 1997; Guhad et al., 1998a). 
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Fig.  2. Regulation of dimorphism in C.albicans by multiple signaling pathways (adapted from Liu, 2001). 
 
 
 
b) cAMP-PKA Pathway  
The cAMP-dependent protein kinase A (PKA) pathway plays a very important role in 
filamentation in S.cerevisiae, C.albicans and other fungi (Sonneborn et al., 2000). In 
C.albicans, an increase in cAMP level accompanies the yeast to hyphal transition, and 
inhibition of the cAMP phosphodiesterase induces this transition (Sabie and Gadd, 1992).  
Genes similar to GPA2, encoding a small G-protein, and GPR1, coding for a G-protein 
coupled receptor have been reported to regulate morphogenesis and hypha formation in 
C.albicans and they act upstream of the cAMP signaling pathway (Miwa et al., 2004), but 
GPA2 also has been shown to act upstream of the MAP kinase pathway (Sanchez-Martinez 
and Perez-Martin, 2002). C.albicans has a single gene homologous to the S.cerevisiae 
adenylate cyclase gene (CDC35/CYR1). The cyclase is not essential for growth in C.albicans, 
but is required for hyphal development (Rocha et al., 2001). Recently, the adenylate cyclase 
associated protein (CAP1) has been identified and disrupted (Bahn and Sundstrom, 2001). An 
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increase in cytoplasmic cAMP is seen to precede germ tube emergence in wild-type strains, 
but not in cap1 mutants. The cap1 mutant is defective in germ tube formation and hyphal 
development, the defects being suppressible by exogenous cAMP or dibuturyl cAMP. The 
cap1 strains are avirulent in a mouse model for systemic candidosis. 
               A single Ras (small G-protein) homolog, Ras1p, has been identified in C.albicans, 
which is not essential for survival (Feng et al., 1999). The ras1 mutant strains have a severe 
defect in hyphal growth in response to serum and other conditions (Feng et al., 1999). In 
addition, while a dominant negative Ras1 mutation (Ras1G16A) caused a defect in 
filamentation, a dominant active Ras1 mutation (Ras1G13V) enhanced the formation of hyphae 
(Feng et al., 1999). The in vitro defects in morphological transition were reversed by either 
supplementing the growth media with cAMP or over expressing components of the filament 
inducing MAP Kinase cascade, demonstrating that it functions upstream of both the cyclic 
AMP as well as the MAP Kinase pathway (Leberer et al., 2001). The Ras1 protein is likely to 
activate the two protein kinase A (PKA) isoforms, Tpk1p and Tpk2p of the cAMP pathway 
through activation of the adenylate cyclase (Bockmühl et al., 2001; Cloutier et al., 2003). 
Efg1p, a basic helix-loop-helix (bHLH) protein functions at downstream of the PKAs. Under 
standard induction conditions, using serum or GlcNAc as inducers in liquid or on solid media, 
there is a complete block of hyphal formation in efg1 null mutants (Lo et al., 1997; Stoldt et 
al., 1997). Contrastingly, under microaerophilic or embedded conditions hyphal formation is 
not defective at all in homozygous efg1 mutants, but rather appears stimulated (Giusani et al., 
2002). These results indicate that depending on environmental cues (and depending on the 
genetic background) Efg1p has a dual role as a transcriptional activator and repressor, whose 
balanced activity is essential for yeast, pseudohyphal and hyphal morphogenesis of 
C.albicans. Strains with mutations in both Cph1p and Efg1p are defective in filament 
formation in most of the filament inducing mediums and are avirulent in mouse model of 
infection (Lo et al., 1997). Recent studies have shown the involvement of EFG1 in normal 
biofilm formation (Ramage et al., 2002). Studies by Sohn et al. (2003) revealed that this 
transcription factor is a major regulator of cell wall dynamics in C.albicans.  
            Apart from these two major signal transduction pathways, other genes like TEC1 or 
CPH2 have also been found to regulate hyphal development in C.albicans (Schweizer et al., 
2000, Lane et al., 2001b). The tec1 mutants exhibit suppressed filamentation in liquid serum-
containing media and the EFG1 overexpression does not suppress the morphological defect of 
the tec1 mutant, whereas TEC1 overexpression has a partial phenotype in the efg1 mutant 
(Schweizer et al., 2000). These results, coupled with the fact that the efg1 strains have a more 
  Introduction 
 
 13
severe defect in hyphal development than do tec1 strains, suggest that TEC1 is one of the 
downstream effectors of Efg1p. The function of Cph2p in hyphal transcription is mediated, in 
part, through Tec1p (Lane et al., 2001b). 
                 A picture of the complex regulatory network that controls morphogenetic switch of 
C.albicans is emerging but a major challenge is to determine how this organism senses the 
environmental factors that induce yeast cells to form hyphae and pseudohyphae. 
 
Other factors involved in virulence 
                  Several other factors are known to influence the virulence of C.albicans though 
the mechanisms involved are still not clear. C.albicans is capable of undergoing a different 
type of morphological change that has been termed as “phenotypic switching”. A simpler, 
biphasic ‘white-opaque’ switching system, found in C.albicans strain WO-1, involves a 
switch between white, domed colonies that contain typical yeast cells and opaque, flat 
colonies that contain characteristically oblong cells. White and opaque cultures have different 
virulence properties (Soll, 1992). Stage specific gene expression of C.albicans in human 
blood showed that differentially expressed genes included those that are involved in the 
general stress response, antioxidative response, glyoxalate cycle as well as putative virulence 
attributes (Fradin et al., 2003). 
             Among the different virulence properties of this fungus, the morphological 
conversion from yeast to filamentous growth forms are of particular interest because these 
morphological spectra are thought to be required for adaptation in warm-blooded hosts, rapid 
colonization of tissues and spread of infection. Numerous conditions promote yeast-hypha 
morphogenesis in vitro. However, the exact nature of many morphogenetic signals is poorly 
understood, particularly how the fungus senses nutrient starvation, e.g. nitrogen starvation. 
 
 
2.3. Nitrogen regulation: Role in virulence and dimorphism 
It is essential that microorganisms sense the nutrients available in the surroundings and 
respond rapidly to changes of the nutritional status. Therefore, the cells must be able to 
perceive how much of each required nutrient is available in its immediate surroundings 
(sensing), transmit this information to the nucleus (signaling) and switch specific sets of genes 
on or off (transcription) to initiate cellular programs to respond to the specific conditions. 
Nitrogen (N) plays a critical role in microorganism biochemistry, being needed for the 
synthesis of many compounds, including amino acids, purines, pyrimidines, some 
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carbohydrates and lipids, enzyme co-factors and proteins, all of which are essential for growth 
processes. Many microorganisms have the ability to use a variety of nitrogen-containing 
compounds as the sole source of all cellular nitrogen. Certain nitrogenous compounds (e.g. 
ammonia, glutamine and glutamate) are preferentially used by the fungi and are considered as 
a good nitrogen sources. However, when these nitrogen sources are not available or are 
present at concentrations low enough to limit growth, many different nitrogen sources can be 
used, e.g., nitrate, nitrite, purines, amides, most amino acids and proteins. This ability of an 
organism to use any compound as nitrogen source requires permeases for the transport of 
these compounds into the cell and enzymes for the generation of ammonia by their 
metabolism. Once inside the cell, ammonia in the presence of the NADP-linked enzyme 
glutamate dehydrogenase, can react with α-ketoglutarate, provided by the metabolism of the 
carbon source of the growth medium, to produce glutamate. Glutamine synthetase catalyzes 
the incorporation of ammonium into glutamate to form glutamine. Glutamate and glutamine 
serve as the source of cellular nitrogen (Magasanik, 1992). Utilization of any of the secondary 
nitrogen sources is highly regulated and nearly always requires the synthesis of a set of  
pathway specific catabolic enzymes and permeases which are otherwise repressed in the 
presence of good nitrogen sources (nitrogen catabolite repression). Nitrogen regulation is 
controlled by global positive and negative transcription factors, as well as pathway specific 
transcription factors (Coffman et al., 1997; Marzluf, 1997). The global factors are members of 
the GATA family of transcription factors, the name reflecting the core DNA sequence 
recognized by the defining zinc-finger domain (Teakle and Gilmartin, 1998). The principal 
transcriptional activator is highly conserved amongst fungi and typified by the AREA protein 
of Aspergillus spp., NIT-2 of Neurospora crassa and, the dual factors encoded by GLN3 and 
GAT1 of S.cerevisiae (Marzluf, 1997). In the absence of, or limitation of, a primary nitrogen 
sources like ammonium, these factors activate expression of genes involved in secondary 
nitrogen metabolism either alone or in conjunction with pathway specific factors (Marzluf, 
1997). Evidence of nitrogen catabolite repression in the opportunistic fungal pathogen 
Candida albicans includes the observations that ammonium inhibits expression of peptide 
transportes (Payne et al., 1991; Basrai et al., 1992), induction of proline uptake (Holmes and 
Shepherd, 1987) and expression of secreted aspartyl proteinase (Ross et al., 1990; Banerjee et 
al., 1991; Hube et al., 1994; White and Agabian, 1995).  
Nutritional limitation of various types, particularly nitrogen deprivation appears to 
have a link to pathogenesis and other morphological switches. For instance, haploid MATα 
cells of Cryptococcus neoformans, which typically grow as yeast, will develop fruiting bodies 
  Introduction 
 
 15
and hyphae in response to nitrogen deficiency and the fruiting bodies form haploid 
basidiospores, which are suspected to be the infectious propagule (Wickes et al., 1996). 
Virulence of Aspergillus fumigatus is dependent upon its ability to respond to nitrogen 
limitation in vivo (Hensel et al., 1998). Nitrogen starvation signals the development of rice 
blast disease symptoms by Magnaporthe grisea (Talbot et al., 1997). Recently Limjindaporn 
et al. (2003) have shown that mutation in the zinc-finger containing transcriptional activator 
GAT1, which control nitrogen catabolite repression of several genes, causes the attenuation of 
virulence in a murine model of disseminated candidiasis. This indicates a significant role of 
nitrogen regulation in the infectious process of C.albicans. Thus, it seems possible that loss of 
a major nitrogen regulatory factor will significantly reduce the virulence of plant or animal 
pathogenic fungi.  
 
2.3.1. Ammonium permeases and nitrogen starvation induced dimorphism of yeast 
 Severe nitrogen starvation induces diploid S.cerevisiae yeast cells to differentiate into 
a filamentous, pseudohyphal growth form, which may enable these non-motile organisms to 
seek a preferable environment (Gimeno et al., 1992). Moreover, the yeast to pseudohyphal 
transition of S.cerevisiae is under nitrogen catabolite repression (Gimeno et al., 1992; Lorenz 
and Heitman, 1998a, b) and for the nitrogen repression a good nitrogen source like 
ammonium has to be transported inside the cell. Multiple transport systems with different 
kinetic properties and regulation are often present to transport molecules into the cells and 
enable the cells to grow in different environmental conditions. The first evidence that specific 
ammonium transport system acts in fungi came from the work of Hackette et al. (1970) in 
Penicillium chrysogenum. The genes involved in ammonium transport were cloned from yeast 
(Marini et al., 1994), Arabidopsis (Ninnemann et al., 1994), bacteria (Thomas et al., 2000), 
fungi (Monahan et al., 2002a, b; Montanini et al., 2002; Javelle et al., 2003a, b; Smith et al., 
2003) and homologues have been found in humans (Marini et al., 2000a). All members in the 
MEP/AMT family are membrane proteins with an extracytosolic amino terminus and a central 
hydrophobic core of 10-12 transmembrane helices (Thomas et al., 2000; Javelle et al., 
2003b). In S.cerevisiae ammonium uptake is well characterized and possibly involves at least 
3 ammonium permeases named as Mep1p, Mep2p and Mep3p. Mep2p displays highest 
affinity for ammonium (Km 1-2 µM), followed closely by Mep1p (Km 5-10 µM), and finally 
Mep3p, whose affinity is much lower (Km ~1.4-2.1 mM) (Marini et al., 1997). The MEP 
genes are subject to nitrogen control and on poor nitrogen sources MEP2 expression is much 
higher than MEP1 or MEP3 expression (Marini et al., 1997). A mutant strain lacking all three 
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Mep proteins can not grow on media containing less than 5 mM ammonium as the sole 
nitrogen source, while the presence of individual ammonium transporters enables growth on 
these media. Growth on media containing higher than 20 mM ammonium does not require 
any of these permeases (Marini et al., 1997). The Mep transporters are also required to retain 
ammonium inside the cells during growth on some nitrogen sources other than ammonium 
(Marini et al., 1997). Among the three Mep proteins, the Mep2p, but not Mep1p or Mep3p, 
has been proposed to act as an ammonium sensor that generates a signal to induce filamentous 
growth of S.cerevisiae in low ammonium conditions (Lorenz and Heitman, 1998a). However, 
how ammonium is sensed by Mep2p and how this signal is transduced to activate 
pseudohyphal growth has not been resolved. The pseudohyphal growth defect of ∆mep2 
mutants of S.cerevisiae was not suppressed when the MAP kinase cascade was activated by 
the dominant STE11-4 allele, but it was suppressed by activated alleles of GPA2 or RAS2 or 
by exogenous cAMP, indicating that Mep2p signals through the cAMP pathway to induce 
pseudohyphal growth under low ammonium conditions (Lorenz and Heitman, 1998a). 
Recently it has also been shown that one of the MEP homologs from the plant pathogenic 
fungus Ustilago maydis is required for triggering filamentous growth on low nitrogen medium 
(Smith et al., 2003). Moreover, this gene can complement the pseudohyphal growth defect of 
the mep2 mutant in S.cerevisiae (Smith et al., 2003).  
Nitrogen starvation induces filamentous growth also in the yeast Candida albicans 
(Csank et al., 1998) and recent work has implicated GCN4, which regulates the general amino 
acid starvation response, and CSH3 which is specifically required for proper uptake and 
sensing extracellular amino acids, in the regulation of dimorphism (Tripathi et al., 2002; 
Martinez and Ljungdahl, 2003) of this pathogen. The potential importance of nitrogen 
regulation and ammonium transporters, in dimorphism of C.albicans is of particular interest 
to understand the molecular basis of one of the virulence determinants of this pathogenic 
fungus.  
 
 
 
2.4. An approach towards anti-candida drug development 
               C.albicans is eukaryote and therefore shares many biological processes with 
humans. Most of the antifungal drugs used to control Candida infections have deleterious side 
effects and at the doses used, are fungistatic rather than fungicidal. Moreover, the use of these 
drugs has resulted in resistant C.albicans strains and limits the use of these agents. So, it is an 
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important goal of C.albicans research to identify appropriate targets for antifungal 
technologies. Understanding virulence properties of this opportunist may lead to the 
development of therapies that will prevent or treat candidiasis in susceptible patients. On the 
other hand, completion of the genome sequencing of this pathogen allows the identification of 
all the potential antifungal targets in a genome, that is, all the gene products whose 
inactivation would lead to growth arrest, and optimally, fungal death. On this basis, rational 
approaches can be developed to search for new antifungal compounds that inhibit the function 
of these gene products and have a fungistatic or fungicidal effect. Target prioritization is 
nevertheless needed for optimal drug development and can rely on several criteria including 
conservation among other pathogenic fungi and significant divergence in higher eukaryotes, 
fungicidality and availability of a gene expression or proteomic signature upon target 
depletion as well as biochemical criteria (Black and Hare, 2000). 
 A category of targets that has attracted interest is virulence factors, as their 
inactivation is likely to block the progression of disease before the return to normal 
immunological status. But the studies, aimed at characterizing the virulence proteins suggest 
that virulence does not depend upon a single molecular determinant. It has therefore become 
evident that the search for new antifungal targets must take into account those genes that are 
essential both in vitro and in vivo. The term ´essential genes` refers most frequently to those 
genes necessary for microbial growth on rich medium. Various technologies to study essential 
genes in C.albicans have been developed in recent years which include post transcriptional 
gene silencing by antisense RNA (De Backer et al., 2001), conditional gene expression by 
deleting one allele of the target gene and placing the second copy under the control of a 
regulatable promoter (Care et al., 1999; Backen et al., 2000; Nakayama et al., 2000) and an 
approach of making conditional lethal null mutants based on inducible deletion of essential 
genes by FLP-mediated excision from the genome (Michel et al., 2002). These approaches 
should enable researchers to identify and characterize essential genes of this opportunistic 
pathogen, which is the subject of intense research efforts in both academia and industry. 
Moreover, conditional expression of an essential gene allows the design of high-throughput 
screens for candidate drug identification and target validation. From a more academic 
viewpoint, several essential genes identified are of unknown function and their 
characterization will represent an interesting source of knowledge on the biology of fungi. 
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2.5. Aim of the study 
The yeast Candida albicans, the most important human pathogenic fungus, serves as a 
model organism for studying fungal virulence. The virulence of this pathogen is associated 
with the ability to switch between the yeast and hyphal morphologies and nutrient starvation 
acts as an inducer for this switch. To understand the virulence properties of C.albicans, the 
nitrogen starvation induced filament formation and the role of ammonium and ammonium 
permeases in this transition were analyzed. Moreover, in an attempt to identify a candidate 
gene for antifungal drug development some genes were also characterized to analyze the 
essentiality of those genes in this pathogen. To select the putative essential genes knowledge 
of functional genomics of S.cerevisiae was used and RAP1 (Repressor/Activator protein1), 
CBF1 (Centromere Binding Factor1) and YIL19 were chosen based on their essential function 
in S.cerevisiae or in other yeasts, conservation among other pathogenic fungi and absence of 
their highly similar homologs in higher eukaryotes. Those genes were functionally 
characterized in C.albicans to select an essential gene for antifungal drug design. 
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3.  Materials and Methods 
 
3.1. Bacteria strain used 
Escherichia coli K12 : E.coli strain DH5α (F-, endA1, hsdR17 [rk-, mk-], supE44, thi-1, 
recA1, gyrA96, relA1, ∆[argF-lac]U169, λ-, ф80dlacZ∆M15) was used for cloning 
experiments. 
 
 
3.2. Plasmids used in this study 
 
Cloning vector used in this study was pBluescript KS II (Stratagene, Heidelberg, Germany). 
 
 
Table 1. 
 
Plasmid                                      Relevant insert                                                       Reference 
 
For CaMEP1 and CaMEP2 deletion  
pMEP1M1               [5´YMR211-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´MEP1]-Fragment         This study                     
                           
pMEP1M2               [5´MEP1-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´MEP1]-Fragment             This study                       
                           
pMEP1M3               [5´MEP1-ACT1T-URA3-3´ACT1]-Fragment                                                        This study 
              
pMEP1M4               [5´MEP1-ACT1T-URA3-3´MEP1]-Fragment                                                        This study 
 
pMEP2M1               [5´MEP2-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´CBF1]-Fragment              This study 
                            
pMEP2M2               [5´MEP2-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´MEP2]-Fragment             This study 
                            
pMEP2M3               [5´CBF1-ACT1T-URA3-3´MEP2]-Fragment                                                        This study 
 
pMEP2M4               [5´MEP2-ACT1T-URA3-3´MEP2]-Fragment                                                       This study  
 
Plasmids containing lacZ reporter gene fusions 
 
pAU36                      Streptococcus thermophilus lacZ                                                                        (Uhl and  
                                                                                                                                                       Johnson, 2001)                                   
pLACZ2                   [lacZ]-Fragment                                                                                                 This study  
  
pLACZ3                   [lacZ-ACT1T]-Fragment                                                                                      This study 
 
pLACZ4                   [ACT1P-lacZ-ACT1T]-Fragment                                                                         This study  
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Plasmid                                      Relevant insert                                                       Reference 
 
pMEP1LACZ2         [MEP2P-lacZ-ACT1T-URA3-3´MEP1]-Fragment                                               This study 
 
pMEP1LACZ3         [MEP1P-lacZ-ACT1T-URA3-3´MEP1]-Fragment                                               This study 
 
pMEP2LACZ1         [MEP2P-lacZ]-Fragment                                                                                      This study 
 
pMEP2LACZ2         [MEP2P-lacZ-ACT1T-URA3-3´MEP2]-Fragment                                               This study 
 
CaMEP1 and CaMEP2 under different promoters 
 
pMEP1K1                 [MEP1P-MEP1-ACT1T-URA3-3´MEP1]-Fragment                                           This study 
 
pMEP1K2                 [MEP2P-MEP1-ACT1T-URA3-3´MEP2]-Fragment                                           This study 
 
pMEP1E2                 [ADH1P-MEP1-ACT1T-URA3-3´ADH1]-Fragment                                           This study 
 
pMEP2K1                 [MEP2P-MEP2-ACT1T-URA3-3´MEP2]-Fragment                                          This study 
 
pMEP2K2                 [MEP1P-MEP2-ACT1T-URA3-3´MEP1]-Fragment                                          This study 
 
pMEP2E2                 [ADH1P-MEP2-ACT1T-URA3-3´ADH1]-Fragment                                          This study 
 
pYPR127E2             [ADH1P-YPR127-ACT1T-URA3-3´ADH1]-Fragment                                       (Kusch et al., 
                                                                                                                                                                 2004) 
GFP-tagged CaMEP1 and CaMEP2 genes 
 
pADH1G2               [ADH1P-GFP-ACT1T-URA3-3´ADH1]-Fragment                                            (Kusch et al., 
                                                                                                                                                                 2004) 
pOP4G1                   [OP4P-OP4-GFP-ACT1T-URA3-3´OP4]-Fragment                                         (Park YN,   
                                         unpublished) 
pMEP1G1                [MEP1P-MEP1-GFP-ACT1T-URA3-3´MEP1]-Fragment                                  This study 
 
pMEP1G2                [MEP2P-MEP1-GFP-ACT1T-URA3-3´MEP2]-Fragment                                  This study 
 
pMEP1G3                [ADH1P-MEP1-GFP-ACT1T-URA3-3´ADH1]-Fragment                                  This study 
 
pMEP2G1       [MEP2P-MEP2-GFP-ACT1T-URA3-3´OP4]-Fragment                                     This study 
 
pMEP2G2                [MEP2P-MEP2-GFP-ACT1T-URA3-3´MEP2]-Fragment                                  This study 
 
pMEP2G4                [ADH1P-MEP2-GFP-ACT1T-URA3-3´ADH1]-Fragment                                  This study 
 
pMEP2G5                [MEP1P-MEP2-GFP-ACT1T-URA3-3´MEP1]-Fragment                                  This study 
 
Truncation of CaMEP1 and CaMEP2 genes 
 
pMEP1∆C1              [MEP1P-MEP1∆C404-ACT1T-URA3-3´MEP1]-Fragment                                  This study 
 
pMEP1∆C2              [MEP1P-MEP1∆C438-ACT1T-URA3-3´MEP1]-Fragment                                  This study 
 
pMEP2∆C1              [MEP2P-MEP2∆C406-ACT1T-URA3-3´MEP2]-Fragment                                  This study 
 
pMEP2∆C2              [MEP2P-MEP2∆C440-ACT1T-URA3-3´MEP2]-Fragment                                  This study 
 
pMEP2∆C3              [MEP2P-MEP2∆C423-ACT1T-URA3-3´MEP2]-Fragment                                  This study 
 
pMEP2∆C4              [MEP2P-MEP2∆C413-ACT1T-URA3-3´MEP2]-Fragment                                  This study 
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MEP Hybrids 
 
pMEP12H2              [MEP1P-MEP11-416-MEP2419-480-ACT1T-URA3-3´MEP1]-Fragment                   This study 
 
pMEP12H3              [MEP2P-MEP11-416-MEP2419-480-ACT1T-URA3-3´MEP2]-Fragment                   This study 
                              
pMEP12H4              [MEP2P-MEP11-416-MEP2419-440-ACT1T-URA3-3´MEP2]-Fragment                   This study 
                              
pMEP21H2              [MEP2P-MEP21-418-MEP1417-534-ACT1T-URA3-3´MEP2]-Fragment                   This study 
 
Dominant active RAS1G13V and GPA2Q354L alleles 
 
pGFP31                    [ACT1P-GFP-ACT1T-URA3-3´ACT1]-Fragment                                          (Morschhäuser 
                                                                                                                                                                et al., 1998) 
pGPA2       [5´CBF1-GPA2Q354L-URA3-FRT-3´ACT1]-Fragment                                           This study 
 
pRAS1E1                 [ACT1P-RAS1G13V-ACT1T-URA3-3´ACT1]-Fragment                                          This study 
 
pGPA2E1                 [ACT1P-GPA2Q354L-ACT1T-URA3-3´ACT1]-Fragment                                       This study  
 
For CaRAP1 deletion and complementation 
  
pRAP1M1                [5´YMR211-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´RAP1]-Fragment            This study 
pRAP1M2                [5´RAP1-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´RAP1]-Fragment                 This study 
pRAP1M3                [5´CBF1-ACT1T-URA3-3´RAP1]-Fragment                                                          This study 
pRAP1M4                [5´RAP1-ACT1T-URA3-3´RAP1]-Fragment                                                          This study 
pRAP1K1                 [RAP1P-RAP1-ACT1T-URA3-3´RAP1]-Fragment                                                This study 
pRSRAP1a                [RAP1P-RAP1-ACT1T]-Fragment           This study 
For the analysis of CaCBF1 
pCBF1M1                [5´YMR211-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´CBF1]-Fragment           This study 
pCBF1M2                [5´CBF1-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´CBF1]-Fragment               This study 
pCBF1M3                [5´CBF1-ACT1T-URA3-3´ACT1]-Fragment                                                         This study 
pCBF1M4                [5´CBF1-ACT1T-URA3-3´CBF1]-Fragment                                                         This study 
pCBF1K1                 [CBF1P-CBF1-ACT1T-URA3-3´CBF1]-Fragment                                               This study 
pADE2M1                [5´ADE2-ACT1T-URA3-3´CBF1]-Fragment                                                        This study 
pADE2M2                [5´ADE2-ACT1T-URA3-3´ADE2]- Fragment                                                      This study 
For the deletion of YIL19 
pYIL19M1               [5´YIL19-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´MEP1]-Fragment             This study 
pYIL19M2               [5´YIL19-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´YIL19]-Fragment             This study 
pYIL19                     [YIL19P-YIL19-3´YIL19]-Fragment                                                                    This study 
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pAFI3                       [ACT1P-FRT-MPAR-FRT-3´ACT1]-Fragment                                                     (Staib et al., 
                                                                                                                                                                       1999) 
pYIL19D1                [ACT1P-FRT-YIL19P-YIL19-3´YIL19-MPAR-FRT-3´ACT1]-Fragment                This study 
pSFL213                   [SAP2-1P-ecaFLP-ACT1T-URA3-3´SAP2]-Fragment                                         (Staib et al., 
                                                                                                                                                         2000). 
pSFL28                     [5´SAP2-URA3-3´SAP2]-Fragment                                                                      (Staib et al., 
                                                                                                                                                                      1999). 
Details of plasmid constructions are described in section A.1. 
a Vector backbone in this plasmid is S.cerevisiae 2µ plasmid pRS426. 
 
 
3.3. C.albicans strains used in this study 
 
 
Table 2. 
 
Strain                  Parent                            Genotypea                                            Reference
 
SC5314                                                                Wild type strain                                                  (Gillum et al., 
                                                                                                                                                                   1984) 
CAI4                           SC5314                 ∆ura3::imm434/∆ura3::imm434                               (Fonzi and Irwin., 
                                                                                                                                                                   1993) 
∆mep1 mutants and reintegrants 
 
MEP1M1A                 CAI4                     ∆mep1-1::URA3-FLIPb/MEP1-2                                       This study 
 
MEP1M1B                 CAI4                    MEP1-1/∆mep1-2::URA3-FLIP                                         This study 
 
MEP1M2A               MEP1M1A            ∆mep1-1::FRT/MEP1-2                                                     This study 
 
MEP1M2B               MEP1M1B            MEP1-1/∆mep1-2::FRT                                                      This study 
 
MEP1M3A               MEP1M2A           ∆mep1-1::FRT/∆mep1-2::URA3-FLIP                                This study 
 
MEP1M3B               MEP1M2B           ∆mep1-1::URA3-FLIP/∆mep1-2::FRT                                This study 
 
MEP1M4A               MEP1M3A          ∆mep1-1::FRT/∆mep1-2::FRT                                             This study 
 
MEP1M4B               MEP1M3B          ∆mep1-1::FRT/∆mep1-2::FRT                                             This study 
 
MEP1M5A               MEP1M4A         ∆mep1-1::FRT/∆mep1-2::URA3                                           This study 
 
MEP1M5B               MEP1M4B         ∆mep1-1::URA3/∆mep1-2::FRT                                           This study 
 
MEP1MK1A            MEP1M4A         ∆mep1-1::FRT/∆mep1-2::MEP1-URA3                               This study 
 
MEP1MK1B            MEP1M4B         ∆mep1-1::MEP1-URA3/∆mep1-2::FRT                               This study 
 
∆mep2 mutants and reintegrants 
 
MEP2M1A                    CAI4              ∆mep2-1::URA3-FLIP/MEP2-2                                          This study 
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MEP2M1B                    CAI4               MEP2-1/∆mep2-2::URA3-FLIP                                            This study 
 
MEP2M2A               MEP2M1A         ∆mep2-1::FRT/MEP2-2                                                          This study 
 
MEP2M2B               MEP2M1B          MEP2-1/∆mep2-2::FRT                                                         This study 
 
MEP2M3A               MEP2M2A         ∆mep2-1::FRT/∆mep2-2::URA3-FLIP                                   This study 
 
MEP2M3B               MEP2M2B         ∆mep2-1::URA3-FLIP/∆mep2-2::FRT                                   This study 
 
MEP2M4A               MEP2M3A        ∆mep2-1::FRT/∆mep2-2::FRT                                                This study 
 
MEP2M4B               MEP2M3B         ∆mep2-1::FRT/∆mep2-2::FRT                                               This study 
 
MEP2M5A               MEP2M4A        ∆mep2-1::FRT/∆mep2-2::URA3                                             This study 
 
MEP2M5B               MEP2M4B        ∆mep2-1::URA3/∆mep2-2::FRT                                             This study 
 
MEP2MK1A            MEP2M4A       ∆mep2-1::FRT/∆mep2-2::MEP1-URA3                                  This study 
 
MEP2MK1B            MEP2M4B       ∆mep2-1::MEP1-URA3/∆mep2-2::FRT                                  This study 
 
∆mep1 ∆mep2 mutants and reintegrants 
 
MEP12M1A             MEP2M4A       ∆mep1-1::URA3-FLIP/MEP1-2                                             This study 
             ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M1B             MEP2M4B       MEP1-1/∆mep1-2::URA3-FLIP                                             This study 
                                                          ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M2A             MEP12M1A    ∆mep1-1::FRT/MEP1-2                                                          This study  
                                                          ∆mep2-1::FRT/∆mep2-2::FRT                                                                
 
MEP12M2B             MEP12M1B     MEP1-1/∆mep1-2::FRT                                                         This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M3A             MEP12M2A     ∆mep1-1::FRT/∆mep1-2::URA3-FLIP                                  This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M3B             MEP12M2B     ∆mep1-1::URA3-FLIP/∆mep1-2::FRT                                  This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M4A             MEP12M3A     ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M4B             MEP12M3B     ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M5A             MEP12M4A     ∆mep1-1::FRT/∆mep1-2::URA3                                           This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M5B             MEP12M4B     ∆mep1-1::URA3/∆mep1-2::FRT                                           This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12M6A             MEP12M4A     ∆mep1-1::FRT/∆mep1-2::FRT                                             This study 
                                                           ∆mep2-1::FRT/∆mep2-2::URA3 
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MEP12M6B             MEP12M4B       ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                             ∆mep2-1::URA3/∆mep2-2::FRT 
 
MEP12MK1A          MEP12M4A       ∆mep1-1::FRT/∆mep1-2::MEP1-URA3                                This study 
                                                             ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12MK1B          MEP12M4B       ∆mep1-1::MEP1-URA3/∆mep1-2::FRT                                This study 
                                                             ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12MK2A          MEP12M4A       ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                             ∆mep2-1::FRT/∆mep2-2::MEP2-URA3 
 
MEP12MK2B          MEP12M4B       ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                             ∆mep2-1::MEP2-URA3/∆mep2-2::FRT 
 
Reporter strains expressing lacZ from ACT1, CaMEP1, or CaMEP2 promoter 
  
CALACZ1                  CAI4               ACT1/act1::ACT1P-lacZ-URA3                                           This study 
 
CLACZ1A                  CAI4               ∆mep1-1::MEP1P-lacZ-URA3/MEP1-2                                This study 
 
CLACZ1B                  CAI4               MEP1-1/∆mep1-2::MEP1P-lacZ-URA3                                This study 
 
CLACZ2A                  CAI4               ∆mep2-1::MEP2P-lacZ-URA3/MEP2-2                                This study 
 
CLACZ2B                  CAI4               MEP2-2/∆mep2-2::MEP2P-lacZ -URA3                               This study 
 
Strains expressing CaMEP1 or CaMEP2 from the ADH1, CaMEP1, or CaMEP2 promoter 
 
MEP12ME1A     MEP12M4A        ADH1/adh1::ADH1P-MEP1                                                This study 
 
MEP12ME1B         MEP12M4B        ADH1/adh1::ADH1P-MEP1                                                 This study 
                                                         
MEP12ME2A         MEP12M4A       ADH1/adh1::ADH1P-MEP2                                                 This study 
 
MEP12ME2B     MEP12M4B        ADH1/adh1::ADH1P-MEP2                                                This study 
 
MEP12MK3A         MEP12M4A       ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                            ∆mep2-1::FRT/∆mep2-2::MEP2P-MEP1-URA3 
 
MEP12MK3B         MEP12M4B       ∆mep1-1::FRT/∆mep1-2::FRT                                              This study 
                                                            ∆mep2-1:: MEP2P-MEP1-URA/∆mep2-2::FRT 
 
MEP12MK4A         MEP12M4A       ∆mep1-1::MEP1P-MEP2-URA3/∆mep1-2::FRT                 This study                                  
                                                            ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12MK4B         MEP12M4B       ∆mep1-1::FRT/∆mep1-2:: MEP1P-MEP2-URA3                This study 
                                                            ∆mep2-1::FRT/∆mep2-2::FRT 
  
Strains expressing GFP-tagged MEP genes from the ADH1, CaMEP1, or CaMEP2 promoter in a wild-type 
or ∆mep1 ∆mep2 mutant background 
 
CMEP1EGA              CAI4                 ADH1/adh1::ADH1P-MEP1-GFP-URA3                          This study 
 
CMEP1EGB              CAI4                 ADH1/adh1::ADH1P-MEP1-GFP-URA3                          This study 
 
CMEP2EGA              CAI4                ADH1/adh1::ADH1P-MEP2-GFP-URA3                           This study 
 
CMEP2EGB              CAI4                ADH1/adh1::ADH1P-MEP2-GFP-URA3                           This study 
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CMEP1GA                CAI4                 ∆mep1-1::MEP1-GFP-URA3/MEP1-2                                   This study 
                                                        
CMEP1GB                CAI4                 MEP1-1/∆mep1-2::MEP1-GFP-URA3                                   This study 
                                                           
CMEP2GA                CAI4                ∆mep2-1::MEP2-GFP-URA3/MEP2-2                                    This study 
 
CMEP2GB                CAI4                MEP2-2/∆mep2-2::MEP2-GFP-URA3                                    This study 
 
CMEP2G1A              CAI4                ∆mep1-1::MEP1P-MEP2-GFP-URA3/MEP1-2                      This study 
 
CMEP2G1B              CAI4                MEP1-1/∆mep1-2::MEP1P-MEP2-GFP-URA3                      This study 
 
CMEP1G2A              CAI4                ∆mep2-1::MEP2P-MEP1-GFP-URA3/MEP2-2                      This study 
 
CMEP1G2B              CAI4                MEP2-2/∆mep2-2::MEP2P-MEP1-GFP-URA3                      This study 
 
MEP12MEG1A     MEP12M4A        ADH1/adh1::ADH1P-MEP1-GFP-URA3                               This study 
 
MEP12MEG1B     MEP12M4B        ADH1/adh1::ADH1P-MEP1-GFP-URA3                               This study 
 
MEP12MEG2A     MEP12M4A        ADH1/adh1::ADH1P-MEP2-GFP-URA3                               This study 
                                                      
MEP12MEG2B     MEP12M4B        ADH1/adh1::ADH1P-MEP2-GFP-URA3                               This study 
 
MEP12MG1A       MEP12M4A        ∆mep1-1::FRT/∆mep1-2:: MEP1-GFP-URA3                        This study 
                                                           ∆mep2-1::URA3/∆mep2-2::FRT 
 
MEP12MG1B       MEP12M4B        ∆mep1-1::MEP1-GFP-URA3/∆mep1-2::FRT                         This study 
                                                           ∆mep2-1::URA3/∆mep2-2::FRT 
 
MEP12MG2A       MEP12M4A       ∆mep1-1::FRT/∆mep1-2::FRT                                                 This study 
                                                          ∆mep2-1::MEP2-GFP-URA3/∆mep2-2::FRT 
 
MEP12MG2B         MEP12M4B     ∆mep1-1::FRT/∆mep1-2::FRT                                                 This study 
                                                          ∆mep2-1::FRT/∆mep2-2::MEP2-GFP-URA3 
 
MEP12MG3A         MEP12M4A     ∆mep1-1::FRT/∆mep1-2::FRT                                                 This study 
                                                          ∆mep2-1::MEP2P-MEP1-GFP-URA3/∆mep2-2::FRT 
 
MEP12MG3B         MEP12M4B      ∆mep1-1::FRT/∆mep1-2::FRT                                                This study 
                                                          ∆mep2-1::FRT/∆mep2-2:: MEP2P-MEP1-GFP-URA3 
 
MEP12MG5A         MEP12M4B     ∆mep1-1::FRT/∆mep1-2:: MEP1P-MEP2-GFP-URA3          This study 
                                                          ∆mep2-1::FRT/∆mep2-2::FRT                                                                       
 
MEP12MG5B         MEP12M4A     ∆mep1-1::MEP1P-MEP2-GFP-URA3/∆mep1-2::FRT           This study         
     ∆mep2-1::FRT/∆mep2-2::FRT     
 
Strains expressing truncated or hybrid MEP genes in ∆mep1 ∆mep2 mutant  
 
MEP12MK1A∆C1  MEP12M4A     ∆mep1-1:: MEP1∆C404-URA3/∆mep1-2::FRT                        This study 
                                                          ∆mep2-1::URA3/∆mep2-2::FRT 
 
MEP12MK1B∆C1  MEP12M4B     ∆mep1-1::FRT/∆mep1-2::MEP1∆C404-URA3                          This study 
                                                          ∆mep2-1::URA3/∆mep2-2::FRT 
 
MEP12MK1A∆C2  MEP12M4A     ∆mep1-1::MEP1∆C438-URA3/∆mep1-2::FRT                         This study 
                                                          ∆mep2-1::FRT/∆mep2-2::FRT 
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MEP12MK1B∆C2   MEP12M4B     ∆mep1-1::FRT/∆mep1-2::MEP1∆C438-URA3                               This study 
                                                           ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12MK2A∆C1   MEP12M4A     ∆mep1-1::FRT/∆mep1-2::FRT                                                      This study 
                                                           ∆mep2-1::MEP2∆C406-URA3/∆mep2-2::FRT 
 
MEP12MK2B∆C1   MEP12M4B     ∆mep1-1::FRT/∆mep1-2::FRT                                                      This study 
                                                           ∆mep2-1::FRT/∆mep2-2:: MEP2∆C406-URA3 
 
MEP12MK2A∆C2   MEP12M4A     ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study 
                                                           ∆mep2-1::MEP2∆C440-URA3/∆mep2-2::FRT 
 
MEP12MK2B∆C2   MEP12M4B     ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study 
                                                           ∆mep2-1::FRT/∆mep2-2::MEP2∆C440-URA3 
 
MEP12MK2A∆C3   MEP12M4A     ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study 
                                                           ∆mep2-1::MEP2∆C423-URA3/∆mep2-2::FRT 
 
MEP12MK2B∆C3   MEP12M4B     ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study 
                                                           ∆mep2-1::FRT/∆mep2-2:: MEP2∆C423-URA3 
 
MEP12MK2A∆C4   MEP12M4A    ∆mep1-1::FRT/∆mep1-2::FRT                                                      This study 
                                                          ∆mep2-1::MEP2∆C413-URA3/∆mep2-2::FRT 
 
MEP12MK2B∆C4    MEP12M4B    ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study 
                                                           ∆mep2-1::FRT/∆mep2-2:: MEP2∆C413-URA3 
 
MEP12MK21H2A    MEP12M4B    ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study  
                                                           ∆mep2-1::MEP21-418-MEP1417-534-URA3/∆mep2-2::FRT                                                    
 
MEP12MK21H2B    MEP12M4A    ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study 
                                                           ∆mep2-1::FRT/∆mep2-2:: MEP21-418-MEP1417-534-URA3     
 
MEP12MK12H2A     MEP12M4A    ∆mep1-1::MEP11-416-MEP2419-480 -URA3/∆mep1-2::FRT          This study 
                                                            ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12MK12H2B     MEP12M4B    ∆mep1-1::FRT/∆mep1-2::MEP11-416- MEP2419-480 -URA3          This study 
                                                            ∆mep2-1::FRT/∆mep2-2::FRT 
 
MEP12MK12H3A     MEP12M4A   ∆mep1-1::FRT/∆mep1-2::FRT                                                     This study                         
                                                           ∆mep2-1::MEP2P-MEP11-416-MEP2419-480-URA3/∆mep2-2::FRT   
                                                                                         
MEP12MK12H3B     MEP12M4B   ∆mep1-1::FRT/∆mep1-2::FRT                                                      This study 
                                                          ∆mep2-1::FRT/∆mep2-2::MEP2P-MEP11-416-MEP2419-480-URA3                                            
                                                                                            
MEP12MK12H4A    MEP12M4B    ∆mep1-1::FRT/∆mep1-2::FRT                                                      This study               
                                                           ∆mep2-1::MEP2P-MEP11-416-MEP2419-440-URA3/∆mep2-2::FRT       
                                                                                                                                                                                                                 
MEP12MK12H4B    MEP12M4A    ∆mep1-1::FRT/∆mep1-2::FRT                                                      This study                      
                                                           ∆mep2-1::FRT/∆mep2-2::MEP2P-MEP11-416-MEP2419-440-URA3                                             
                                                                                             
Signaling mutants expressing wild type or hyperactive CaMEP2 alleles 
 
JKC18                           CAI4           ∆cph1::hisG/∆cph1::hisG                                                     (Liu et al., 1994)        
 
∆cph1MEP2K2A          JKC18         ∆mep2-1::MEP2-URA3/MEP2-2                                                 This study 
 
∆cph1MEP2K2B          JKC18         MEP2-2/∆mep2-2::MEP2-URA3                                                 This study 
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∆cph1MEP2K2A∆C2   JKC18         ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                       This study 
 
∆cph1MEP2K2B∆C2   JKC18         MEP2-2/∆mep2-2::MEP2∆C440-URA3                                       This study 
 
HLC67                           CAI4           ∆efg1::hisG/∆efg1::hisG                                                    (Lo et al., 1997)                           
     
∆efg1MEP2K2A           HLC67        ∆mep2-1::MEP2-URA3/MEP2-2                                               This study 
 
∆efg1MEP2K2B           HLC67        MEP2-2/∆mep2-2::MEP2-URA3                                               This study 
 
∆efg1MEP2K2A∆C2    HLC67        ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                     This study 
       
∆efg1MEP2K2B∆C2    HLC67       MEP2-2/∆mep2-2::MEP2∆C440-URA3                                      This study 
 
HLC69                          CAI4           ∆cph1::hisG/∆cph1::hisG                                                   (Lo et al., 1997)           
                                                         ∆efg1::hisG/∆efg1::hisG 
 
∆cph1 ∆efg1                 HLC69        ∆mep2-1::MEP2-URA3/MEP2-2                                              This study 
MEP2K2A  
  
∆cph1 ∆efg1                 HLC69        MEP2-2/∆mep2-2::MEP2-URA3                                              This study 
MEP2K2B      
                                                          
∆cph1 ∆efg1                 HLC69         ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                    This study 
MEP2K2A∆C2  
 
∆cph1 ∆efg1                 HLC69         MEP2-2/∆mep2-2::MEP2∆C440-URA3                                    This study 
MEP2K2B∆C2    
                                                          
CaAS15                         CAI4          ∆tec1::hisG/∆tec1::hisG                                                    (Schweizer et al.,                                
                                                                                                                                                                        2000) 
 
∆tec1MEP2K2A           CaAS15      ∆mep2-1::MEP2-URA3/MEP2-2                                             This study 
 
∆tec1MEP2K2B           CaAS15      MEP2-2/∆mep2-2::MEP2-URA3                                             This study 
                                                          
∆tec1MEP2K2A∆C2    CaAS15      ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                    This study 
 
∆tec1MEP2K2B∆C2    CaAS15      MEP2-2/∆mep2-2:: MEP2∆C440-URA3                                   This study 
      
CDH108                        CAI4           ∆ras1::hisG/∆ras1::hisG                                                   (Leberer et al., 
            2001) 
∆ras1MEP2K2A           CDH108      ∆mep2-1::MEP2-URA3/MEP2-2                                            This study 
 
∆ras1MEP2K2B           CDH108      MEP2-2/∆mep2-2::MEP2-URA3                                            This study                                
 
∆ras1MEP2K2A∆C2    CDH108      ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                  This study 
 
∆ras1MEP2K2B∆C2    CDH108      MEP2-2/∆mep2-2::MEP2∆C440-URA3                                  This study 
      
CCS14                           CAI4           ∆gpa2::hisG/∆gpa2::hisG                                                         (Sanchez-  
                                                                                                                                                          Martinez  and 
                                                                                                                                                           Perez-Martin,                      
                                                                                                                                                                       2002b) 
∆gpa2MEP2K2A          CCS14         ∆mep2-1::MEP2-URA3/MEP2-2                                          This study 
 
∆gpa2MEP2K2B          CCS14         MEP2-2/∆mep2-2::MEP2-URA3                                          This study 
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Strain                  Parent                  Genotypea                                                     Reference 
 
∆gpa2MEP2K2A∆C2  CCS14         ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                    This study 
 
∆gpa2MEP2K2B∆C2  CCS14         MEP2-2/∆mep2-2::MEP2∆C440-URA3                                    This study 
 
CR276                          CAI4            ∆cdc35::hisG/∆cdc35::hisG                                                   (Rocha et al., 
                                                                                                                                                                      2001)            
∆cdc35MEP2K2A       CR276         ∆mep2-1::MEP2-URA3/MEP2-2                                              This study 
 
∆cdc35MEP2K2B       CR276        MEP2-2/∆mep2-2::MEP2-URA3                                               This study 
 
∆cdc35MEP2K2A       CR276        ∆mep2-1::MEP2∆C440-URA3/MEP2-2                                      This study 
∆C2  
 
∆cdc35MEP2K2B       CR276       MEP2-2/∆mep2-2::MEP2∆C440-URA3                                       This study 
∆C2      
 
Strains expressing dominant active GPA2 or RAS1 alleles or GFP in wild-type and ∆mep2 backgrounds 
 
CAG31                          CAI4          ACT1/act1::ACT1P-GFP-URA3                                          (Morschhäuser 
                                                                                                                                                             et al., 1998) 
MEP2MAG1A         MEP2M4A     ACT1/act1::ACT1P-GFP-URA3                                                 This study 
 
MEP2MAG1B          MEP2M4B    ACT1/act1: ACT1P-GFP-URA3                                                  This study 
 
GPA2E1A                     CAI4         ACT1/act1::ACT1P-GPA2Q354L-URA3                                         This study 
 
GPA2E1B                     CAI4         ACT1/act1::ACT1P-GPA2Q354L-URA3                                         This study 
 
 MEP2M                   MEP2M4A    ACT1/act1::ACT1P-GPA2Q354L-URA3                                        This study 
GPA2E1A   
     
MEP2MGPA2E1B    MEP2M4B    ACT1/act1::ACT1P-GPA2Q354L-URA3                                       This study 
 
RAS1E1A                     CAI4          ACT1/act1::ACT1P-RAS1G13V-URA3                                         This study 
 
RAS1E1B                     CAI4          ACT1/act1::ACT1P-RAS1G13V-URA3                                         This study 
 
MEP2MRAS1E1A    MEP2M4A   ACT1/act1::ACT1P-RAS1G13V-URA3                                         This study 
 
MEP2MRAS1E1B    MEP2M4B   ACT1/act1::ACT1P-RAS1G13V-URA3                                         This study 
 
∆rap1 mutants and reintegrants 
 
RAP1M1A                    CAI4          RAP1/∆rap1::URA3-FLIP                                                        This study 
 
RAP1M1B                    CAI4          RAP1/∆rap1::URA3-FLIP                                                        This study 
 
RAP1M2A                 RAP1M1A    RAP1/∆rap1::FRT                                                                    This study 
 
RAP1M2B                 RAP1M1B     RAP1/∆rap1::FRT                                                                   This study 
 
RAP1M3A                 RAP1M2A    ∆rap1::URA3-FLIP/∆rap1::FRT                                             This study 
 
RAP1M3B                 RAP1M2B    ∆rap1::URA3-FLIP/∆rap1::FRT                                              This study 
 
RAP1M4A                 RAP1M3A    ∆rap1::FRT/∆rap1::FRT                                                          This study 
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Strain                   Parent                  Genotypea                                                     Reference
 
RAP1M4B                 RAP1M3B           ∆rap1::FRT/∆rap1::FRT                                                      This study 
  
RAP1M5A                 RAP1M4A           ∆rap1::FRT/∆rap1::URA3                                                   This study 
 
RAP1M5B                  RAP1M4B          ∆rap1::FRT/∆rap1::URA3                                                    This study 
 
RAP1MK1A               RAP1M4A          ∆rap1::FRT/RAP1-URA3                                                     This study 
 
RAP1MK1B               RAP1M4B          ∆rap1::FRT/RAP1-URA3                                                     This study 
 
Strains used for the analysis of CaCBF1 
 
CBF1M1A                    CAI4                  CBF1/∆cbf1::URA3-FLIP                                                   This study 
 
CBF1M1B                    CAI4                  CBF1/∆cbf1::URA3-FLIP                                                   This study 
 
CBF1M2A                 CBF1M1A            CBF1/∆cbf1::FRT                                                               This study 
 
CBF1M2B                 CBF1M1B            CBF1/∆cbf1::FRT                                                                This study 
 
CBF1M3A                 CBF1M2A            ∆cbf1::URA3-FLIP/∆cbf1::FRT                                          This study 
 
CBF1M3B                 CBF1M2B            ∆cbf1::URA3-FLIP/∆cbf1::FRT                                      This study 
 
CBF1M4A                 CBF1M3A           ∆cbf1::FRT/∆cbf1::FRT                                                       This study 
 
CBF1M4B                 CBF1M3B            ∆cbf1::FRT/∆cbf1::FRT                                                      This study 
 
CBF1M5A                 CBF1M4A            ∆cbf1::FRT/∆cbf1::URA3                                                   This study 
 
CBF1M5B                 CBF1M4B            ∆cbf1::FRT/∆cbf1::URA3                                                    This study 
 
CBF1MK1A              CBF1M4A            ∆cbf1::FRT/CBF1-URA3                                                    This study 
 
CBF1MK1B              CBF1M4B            ∆cbf1::FRT/CBF1-URA3                                                    This study 
 
ADE2M1A                     CAI4                ADE2/ade2::URA3                                                              This study 
  
ADE2M1B                     CAI4                ADE2/ade2::URA3                                                              This study 
 
ADE2∆cbfM1A1       CBF1M4A           ADE2/ade2::URA3                                                              This study 
 
ADE2∆cbfM1A2       CBF1M4A           ADE2/ade2::URA3                                                              This study 
 
ADE2∆cbfM1B1       CBF1M4B           ADE2/ade2::URA3                                                              This study 
 
ADE2∆cbfM1B2       CBF1M4B          ADE2/ade2::URA3                                                               This study 
 
Strains used for the analysis of YIL19 
 
YIL19M1A                     CAI4               ∆yil19-1::URA3-FLIP/YIL19-2                                          This study 
 
YIL19M1B                     CAI4               YIL19-1/∆yil19-2::URA3-FLIP                                          This study 
 
YIL19M2A                 YIL19M1A         ∆yil19-1::FRT/YIL19-2                                                      This study 
 
YIL19M2B                 YIL19M1B         YIL19-1/∆yil19-2::FRT                                                      This study 
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Strain                Parent                  Genotypea                                                     Reference 
 
YIL19M3A            YIL19M2A             ∆yil19-1::FRT/YIL19-2                                                     This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
 
YIL19M3B             YIL19M2B            YIL19-1/∆yil19-2::FRT                                                       This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
 
YIL19M4A             YIL19M3A            ∆yil19-1::FRT/∆yil19-2::URA3-FLIP                                This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
 
YIL19M4B             YIL19M3B            ∆yil19-1::URA3-FLIP/∆yil19-2::FRT                                This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
 
YIL19M5A             YIL19M4A            ∆yil19-1::FRT/∆yil19-2::FRT                                            This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
 
YIL19M5B     YIL19M4B            ∆yil19-1::FRT/∆yil19-2::FRT                                            This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
 
YIL19M6A             YIL19M5A           ∆yil19-1::FRT/∆yil19-2::FRT                                             This study 
                                                              ACT1/act1::FRT-YIL19-MPAR-FRT 
                                                              sap2-1::SAP2-1P-ecaFLP/SAP2-2 
 
YIL19M6B             YIL19M5B            ∆yil19-1::FRT/∆yil19-2::FRT                                             This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
                                                               sap2-1::SAP2-1P-ecaFLP/SAP2-2 
 
YIL19M7A             YIL19M3A            ∆yil19-1::FRT/YIL19-2                                                      This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
                                                               sap2-1::SAP2-1P-ecaFLP/SAP2-2 
 
YIL19M7B             YIL19M3B            YIL19-1/∆yil19-2::FRT                                                      This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
                                                               sap2-1::SAP2-1P-ecaFLP/SAP2-2  
 
YIL19M8A             YIL19M5A             ∆yil19-1::FRT/∆yil19-2::FRT                                           This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
                                                               sap2-1::URA3/SAP2-2 
 
YIL19M8B             YIL19M5B             ∆yil19-1::FRT/∆yil19-2::FRT                                           This study 
                                                               ACT1/act1::FRT-YIL19-MPAR-FRT 
                                                               sap2-1::URA3/SAP2-2 
 
 a. Apart from the indicated features, all strains constructed in this study are identical to their parent strain. 
 b. URA3-FLIP denotes the URA3 flipper cassette. 
 
 
 
 
3.4. Primers used in this study 
 
Primers were obtained either from MWG (Ebersberg, Germany) or ARK-Sigma 
(Darmstadt, Germany). Introduced restriction sites are underlined and the bases which were 
changed from the original sequence either to incorporate the restriction site or to change 
amino acids are in lower-case letters. Start or stop codons in the primer sequences are shown 
in bold letters.  
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Table 3. 
 
Name      No of               Tm(°C)                                             Sequence 
               nucleotides       
 
MEP3             34                         62.1          5´-TAAATACggTACCCAAACGATTGGCTTGAATGTC-3´  
 
MEP4             29                         63.9          5´-TTGAACACATCTCgAgCTGTGCCTGTTCC-3´ 
 
MEP5             28                         58.2          5´-GAACCTATCaGaTCTACTACTATAAGCC-3´ 
 
MEP6             29                         59.6          5´-TTCTACTATGAGctCCTTCTATGGTAACC-3´ 
 
MEP7             29                         74.7          5´-TTGAACACATCTCCAgaTcTGCCTGTTCC-3´ 
 
MEP8             28                         70.4          5´-GAACCTATCCGTTCTgCagCTATAAGCC-3´ 
 
MEP9             29                         68.2          5´-CCATGAGTTGAGatctCAGTATCATTGTG-3´ 
 
MEP11           27                         75.4          5´-TTGCGATGGGTaccAAAGCTTGAAACG-3´ 
 
MEP12           26                         65.2          5´-CTTCTGCTGACtcGAgGTGTATAGAC-3´ 
 
MEP13           30                         72.1          5´-AGAGAAGCAgatcTgCAGTGGAATATCGTC-3´ 
 
MEP14           26                         62.5          5´-ATGAGTAAATGAGctcTTAGTATGCG-3´ 
 
MEP15           26                         70.1          5´-GTTTCACCTcgagGTTGTTGTTGTTG-3´ 
 
MEP16           26                         54.1          5´-AAAAATATAgATCtACCTGACTAATC-3´ 
 
MEP17           27                         62.1          5´-TGTATTACTagaTCTGCTGACATGATG-3´ 
 
MEP18           27                         76.7          5´-GCGATGGGTTctcgAGCTTGAAACGAG-3´ 
 
MEP19           34                         74.7          5´-AATGGGAgatctTaCATGGCAAGCAAAATAATGG-3´ 
 
MEP20           33                         67.4          5´-AGGGAagaTcTTaAATGACAAAACATAATATGG-3´ 
 
MEP21            33                        72.0          5´-GTTAATctCgAgaATGTCTGGAAATTTCACTGG-3´ 
 
MEP22            34                        73.3          5´-TGGGTTGagaTCtaATCGTCATCAGCATAATAGG-3´ 
 
MEP23            35                        68.6          5´-AGAAATCagaTCTaCACTTCAACGTAATCATAAGC-3´ 
 
MEP24            30                        64.9          5´-CCAGACActcgaGTTATTAACTATTCAGAG-3´ 
 
MEP25            31                        78.7          5´-TTGGGCCAgaTCtGTTCaCAACATTTCCTCG-3´ 
 
MEP26            32                        73.7          5´-TCGTGGAGAtcttaTCTGAGAATGGGATTCTG-3´ 
 
MEP27            30                        68.4          5´-AGTCTATctcgAgaATGTCAGCAGAAGAAG-3´ 
 
MEP32            29                        68.4          5´-AAAGAACTGgATccATTTTTAGCTTCTCC-3´ 
 
MEP33p          21                        66.5          5´-TTCGTGGAGACGGATTCTGAG-3´ 
 
MEP34p          22                        64.3          5´-AATGGAGAAGAAGCTGGTGTTG-3´ 
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Name      No of             Tm(°C)                           Sequence 
               nucleotides       
 
MEP35            38                      78.9               5´CCTTAGAATCGATTATGACGAGGAAATGTTG-  
                                                                                               GGAACCG-3´ 
                                                                                 
MEP37            29                      77.0               5´-ACCTGACggATCcACTGGGACGATATTCC-3´ 
 
ACT16            28         59.3               5´-TTCTAAGAtctAAATTCTGGAAATCTG-3´ 
 
ACT19            35                      62.0                5´-ATATACCGCGGACATTTTATGATGGAATGAATGGG-3´ 
                                                                                                    
ACT20            38                      56.5                5´-TTTGtcgacTTATATTTTTTTAATATTAATATCGAG-3´ 
 
ACT31            27                      58.9               5´-CAGCGTCAAAtCTAGAGAATAATAAAG-3´ 
 
LACZ1           34                      62.1               5´-CAGCCctcgagaATGAACATGACTGAAAAAATTC-3´ 
 
LACZ2           22                      57.7               5´-CCATGTACCGTGTGTTTCAAGG-3´ 
 
RAS1             59                       82.9              5´-CATATgtcgACCATGTTGAGAGAATATAAATTAGTT- 
                                                                                 GTTGTTG GAGGTGtTGGTGTTGG-3´ 
 
RAS2             31                       66.4              5´-TTTAGagatCTCAAACAATAACACAACATCC-3´ 
 
GPA1             30                       77.6              5´-AACTTgtcgACCATGGGTTCTTGTGCTTCG-3´ 
 
GPA2             30                       63.4             5´-ACCAACATCAAATAAATTCATATTTAATCC-3´ 
 
GPA3             30                       67.6             5´-GGTttAAGGTCAGAAAGAAAAAAATGGATC-3´ 
 
GPA4             35                       63.5             5´-TGCATagatCTATAAAATACCACTATCTTTAAGAG-3´ 
 
RAP3            27                        56.6             5´-AGTAGGTATGGaTCCTAGATGTTTAAC-3´ 
  
RAP5            28                        59.6             5´-ATATTCACAACggTACCATTTGGAGCAG-3´  
 
RAP6            28                        59.6             5´-GTCCATCATCTTCtcgAGATGAATAAGG-3´ 
 
RAP7            30                        63.7             5´-AAACACcgcGGTAGTTGTGTCCACTTATCC-3´ 
 
RAP8               30                     65.1             5´-GATGAATAAGGATccTTCATACTTTATTGG-3´ 
 
RAP9               34                     66.2             5´-CATACTTTACAATCTgcaGAGAGATAGATTTAGG-3´ 
 
RAP10             29                     73.0             5´-CAAACACAAACgagCTcGTAGTTGTGTCC-3´ 
 
RAP11             27                     67.5             5´-CATAATTTCAggaTCCCTGATTAACCC-3´ 
 
CBF1               26                     67.5             5´-GTCACGAGGTAccAAGGGGGCAGGAG-3´  
 
CBF2               28                     58.2             5´-CCATATCATCTcgAGAAATCTTATTGGC-3´ 
 
CBF3               26                     61.2             5´-GAGAGGGAAGAtcTAAGGGGGATAAG-3´ 
 
CBF4               32                     64.8             5´-CCTGTATTGTCAgagCTCTTCCTTTTCACGGG-3´ 
 
CBF5               28                     64.0             5´- GAGAGGGAAGActgcAGGGGGATAAG-3´ 
 
CBF6               28                     56.7             5´-CCATATCATCTTTAGAtcTCTTATTGGC-3´ 
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Name      No of             Tm(°C)                           Sequence 
               nucleotides       
 
CBF7               29                     56.8               5´-CTCCAAACTTATagatCTTATTTCTTCCC-3´ 
 
ADE3              25                     69.7               5´-ACTGTTGGTAccTTAGGAGGTGGCC-3´ 
 
ADE4              29                     67.6               5´-CAACAAAGTTAgaTCTACCATCATACGCC-3´ 
 
ADE5              28                     66.0               5´-TAGAATGTCTGcAGTATGCTATTGAAGC-3´ 
 
ADE6              22                     53.9               5´-CAGTTAAATAGagcTCATATCC-3´ 
 
YIL 1              24                     67.5               5´-ATTACGTGTGgTaCCCCTTGATCC-3´ 
YIL2               23                     66.0               5´-CATCTTCACTCgagATAGCCCAG-3´ 
YIL3               23                     52.9               5´-AAAGAAGATctAACGTACAATAG-3´ 
YIL4               26                     64.2               5´-CTGAAACTCAGAGctcTATGGGTAAG-3´ 
YIL5          28                     71.8               5´-GAGGTCAAACTCgaGGTGGTAGAACACC-3´ 
YIL6              27                      66.7               5´-TTCATCAAGCTtAATGTGAAGATTTCG-3´ 
ITS1.3           22                      71.4               5´- GACCTCTGGCGGCAGGCTGGGC-3´ 
ITS 2.1          26                      68.0               5´-CAACACCAAACCCAGCGGTTTGAGGG-3´ 
 
 
 
3.5. Sources of chemicals, enzymes and equipments used in this study 
Chemicals used were of analytical grade from Applichem (Darmstadt, Germany), 
Merck (Darmstadt, Germany), Roth (Karlsruhe, Germany) or molecular biology grade mostly 
from Sigma (Taufkirchen, Germany). Restriction enzymes and DNA modifying enzymes 
were obtained from NEB (Schwalbach/Taunus, Germany), Invitrogen (Karlsruhe, Germany), 
or Amersham (Freiburg, Germany). Buffers provided with the enzymes or one-for-all buffer 
were used. Media used were from Oxoid (Wesel, Germany), Invitrogen (Karlsruhe, Germany) 
or Roth (Karlsruhe, Germany). 
 
Table 4. 
 
Name of  the equipments used                                                                    Source    
 
Incubators 
 For E.coli (37°C) (Type B6200)           Heraus 
 For C.albicans (30°C) (Model 400)          Memmert 
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Name of  the equipments used                                                                    Source    
 
Shaking incubators 
  For E.coli (37°C) Innova 4300                        New Brunswick 
  For C.albicans (30°C) Innova 4230          Scientific 
 
Electrophoresis apparatus 
 Agarose gel (DNA Sub Cell/GNA 100)                      Bio-Rad/Pharmacia 
 Agarose-Formaldehyde-Gel           Fröbel 
 
Electroporation apparatus (Easyject prima)                       Equibio 
 
Geldocumentation system                         Bio-Rad 
 
Hybridization oven            MWG 
 
Spectrophotometer            Pharmacia 
 
Thermocycler             Techne 
 
UV-crosslinker (GS Gene linker)                        Bio-Rad 
 
Tabletop centrifuge            Heraeus Sepatech 
 
 
 
3.6. Commonly used molecular microbiological techniques 
All solutions and media were made in double distilled and distilled water respectively. 
All solutions and media were sterilized by autoclaving at 15 lb/sq inch for 15 minutes or filter 
sterilized by passing through a 0.22 micron Millipore filter. All % shown are on a w/v basis 
unless mentioned otherwise. 
 
3.6.1. Growth and maintainance of strains 
Recombinant E.coli strains were routinely grown in LB liquid medium (1% Tryptone, 
0.5% NaCl, 0.5% Yeast Extract) containing 100 µg/ml ampicillin and were maintained on LB 
agar plates (1.5% agar) containing 100 µg/ml ampicillin. The C.albicans strains were 
routinely grown in YPD liquid medium (1% Yeast extract, 2% Peptone, 2% Dextrose) and 
were maintained on SD agar plates (0.67% Yeast nitrogen base without amino acids [BIO 101 
Vista Calif.], 2% dextrose, 1X CSM-URA [BIO 101 Vista Calif.] and 1.5% agar). To support 
growth of uridine-auxotrophic strains, 100 µg/ml uridine was added to the media. The ura3-
negative derivatives of strains containing the URA3 flipper were isolated after inducing FLP 
expression by overnight growth in YCB-BSA (23.4 g Yeast Carbon Base [Difco], 2 g Yeast 
extract, 0.4% BSA [Bovine serum albumin, Fraction V, Gerbu], pH 4.0) containing 100 µg/ml 
uridine and screening for smaller colonies after growing the cells on SD agar plates 
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containing 10 µg/ml uridine. Selection of the transformants for mycophenolic acid (MPA) 
resistance was done in SD agar plates containing 10 µg/ml MPA (Sigma, Deisenhofen, 
Germany). To screen for MPA-resistant and MPA-sensitive clones, 100-200 cfu was plated 
on SD agar containing 1.8 µg/ml MPA which resulted in the generation of large MPAR and 
small MPAS colonies, respectively (Staib et al., 1999). E.coli and C.albicans strains were 
routinely grown at 37°C and 30°C respectively. 
To study CaMEP1 and CaMEP2 expression in response to nitrogen availability, 
strains were grown to log phase in liquid SD-CSM medium (0.67% Yeast nitrogen base 
without amino acids [BIO 101 Vista Calif.], 2% dextrose), washed twice in YNB medium 
(0.17% YNB without amino acids and [NH4]2SO4 [BIO 101 Vista Calif.], 2% Dextrose, pH 
4.0), and grown for six hours in fresh YNB medium in which the standard ammonium 
concentration of 76 mM (38 mM [NH4]2SO4) was altered or replaced by other nitrogen 
sources as indicated. Growth at different ammonium concentrations was assayed by 
incubating the strains for 4 days at 30°C on YNB agar plates (2% agar [washed 4 times]) 
containing the indicated ammonium concentrations.  
 
3.6.2. In vitro DNA manipulation 
 
3.6.2.1. DNA digestion with restriction enzymes  
Digestions of   DNA was done in 1X ‘one-for all buffer’ (33 mM Tris-acetate pH 7.9, 
66 mM K-acetate, 10 mM Mg-acetate, 0.5 mM DTT, 0.1 mg/ml BSA) and the manufacturer’s 
instructions were followed with respect to the amount of enzyme per µg of DNA, incubation 
temperature and reaction time. The digests were then mixed with 10X DNA stop buffer (0.2% 
Bromophenol blue, 0.2M EDTA, 50% Glycerol) to a final concentration of 1X, and loaded on 
a 1% agarose gel along with 1 kb DNA ladder (Invitrogen). 
  
3.6.2.2. Polymerase Chain Reaction (PCR) 
PCR was carried out using either Elongase-Enzyme-Mix (Invitrogen) or Pfu-DNA-
Polymerase (Promega, Mannheim, Germany). Typically the amplification reactions were 
carried out for 30 cycles. 
The program was as follows 
           Denaturation at 94°C for 2 minutes only in the first cycle 
           Denaturation at 94°C for 1 minute for all cycles 
           Optimum annealing temperature (Ta OPT) for 30 seconds, for all cycles 
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           Extension at 68°C (72°C for Pfu-DNA-Polymerase) for 1 minute for 1 kb product (2 
minutes extension time for 1 kb product in case of Pfu-DNA-Polymerase) for all cycles. 
Finally to fill the incomplete extension products, the reaction mix was incubated at 
68°C (72°C for Pfu-DNA-Polymerase) for 10 minutes. 
The annealing temperature was adjusted on the basis of the Tm of the primers used to 
amplify the product. Using the above parameters, the template amount and number of cycles 
were varied and an ideal combination was arrived at to maximize the yield. Usually the 
reaction was carried out in a 50 µl reaction mix containing 1-2 ng plasmid DNA or 0.1-1.0 µg 
genomic DNA as template, 0.2 mM of each dNTPs , 1 unit of enzyme and the provided buffer 
in 1X concentration. 
Successful amplification was confirmed by agarose gel electrophoresis and the PCR 
product then extracted once with phenol: chloroform: IAA (25:24:1) and once with 
chloroform: IAA (24:1). It was then precipitated with 1/10th volume of 3M sodium acetate 
pH 5.2 and 2.5 volumes of 100% ethanol. After precipitation excess salts were removed by 
washing in 70% ethanol and the DNA was dissolved in an appropriate volume of sterile 
double distilled water for further process (e.g. restriction digestion). 
 
3.6.3. Gel electrophoresis and gel elution of DNA fragments 
 
3.6.3.1. Agarose gel electrophoresis   
Agarose gel electrophoresis of DNA was routinely carried out in 1X TAE (50X TAE 
stock solution: 242 g Tris base, 57.1 ml Glacial acetic acid and 100 ml 0.5 M EDTA pH 8.0 
for 1 litre). For most purposes a 1% gel was used. After electrophoresis, the gels were stained 
in ethidium bromide (10 mg/ml in water) and photographed using a geldocumentation system. 
The sizes of the fragments were estimated by measuring the relative mobility of the bands in 
comparison to markers of known molecular size (1 kb DNA ladder, Invitrogen), run in a lane 
alongside.  
           Before performing any Southern blot, the integrity of the nucleic acid was also verified 
by such methods. All procedures were performed according to Sambrook et al., 1989, or 
Ausubel et al., 1994. 
 
3.6.3.2. Gel elution of inserts from agarose gel 
             Large scale digestion of the plasmid containing the DNA of interest was done with 
appropriate enzymes to release the insert. The digested DNA was loaded on the agarose gel 
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and run at low voltage till the band of interest was well separated from the vector backbone. 
The band of interest was cut out with a scalpel. The DNA was prepared from the gel slice 
using the ‘Gene Clean Kit’ (QBiogene, Heidelberg, Germany). 400 µl NaI was added to the 
gel slice and incubated at 50°C till the agarose melted (5-10 minutes). After thorough mixing 
with 7 µl glass-milk, it was then incubated on ice for 5 minutes and washed 3 times with 200 
µl ‘New Wash’ solution. 11 µl distilled water was added to the pellet, mixed well, and 
incubated at 50°C for 5 minutes. After centrifugation at 13,000 rpm for 2 minutes in a 
tabletop centrifuge, the supernatant was taken which contains the fragment of interest. PCR 
products were purified from the gel similarly. For transformation of C.albicans linear DNA 
fragments were eluted in 6 µl distilled water, instead of 11 µl. 
 
 
3.6.4. Cloning of gene of interest in vectors 
 
3.6.4.1. Ligation 
The vector most commonly used in these studies was pBluescript KS II (Stratagene, 
Heidelberg, Germany). All the preparative digestions for the preparation of inserts were 
generally set up in a 50 µl reaction volume containing 10-15 µg of plasmid DNA. For the 
preparation of vectors 1-2 µg of plasmid DNA was digested in a 50 µl reaction volume. 
Digests were resolved on a 1% agarose gel and appropriate DNA fragments were eluted from 
the gel piece using ‘Gene Clean Kit’ (see section 3.6.3.2). DNA amounts were empirically 
estimated and ligation reactions were set up at 1:4 ratio of vector and insert (in general) in a 
15 µl reaction volume containing 1X ligase buffer and 1 unit of T4 DNA ligase (Invitrogen). 
A vector-only control ligation reaction was also set up during each ligation experiment. 
Ligation reactions were carried out at room temperature (RT) for 3 hours. 
 
3.6.4.2. Transformation of E. coli 
 
Preparation of E. coli DH5α competent cells 
DH5α cells were streaked on a fresh LB agar plate from a glycerol stock. A single 
colony was inoculated from the freshly streaked plate in 10 ml LB medium and grown at 
37°C with shaking at 200 rpm for 16-18 hours. 
The overnight grown culture was diluted 1:100 in fresh LB medium and incubated at 
37°C with shaking at 200 rpm till A600 reached 0.7-0.9 (3-4 hours). The culture was then 
  Materials and Methods 
 
 38 
transferred to chilled 50 ml tubes and centrifuged at 3,000 rpm for 10 min at 4°C in a chilled 
rotor. The supernatant was discarded and the cell pellet was suspended in 100 mM calcium 
chloride in 4/5th volume of the starting culture. The cell mix was incubated on ice for 30-45 
minutes and centrifuged at 3,000 rpm for 10 minutes at 4°C. Competent cells were then 
suspended in 100 mM calcium chloride in 1/20th volume of the starting culture volume and 
86% glycerol was added to a final concentration of 15% (v/v). Cells were aliquoted in the 
microfuge tubes and stored at -70°C until further use. 
 
Transformation of competent cells 
For each transformation, an aliquot of 200 µl competent cells was used. The ligation 
mixture was added to the competent cells and incubated for 45 minutes on ice with gentle 
mixing at regular intervals. The cells were subjected to heat shock in a 42°C water-bath for 90 
seconds and then chilled on ice for 5 minutes. After adding 1 ml LB medium the cells were 
allowed to grow for 90 minutes at 37°C.  
 
Plating of transformation mix  
An aliquot of 200 µl from the 1 ml transformation mix was spread on a selection plate 
(e.g. LB plate containing 100 µg/ml ampicillin). The rest of the transformation mix was 
concentrated and plated on another selection plate.  The plates were dried in laminar flow air 
and incubated at 37°C until the colonies appeared (~16 hours).  
 
 
3.6.4.3. Screening and analysis of recombinants  
 
Plasmid isolation 
The recombinant colonies were picked and streaked on a fresh LB agar plate 
containing ampicillin and simultaneously inoculated into 3 ml LB medium containing 100 
µg/ml ampicillin.  The cells in liquid culture were grown at 37°C in a shaking incubator for 
18-20 hours and the plate was incubated at 37°C until the colonies appeared (~16 hours). 
The cultures were processed to isolate plasmid DNA by the miniprep protocol and 
analyzed by restriction digestion. 
Small scale plasmid DNA isolation was carried out by modified alkaline lysis method 
(Sambrook et al., 1989). Cells were centrifuged at 12,000 rpm for 30 seconds at room 
temperature. The supernatant was removed by aspiration, leaving the bacterial pellet as dry as 
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possible. The pellets were suspended completely in 100 µl TEG (25 mM Tris-HCl  pH 8.0, 10 
mM EDTA pH 8.0, 50 mM Dextrose). 200 µl freshly prepared Solution II (1% SDS, 0.2N 
NaOH) was added and the tubes were inverted a few times to mix well. The tubes were 
incubated on ice for 5 minutes till a visible cell lysis occurred and the liquids became 
transparent. 150 µl Solution III (3M sodium acetate pH 5.2) was added to the cell lysates and 
mixed well. These were then incubated at RT for 10 minutes and centrifuged at 12,000 rpm 
for 7 minutes at RT. The supernatant was transferred to another tube, extracted once with 
phenol: chloroform: IAA (25:24:1) and 1 ml 100% ethanol was added to the each supernatant. 
These were then mixed by inversion and incubated at RT for 5-10 minutes to precipitate the 
plasmid DNA. The plasmid pellets were recovered by centrifugation at 12,000 rpm for 5 
minutes at RT. The supernatants were removed by gentle aspiration, pellets were washed once 
with 70% ethanol and dried. The pellets were dissolved in 50 µl double distilled water and 1 
µl RNase A (50 mg/ml) was added to each sample. 
From each sample 3 µl (100-200 ng) DNA was digested with suitable restriction 
enzymes at the appropriate temperature (mostly at 37°C) in a 20 µl reaction mix for 1-2 h and 
separated on a 1% agarose gel along with the marker. After staining in ethidium bromide the 
gel was observed in geldocumentation system and correct recombinants were selected based 
on their expected band pattern on gel. 
 
DNA-Sequencing 
Sequencing of DNA was done according to the chain termination method (Sanger et 
al., 1977). For sequencing of the cloned fragments, plasmid DNA was isolated as described 
above and after RNase treatment 150 µl distilled water was added to it. After extracting once 
with phenol: chloroform: IAA (25:24:1) and once with chloroform: IAA (24:1), the DNA was 
precipitated by addition of 1/10th volume 3M sodium acetate pH 5.2 and 2.5 volumes 100% 
ethanol and incubation at -70°C for 1 h. After washing with 70% ethanol the DNA pellet was 
dissolved in 26 µl distilled water. Sequencing was done using the ‘Thermo-Sequenase 
fluorescent labelled primer cycle sequencing kit with 7-deaza-dGTP’ [RPN 2438] 
(Amersham) with 1 pmol fluorescence labelled (IRD 800) sequencing primer (MWG) and 6 
µl plasmid (~500 ng) in a thermocycler. The programme was: denaturation at 95°C for 2 
minutes and then for 30 cycles 95°C for 30 seconds (denaturation), primer annealing for 30 
seconds, 70°C for 30 seconds (polymerization). The product was then run on a 
polyacrylamide gel and analysed using a ‘LI-COR’ model 4000 automated sequencer 
(MWG). 
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3.6.5. Transformation of C.albicans 
Transformation was done by electroporation as described by Köhler et al., (1997) with 
the gel-purified linear DNA fragments. A single colony of the uridine-auxotrophic C.albicans 
strain to be transformed was inoculated in 10 ml of YPD supplemented with uridine and 
grown at 30°C at 200 rpm shaking for 16-18 hours. 5 µl of the preculture was added to 50 ml 
YPD and grown till the culture reached mid log phase (O.D600= 1.8 to 2.0). The cells were 
then centrifuged at 4,000 rpm at RT for 5 minutes. The pellet was suspended in 8 ml sterile 
distilled water and, 1 ml 1M lithium acetate and 1 ml 10X TE buffer pH 7.5 (100 mM Tris-Cl  
pH 7.5, 10 mM EDTA) were added. The cell mix was then incubated at 30°C in a water-bath 
with gentle shaking. After 45-60 minutes incubation 250 µl 1M DTT was added to the cell 
mix and incubated at 30°C water bath for another 30 minutes with gentle shaking. 40 ml 
sterile distilled water was added and the cell mix was centrifuged at 4,000 rpm for 5 minutes 
at 4°C. The cell pellet was then washed once with 25 ml sterile distilled water and once with 5 
ml 1M sorbitol. The supernatant was discarded and the cell pellet was suspended in the 
residual liquid. 5 µl DNA was then mixed with 40 µl of competent cells in a 0.2 cm 
electroporation cuvette (Peq lab, Erlangen, Germany). For control, 5 µl sterile distilled water 
was used instead of DNA. These mixtures were then electroporated at 1.8 Kv using an 
electroporation apparatus. After electroporation 1 ml 1M sorbitol was added to the cells and 
100 µl was plated on selection plates. The remaining cells were concentrated and plated on 
another plate. The plates were then dried and incubated at 30°C until the colony appeared (2 
days). 
 
 
3.6.6. Genomic DNA isolation from C.albicans 
Glass-bead method 
The C.albicans strains were inoculated in 10 ml YPD and grown at 30°C with shaking 
at 200 rpm for 18-20 hours. The cells were collected by centrifugation at 5,000 rpm for 5 
minutes, suspended in 0.5 ml distilled water and transferred to micro centrifuge tubes. The 
cells were washed by centrifugation at 5,000 rpm for 2 minutes and the supernatants were 
decanted. The cell pellets were then suspended in the residual liquid. 0.2 ml of freshly 
prepared breaking buffer (10 mM Tris-Cl pH 8.0, 1% SDS, 1 mM EDTA, 2% Triton-X-100 
and 100 mM NaCl) was added to each tube. After adding 0.2 ml phenol: chloroform: 
isoamylalcohol (25:24:1) and 0.3 g glass beads (0.2-0.4 micron, Roth), the cells were 
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vortexed at full speed for 4 minutes and centrifuged at 10,000 rpm for 5 minutes in a 
microcentrifuge. The aqueous layer was transferred to a new tube and 1 ml chilled 100% 
ethanol was added to precipitate DNA. The tubes were centrifuged at 10,000 rpm for 5 
minutes. After discarding the supernatant, the pellets were air-dried, and suspended in 0.4 ml 
distilled water. 30 µg RNaseA was added to each sample and after incubation at 37°C for 15 
minutes 10 µl 4M ammonium acetate and 1 ml 100% ethanol was added to each sample and 
mixed gently by inverting the tubes, to precipitate DNA. The tubes were centrifuged at 10,000 
rpm for 5 minutes. The DNA pellets were then washed with 70% ethanol, air-dried, and 
dissolved in 50 µl distilled water. 
Enzymatic method 
After overnight growth in 10 ml YPD at 30°C the cells were collected by 
centrifugation at 5,000 rpm for 5 minutes, suspended in 1 ml 1M sorbitol and transferred to 
the 2 ml micro centrifuge tubes. The cells were washed by centrifugation at 5,000 rpm for 5 
minutes and the supernatant was discarded. The cell pellet was then suspended in 1 ml lyse 
buffer (1M sorbitol, 100 mM sodium citrate pH 5.8, 50 mM EDTA, 2% β-mercaptoethanol, 
500 u/ml lyticase [Sigma]) and incubated at 37°C for 45 minutes. The cells were then 
centrifuged (13,000 rpm, 5 minutes), suspended in 800 µl proteinase-buffer (100 mM Tric-Cl 
pH 7.5, 50 mM EDTA pH 7.5, 0.5% SDS, 1 mg/ml proteinase K [Sigma]) and incubated at 
60°C for 30 minutes. After 2 times extraction with phenol: chloroform: IAA (25:24:1), the 
nucleic acids were precipitated by adding 600 µl isopropyl alcohol to the each sample. After 
centrifugation at 13,000 rpm for 5 minutes the pellet was washed with 70% ethanol, air-dried 
and dissolved in 200 µl distilled water containing 2 µl RNaseA (10 mg/ml). After 30 minutes 
incubation at 37°C, the DNA was extracted once with phenol: chloroform: IAA (25:24:1) and 
once with chloroform: IAA (24:1) and precipitated with 200 µl isopropanol. It was then 
centrifuged at 13,000 rpm for 5 minutes, washed in 70% ethanol, air-dried and dissolved in 
100 µl distilled water. The concentration of DNA was estimated by measuring the absorbance 
at 260 nm (OD260 1.0 = 50 µg/ml DNA). 
 
 
3.6.7. Southern hybridization technique  
This technique was developed by Southern (1975), for the detection of specific DNA 
fragments among a population of digested DNA separated by gel electrophoresis. 
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Restriction digestion of genomic DNA 
          10 µg of genomic DNA from C.albicans transformants was digested with appropriate 
restriction enzymes in a 30 µl reaction volume at 37°C. After overnight incubation reactions 
were stopped by adding DNA stop buffer to 1X final concentration. 
Agarose gel electrophoresis 
The digestions, along with 1 kb DNA ladder (Invitrogen) as marker, were loaded on a 
1% agarose gel. The gel was run as usual with 1X TAE buffer at constant low voltage 
overnight. After electrophoresis, the gel was stained with ethidium bromide, and 
photographed. 
DNA transfer 
 A Nylon membrane was pre-wet for few seconds in distilled water and equilibrated in 
20X SSC (3M sodium acetate and 0.3M tri-sodium citrate) for 15 minutes. The gel was rinsed 
with distilled water and aligned on top of the membrane in a vacuum blot. Depurination of the 
DNA was done under vacuum for 15 minutes with 0.25N HCl. The solution was discarded 
and the gel was treated with denaturing solution (0.6M NaCl and 0.4N NaOH) for 15 minutes 
and with neutralizing solution (1.5M NaCl, 0.5M Tris-Cl pH 7.5) for 15 minutes, under 
similar conditions. Transfer was done with 20X SSC for 90 minutes. After transfer, the 
membrane was soaked in 0.4N NaOH for 1 minute to denature the DNA. The membrane was 
then neutralized in 0.2M Tris-HCl (pH 7.5)/1X SSC for 1 minute. UV-cross linking of nucleic 
acids to the membrane was done in Stratalinker. 
Hybridization 
The membrane was pre-wet in 2X SSC for 1 minute and then placed in a hybridization 
bottle and prehybridized for 1-2 h, using the prehybridization buffer of the ‘ECL labelling and 
detection kit’ (Amersham) at 42°C in a hybridization oven. The probe was prepared according 
to the manufacturer’s instruction using 100 ng gel eluted DNA and 2 ng 1 kb DNA ladder 
(Invitrogen) and added to the prehybridization buffer. Hybridization was carried out in 
hybridization bottles at 42°C for 16 hours. After hybridization, the membrane was washed at 
42°C, 1X with 5X SSC for 10 minutes, 2X with Wash Buffer I (6M Urea, 0.4% SDS, 0.5X 
SSC) for 10 minutes and finally in 2X SSC at RT for 10 minutes. Signal detection was done 
according to the manufacturer’s instructions. The membrane was then wrapped securely in 
saran wrap, and exposed to Amersham hyperfilm ECL in a film cassette for 5-90 minutes. To 
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rehybridize the membrane, it was incubated in detection solution overnight, washed in 2X 
SSC for 1 minute and rehybridized with another probe. 
 
 
3.6.8. RNA isolation from C.albicans  
Total RNA from C.albicans cells was isolated by the hot phenol method (Ausubel et 
al., 1994). All the solutions used for RNA isolation were made either in DEPC treated water 
or treated with DEPC after preparing the solutions. For DEPC treatment 0.1% DEPC (v/v) 
was added and the solutions were incubated at 37°C overnight and autoclaved.  
The cell pellets from various conditions to be tested were collected by centrifugation 
and suspended in 600 µl TES buffer (10 mM Tris-Cl pH 7.5, 10 mM EDTA, 0.5% SDS). 600 
µl water saturated phenol was added and mixed thoroughly. The mixture was incubated at 
65°C for 1 h with intermittent mixing. The hot mixture was then chilled in an ethanol-dry ice 
bath for 5 seconds and then centrifuged at 12,000 rpm for 10 minutes at RT. The aqueous 
phase was carefully transferred to another tube, without disturbing the interphase, even if it 
meant leaving some of the aqueous phase behind. The aqueous phase was then extracted once 
again with water saturated phenol and twice with TE saturated phenol: chloroform: IAA 
(25:24:1). The RNA was precipitated by adding 1/10th volume 3M sodium acetate pH 5.2 and 
twice the volume chilled 100% ethanol. The RNA was recovered by centrifugation at 12,000 
rpm for 10 minutes at RT in a microfuge.  The RNA pellet was washed with 70% ethanol 
(prepared in DEPC water), dried and dissolved in DEPC treated water. 
 
 
3.6.9. Northern hybridization 
 
Agarose gel electrophoresis of RNA and Northern blotting 
Formaldehyde denatured RNA gel was prepared as described by Sambrook et al. 
(1989). Formaldehyde (Applichem) of pH 3-3.5, was used.  Formamide was deionised and 
stored at 4°C. To prepare the RNA sample, 30 µg RNA in 11.25 µl DEPC water was mixed 
with 5 µl 10X MOPS buffer (0.2M MOPS pH 7.0, 20 mM sodium acetate, 10 mM EDTA), 25 
µl formamide and 8.75 µl formaldehyde. After incubation at 55°C for 15 minutes, 10 µl 
loading buffer (50% glycerol, 1 mM EDTA, 0.002% bromophenol blue and 0.002% xylene 
cyanol) was added to the mix. 
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1.2% agarose gel containing 1X MOPS buffer and 2.2M formaldehyde was prepared. 
The denatured RNA was loaded in the wells and the electrophoresis was done in 1X MOPS 
buffer at constant voltage (150V) till the bromophenol blue had migrated 2/3 length of the gel 
(2-3 hours). 
After electrophoresis, the gel was rinsed in DEPC treated water for 1 h, followed by 
soaking in 10X SSC for 45 minutes. The RNA was transferred to a Nylon membrane by 
capillary transfer using 20X SSC as transfer buffer. The amount of RNA loaded was verified 
by methylene blue staining (0.02% methylene blue in 0.3M sodium acetate) of the blot. The 
RNA was cross linked to the membrane by UV-cross linking. 
 
Probe labelling and hybridization 
The membrane was pre-wet in 6X SSC for 1 minute and then placed in 15 ml 
prehybridization solution (50% deionized formamide, 5X SSC, 0.1% SDS, 1 mM EDTA pH 
7.5, 5X Denhardt´s solution [50X Denhardt´s solution: 1 g polyvinyl pyrrolidone, 1 g Ficoll 
400 and 1 g BSA in 100 ml distilled water], 50 mM Tris-Cl pH 7.5, 100 µg/ml denatured 
Salmon sperm [10 mg/ml in 1X TE pH 8.0, sonicated and extracted with phenol: chloroform: 
IAA twice and once with chloroform: IAA, precipitated with ethanol, washed and 
resuspended and  boiled at 100°C for 10 minutes and then chilled (Sambrook et al., 1989)]) in 
a hybridization bottle and prehybridized for 4 hours at 42°C. Labelling of probe was done 
using the random labelling kit (Invitrogen). 100 ng template DNA fragment (gel eluted) was 
taken in 23 µl distilled water. The DNA was denatured by incubating in a boiling water bath 
for 10 minutes and then chilled by quickly placing on ice for 5 minutes, and centrifuged 
briefly at 4°C. The DNA was then mixed with 15 µl 10X Labelling Buffer which includes 
Random Octadeoxyribonucleotides, 6 µl dNTP mixture (2 µl each of dCTP, dTTP, and 
dGTP), 5 µl α 32P-dATP (50 µCi from 3,000 Ci/mmol specific activity) and 1 µl DNA 
Polymerase I-Klenow fragment (5 units). The reaction mix was incubated at 37°C for 1 h and 
terminated by adding 5 µl stop buffer (provided with kit).  
For labelling oligonucleotides to use as probe, a kinase reaction was carried out using 
γ 32P-ATP in a reaction mixture containing 30 pmol oligo, 30 pmol γ 32P-ATP (the molar 
ration of oligo and γ 32P-ATP should be 1:1), 5 µl 10X T4 PNK (polynucleotide kinase) 
buffer and 2 µl T4 PNK  (5 units) (NEB). The reaction mixture was incubated at 37°C for 40 
minutes.  
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Before adding to the prehybridization solution the labelled probe was denatured by 
incubation at 100°C for 10 minutes and quickly placed on ice for 5 minutes. 
Hybridization was carried out in hybridization bottles, at 42°C for 16 hours in a 
hybridization oven. The membrane was washed with Wash solution I (2X SSC, 0.1% SDS) 
for 10 minutes at 42°C and 2X for 10 minutes in Wash solution II (0.1X SSC and 0.1% SDS ) 
at 56°C. Washing time was varied according the radioactivity present in the blot. After each 
wash the background count was monitored with a Hand Monitor to avoid washing off the 
specifically bound signal. The membrane was then wrapped securely in a polythene packet 
and was exposed to Kodak X-Omat film in a film cassette, and incubated at -80°C for 6 
hours to 2 days, depending on the signal strength. The film was developed and aligned with 
the blot to mark the positions of the bands. 
 
 
3.7. Phenotypic assays 
To study nitrogen starvation induced filamentation, the strains were grown for 6 days 
at 37°C on YNB agar plates (see section 3.6.1) containing ammonium or other nitrogen 
sources at the concentrations described in the text. Where indicated, 10 mM dibutyryl cAMP 
(Sigma, Deisenhofen, Germany) was added. Filamentous growth was also induced by 
growing the cells for 6 days at 37°C on agar plates containing 10% fetal calf serum (FCS) or 
by embedding the cells in YPS agar (2% peptone, 1% yeast extract, 2% sucrose, 1.5% agar) 
and incubating the plates at 25°C for 6 days. Filamentation in liquid medium was studied by 
inoculating cell grown overnight in YPD into the RPM I 1640 medium with 10% fetal calf 
serum or in 2.5 mM N-acetyl glucosamine (GlcNAc) in salt base (0.45% NaCl and 0.335% 
YNB without  amino acids [BIO 101 Vista Calif.], adopted from Delbruck and Ernst, 1993), 
10 mM MES-Tris buffer pH 6.4 supplemented with 1 mM proline (Holmes and Shepherd, 
1987), Lee´S medium (see section A.2), or Spider medium (1% Nutrient Broth, 1% Mannitol, 
0.2% K2HPO4  pH 7.2  adopted from Liu et al., 1994) and incubating at 37°C for 6-8 hours. 
Growth and temperature sensitivity of the strains were tested by incubating them on 
YPD agar plates at 30°C, 37°C, and 42°C. To measure survival of the cells at 42°C the strains 
were grown overnight in YPD medium at 30°C, diluted 10-2 in fresh YPD medium and grown 
to log phase (OD600 =1.5 to 2.0). The culture was then transferred to 42°C and incubated for 
24 hours. Alternatively, 1 ml of the culture was washed in PBS (0.8% NaCl, 0.02% KCl, 
0.144% Na2HPO4, 0.024% KH2PO4, pH 7.0), suspended in 1 ml PBS, and incubated for 
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24 hours at 42°C. In both cases samples were taken at 0 h and 24 hours after transfer to 42°C. 
Appropriate dilutions were spread on YPD plates and incubated at 30°C to determine the 
number of viable cells. The % survival was calculated by dividing the number of colonies 
obtained after 24 hours at 42°C by the number of colonies obtained at 0 h. For auxotrophy 
tests, strains were grown on SD agar plates without CSM, supplemented with methionine, or 
cysteine, or no amino acids. Thiabendazole sensitivity was tested by spotting serial 10-fold 
dilutions of stationary phase cells of the strains on YPD agar plates with or without 100 µg/ml 
thiabendazole and monitoring growth at 30°C. 
 
 
3.8. Microscopy 
Microscopic analysis of C.albicans cells was performed with a Zeiss Axiolab 
microscope equipped for epifluorescence microscopy with a 50-W mercury high-pressure 
bulb using a 40x objective. To determine the percentage of yeast and pseudohyphal cells, cells 
were grown to mid log phase in YPD medium at 30°C, fixed with PBS containing 4% 
formaldehyde and counted in a Neubauer hemocytometer. For chitin staining the cells were 
fixed with PBS containing 4% formaldehyde and then washed in PBS. One hundred 
microlitres of the cell suspensions were mixed with 10 µl of 1 mg/ml calcofluor solution, 
incubated in the dark at RT for 1 h, and washed five times in PBS. For visualizing nuclei cells 
were fixed in 70% ethanol and resuspended in PBS. One hundred and fifty microlitres of the 
cell suspensions were mixed with 20 µl of 1:1500 diluted Hoechst dye 33258 and incubated in 
the dark at room temperature for 30 minutes. For visualizing live cells, log phase cells were 
suspended in 0.1M MOPS-50 mM citric acid pH 3.0 and CFDA (Molecular Probes, 
Karlsruhe, Germany) was added from a 5 mg/ml stock in 100% dimethyl sulfoxide to a final 
concentration of  50 µg/ml. The cells were then incubated in the dark at 37°C for 45 minutes 
with gentle agitation and stored on ice until analysis (Bowmann et al., 2002). To visualize 
dead cells, log phase cells were washed, suspended in 0.1M MOPS pH 7.0 and DiBAC 
(Molecular Probes, Karlsruhe, Germany) was added from 1 mg/ml stock in 100% ethanol to a 
final concentration of 2 µg/ml. After 1 h incubation in the dark at RT with gentle agitation, 
cells were washed twice with 0.1M MOPS pH 7.0 and stored on ice until analysis (Bowmann 
et al., 2002). The stained cells were observed by phase contrast and epifluorescence 
microscopy. 
Fluorescence of cells expressing GFP fusions was detected using a Zeiss LSM 510 
inverted confocal laser scanning microscope equipped with a ZEISS Axiovert 100 
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microscope. Imaging scans were acquired with an Argon laser of 488 nm wavelength and 
corresponding filter settings for GFP and parallel transmission images. Observation was 
performed with 63× immersion oil objective. 
 
 
3.9. Ammonium uptake assays 
Ammonium uptake was assayed as described previously (Lorenz and Heitman, 1998a; 
Marini et al., 1994). Briefly, strains were grown to late log phase in minimal proline medium 
(0.17% YNB without amino acids and [NH4]2SO4 [BIO 101 Vista Calif.], 0.1% proline, 2% 
glucose) and the cultures were diluted to an OD600 of 1.0 in the same medium plus 500 µM 
ammonium sulfate. At the indicated times a portion of the culture (1 ml) was taken, the cells 
removed by centrifugation, and the ammonium concentration in the culture supernatant 
determined using a glutamate dehydrogenase-linked assay in a reaction mixture containing 50 
mM imidazole pH 7.3, 20 mM α-ketoglutarate, 0.1 mg/ml NADH, 0.01 mg/ml EDTA and 10 
units of glutamate dehydrogenase from bovine liver (Sigma). In this reaction NH4+ + NADH 
+ H+ + α-ketoglutarate is converted to glutamate + NAD+ + H2O and an increase in the 
NADH concentration (measured by determining the absorbance at 340 nm) indicates 
ammonium removal by the cells. 
 
 
3.10. X-Gal agarose overlay assay 
β-galactosidase activity was determined using an X-Gal agarose overlay assay as 
described by the Herskowitz lab (http://biochemistry.ucsf.edu/%7Eherskowitz/xgalagar.html). 
Strains were grown as single colonies on YNB agar plates containing the indicated 
ammonium concentrations at 37°C for 6 days. To perform the assay, 5 mg/ml low melting 
agarose was boiled in 10 ml stock solution containing 9.3 ml 0.5M potassium phosphate 
buffer pH 7.0 (61 ml of 1M K2HPO4 and 39 ml of 1M KH2PO4 was mixed to make 200 ml of 
buffer, and filter sterilized). Then 0.5 mg/ml X-Gal and 1 drop of β-mercaptoethanol (i.e., 
about 50 µl/ 100 ml) was added to the warm solution (50-60°C) and using a Pasteur pipette, 
the surface of each plate was covered with this warm solution. After the agarose solidifies 
(~5-10 minutes), plates were incubated for 2 hours at 30°C until the blue color developed. 
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4. Results 
 
4.1. Nitrogen starvation induced filamentous growth and ammonium 
transporters of C.albicans 
 
4.1.1. Nitrogen starvation induced filament formation in C.albicans is controlled by the 
availability of ammonium 
Candida albicans grows in different morphological forms: yeast, pseuodohyphae and 
hyphae. These morphological transitions are induced by various factors like, pH, temperature, 
presence of serum, or nutritional starvation. On agar plates containing low ammonium 
concentrations (100 µM) C.albicans switches from yeast to filamentous growth, with hyphae 
and pseudohyphae emanating from the borders of the colonies after several days of incubation 
at 37°C (Csank et al., 1998). To study nitrogen starvation induced filamentous growth in 
more detail, the C.albicans wild-type strain SC5314 was grown on agar plates containing 
various concentrations of ammonium and other nitrogen sources. The strain formed filaments 
at low ammonium concentration but grew in the yeast form at 10 mM or higher 
concentrations of ammonium (Fig. 3A). Filamentous growth was also observed when 
ammonium was replaced by urea or different amino acids as sole source of nitrogen, and was 
inhibited by the addition of 10 mM or higher concentrations of ammonium (Fig. 3B). In 
contrast, when the concentration of amino acids in the agar plates were increased from 
100 µM to 10 mM, the colonies still exhibited various degrees of filamentation, but 
filamentous growth was suppressed when sufficient amounts of ammonium were provided in 
addition (Fig. 3C). Although some amino acids have been reported to be inducers of filament 
formation in C.albicans (Land et al., 1975), these results demonstrate that the filamentous 
growth seen under these conditions is a response of C.albicans to nitrogen starvation or to an 
imbalance in nitrogen metabolites which is suppressed by the presence of sufficient amounts 
of a preferred nitrogen source, ammonium. In contrast, ammonium even at very high 
concentration could not repress the filamentation induced by other environmental signals, like 
the presence of serum (Fig. 3D). 
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Fig. 3. Nitrogen starvation induced filamentous growth of C.albicans is controlled by ammonium availability. 
The wild-type strain SC5314 was grown on the indicated agar plates for 6 days at 37°C and individual 
representative colonies were photographed. (A) Growth on YNB plates containing 100 µM (SLAD) or 10 mM 
ammonium as the sole nitrogen source. (B) Growth on YNB plates containing urea, glutamine, glutamate, 
histidine, proline, arginine, or complete supplement medium (CSM) at 100 µM concentration as the sole nitrogen 
source (upper row) or together with 10 mM ammonium (lower row). (C) Growth on YNB plates containing urea, 
glutamine, glutamate, histidine or proline at 10 mM concentration as the sole nitrogen source (upper row) or 
together with 100 mM ammonium (lower row).  (D) Serum induced filamentous growth in the absence (left) or 
presence of 100 mM ammonium (right). 
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4.1.2. Identification of C.albicans ammonium permeases 
Since ammonium controls the filamentation of C.albicans in the presence of limiting 
nitrogen concentrations, it was interesting to study the role of ammonium permeases in 
C.albicans morphogenesis. A BLAST search of the C.albicans genome sequence 
(http://www-sequence.stanford.edu/group/candida/) identified two putative ammonium 
permeases Mep1p and Mep2p on the basis of high homology to S.cerevisiae Mep1, Mep2 and 
Mep3 proteins. ORF 6.6912 encodes a putative 51.9 kD protein of 480 amino acids that 
exhibits highest similarity to ScMep2p (72% similarity, 64% identity). This ORF shows lower 
level of homologies to ScMep1p (51%/41%) and ScMep3p (52%/42%) and so the 
corresponding gene was termed CaMEP2. ORF 6.1090 encodes a putative 59.4 kD protein of 
534 amino acids that exhibits high similarity to both ScMep1p (63%/54%) and ScMep3p 
(65%/57%), and lower similarity to ScMep2p (52%/41%) and the corresponding gene was 
termed as CaMEP1. A third open reading frame, ORF 6.7259, encodes a protein that has 
much lower homology than CaMep1p and CaMep2p to all three ScMep proteins (43 to 45% 
similarity, 32 to 36% identity) and the results of this study (see below) suggest that this ORF 
may not encode a functional ammonium permease. CaMep1p and CaMep2p have 52% 
similarity and 43% identity to each other. All these three proteins have 11 transmembrane 
domains, with an extracytosolic N-terminus and a C-terminal cytoplasmic tail, as predicted by 
the TMpred programme (Fig. 4). 
  
 
                                                          OUT                                                                                                     IN 
CaMep1p         MSAEEVIQYISRRKLFTENNE-YNESYLLLFTIASSMIWIMIPGLAFLYSGLARRKSALS 59 
ORF 6.7259      ---------MSTDVEPMTSLDVTTGLNSLYMLYCTAPLPLVVIGIAFFYSGLTQRRSALT 51 
CaMep2p         MSGNFTGTGTGGDVFKVDLNEQFDRADMVWIGTASVLVWIMIPGVGLLYSGISRKKHALS 60 
                          .         :       : :  .:  : ::: *:.::***::::: **: 
 
                                                 
                                              OUT 
CaMep1p         MIWIVIMSSFVGIFQWYFWGYSLAFSDTSKNSFIGDLHFFGFKNLLGASDDKTT-----Y 114 
ORF 6.7259      MFAVPFLLAPMIIIDWFIWGYSLCYSASS-NHFIGNLNYVVLRQFRNALTAEFTNTRGHV 110 
CaMep2p         LMWAALMAACVAAFQWFWWGYSLVFAHNG-SVFLGTLQNFCLKDVLGAPSIVKT-----V 114 
                ::   :: : :  ::*: ***** :: .. . *:* *: . :::. .*     *       
 
                                           IN                           OUT 
CaMep1p         PDIAYSLFQLQFLLVTLAIIAGGCIAERGRFLPALVFMFCWATVVYCPVVYWIWGG-GWA 173 
ORF 6.7259      LAGAHVLFNMFFKLICVSLTFPGCIAERGRVLPMILFAFIWSVIIYNPVTYWFWNSNGWL 170 
CaMep2p         PDILFCLYQGMFAAVTAILMAG-AGCERARLGPMMVFLFIWLTVVYCPIAYWTWGGNGWL 173 
                    . *::  *  :   :    . .**.*. * ::* * * .::* *:.** *.. **  
 
                                                         IN 
CaMep1p         SSYR--SGALDYAGGGPVEILSGMSAFVYSAFLGRRNETLMIN----YRPHNISTIFLGT 227 
ORF 6.7259      SVDLGRLPVLDFAGGNCVHIVSGFTCLAYSYILGPRNPKLLYN----YRNSNTGHIIFGT 226 
CaMep2p         VS----LGALDFAGGGPVHENSGFAALAYSLWLGKRHDPVAKGKVPKYKPHSVSSIVMGT 229 
                        .**:***. *.  **::.:.**  ** *:  :  .    *:  . . *.:** 
                                  OUT                              IN                                    
CaMep1p         SLLYVGWLFFNGFSCGNPSLKVAYSMMNTHLCGAFGAISWCLLD-FRLEN---------- 276 
ORF 6.7259      FLVFMGWIGYIAGCDFKFSFNSIYIILNTLIAACASGIVWTAIDFFFSSVPLEGESVGLK 286 
CaMep2p         IFLWFGWYGFNGGSTGNSSMRSWYACVNTNLAAATGGLTWMLVDWFRTGG---------- 279 
                 :::.**  : . .  : *:.  *  :** :... ..: *  :* *               
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CaMep1p         --------------------------------------------KWSMVAVCSGCISGLV 292 
ORF 6.7259      HGDSKLSNSSGDNHSPMLQAIVSRTGVSINQRLHESKSNFVEKRKFSMISFSSGIMTGLV 346 
CaMep2p         --------------------------------------------KWSTVGLCMGAIAGLV 295 
                                                            *:* :... * ::*** 
 
                       OUT                            IN 
CaMep1p         AATPSSGMIP----LWASVILGITAGIVCNLSTKIKYLLHVDDSLDVWAEHGMAGVVGLI 348 
ORF 6.7259      VFTPGGGYVSSNAEFWKGIIFGVVGAISGNLATRLKYFFNIDDALDLFAVHGIPGIVGSM 406 
CaMep2p         GITPAAGYVP----VYTSVIFGIVPAIICNFAVDLKDLLQIDDGMDVWALHGVGGFVGNF 351 
                  **..* :.    .: .:*:*:. .*  *::. :* ::::**.:*::* **: *.** : 
                                                                       
          ∆C404 
                                      OUT                                IN 
CaMep1p         FNALFGSATVIGYDGVTDHQGGWIDHNWKQLYIQIVYILATMAYSGVVTAILCFVINKIP 408 
ORF 6.7259      LTGIFAN-------DLYDSKGGWVKGHWKQFGYQLLGLVVTSAYVFIMSMVFLYLIDLIP 459 
CaMep2p         MTGLFAADYVAMIDG-TEIDGGWMNHHWKQLGYQLAGSCAVAAWSFTVTSIILLAMDRIP 410 
                :..:*.        .  : .***:. :***:  *:    .. *:   :: ::   :: ** 
               ∆C406 
                                            ∆C438     
 
CaMep1p         GLHLRIDYNGEEAGVDEDQIGEFAYDYVEVRRDFLDWGIPTVNPTYQNSINDQQQQQQPE 468 
ORF 6.7259      GFHLRIDKDFNRREREKTLKAKQLDQELESQTS-----PQQVVPHMSNSTEQMSFWEQVE 514 
Camep2p         FLRIRLHEDEEMLGTDLAQIGEYAY-YADDD--------PETNPYVLEPIRSTTISQP-- 459 
                 :::*:. : :    :    .:      :            . *   :. ..    :    
                 ∆C413     ∆C423             ∆C440 
 
 
CaMep1p         VPEITSQQKRGGGLSGIEEAEEKQVQGIPIKRQTQIIDGTTTQSNSDTTSNTSIQEKHDP 528 
ORF 6.7259      LQGTDGYEFNGEFMLDFMEFIRAIRPQDYEDDDLKDIIQAPNQYEGYIGQDFELHQEGVH 574 
Camep2p         LPHIDG-----------------------------VADGSSNNDSGEAKN---------- 480 
                :    .                                 :..: ..   .           
 
 
CaMep1p         VEYRPS 534 
ORF 6.7259      NLTKRE 580 
CaMep2p         ------ 
 
 
 
Fig.  4. Sequence alignment of CaMep1p, ORF 6.7259 and CaMep2p using the ClustalW program 
(http://www.ebi.ac.uk/clustalw/#). Amino acid positions are shown on the right. Identical, conserved, and semi-
conserved residues are indicated by stars, colons, and dots, respectively, below the sequence. The 11 
transmembrane domains predicted by the TMpred program 
(http://www.ch.embnet.org/software/TMPRED_form.html) are highlighted in red. The extracytosolic and 
intracellular domains of the permeases are labeled as OUT and IN, respectively. The positions of the generated 
C-terminal truncations in CaMep1p and CaMep2p are marked by open triangles. 
 
 
 
4.1.3. Construction of C.albicans strains with different MEP gene deletions 
In order to study the role of CaMEP1 and CaMEP2 in ammonium uptake and 
filamentous growth of C.albicans, a series of mutants was constructed in which these genes 
were specifically deleted from the genome. To construct the mutant strains in the diploid 
C.albicans the URA3-flipping strategy (Morschhäuser et al., 1999) was used. The URA3 
flipper cassette contains the C.albicans URA3 gene as a selectable marker and C.albicans 
adapted recombinase caFLP gene under control of the inducible SAP2 promoter, flanked by 
FLP recognition sites (FRT).  
When such a construct is cloned between the upstream and downstream regions of a 
gene and integrated into the yeast genome by homologous recombination, one of the two 
alleles of the target gene is inactivated. Upon induction of the SAP2 promoter the FLP 
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recombinase is expressed and recombines its target sites, resulting in the excision of the 
URA3 flipper cassette from the genome. The ura3 derivatives can easily be identified on SD 
agar plates containing 10 µg/ml uridine where these strains grow as smaller colonies than 
URA3 strains. A second round of insertion/excision of the URA3 flipper generates 
homozygous mutant. To construct complemented strains and appropriate controls, these ura3 
homozygous mutants serve as a host for the integration of URA3 marker alone or along with a 
complete copy of the gene of interest into one of the inactivated alleles.   This process is 
schematically explained in Fig.  5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5. Schematic representation of disruption of a gene of interest in C.albicans and reintroduction of a 
functional allele. 
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To obtain a ∆mep2 mutant, the ura3-negative strain CAI4 was transformed with a 
deletion cassette in which the whole CaMEP2 coding sequence had been replaced by the 
URA3 flipper (see section 3.2 and Fig. 6A). The two CaMEP2 alleles of strain CAI4 could be 
distinguished by EcoRI restriction site polymorphism. In each case, the two alleles were 
arbitrarily assigned a suffix (e.g., MEP2-1 and MEP2-2), and two transformants carrying the 
integration of the URA3 flipper in either of the two possible CaMEP2 alleles were selected. 
The URA3 flipper was then excised by FLP-mediated recombination from two transformants 
in which the deletion cassettes had been correctly integrated into either  the CaMEP2-1 allele 
(strains  MEP2M1A) or into the CaMEP2-2 allele (MEP2M1B, Fig. 7, lanes 2 and 3), 
resulting in the uridine-auxotrophic strains MEP2M2A and MEP2M2B (Fig. 7, lanes 4 and 5).  
When these strains were transformed again with the same deletion cassette, integrations were 
successfully targeted to the remaining wild-type MEP2 alleles in several transformants of 
both parent strains and generated the strains MEP2M3A and MEP2M3B (Fig. 7, lanes 6 and 
7). The URA3 flipper was excised again from MEP2M3A and MEP2M3B to generate the 
uridine-auxotrophic derivatives MEP2M4A and MEP2M4B (Fig. 7, lanes 8 and 9).  
 
 
 A.                                                                       B. 
 
 
 
 
 
  
 
 
 
 
 
Fig.  6. (A) Structure of the deletion cassette from plasmid pMEP2M2 (top) and genomic structure of the 
CaMEP2 locus in the parent strain CAI4 (bottom). The CaMEP2 coding region is represented by the white 
arrow, and the upstream and downstream sequences by the solid lines. Details of the URA3 flipper (grey 
rectangle bordered by FRT sites [black arrows]) are presented in Fig. 5. The 34 bp FRT sites are not drawn to 
scale. The probe used for Southern hybridization analysis of the mutants is indicated by the black bar. (B) 
Structure of the DNA fragments from pMEP2K1 (top) and pMEP2M4 (bottom), which were used for 
reintegration of an intact CaMEP2 copy (white arrow) or only the URA3 marker (grey arrow), respectively, into 
one of the inactivated ∆mep2 alleles (middle). The ACT1 transcription termination sequence (ACT1T) is 
indicated by the black diamond. Only relevant restriction sites are given. Bg, BglII; E, EcoRI; K, KpnI; P, PstI; 
ScI, SacI; Xh, XhoI. The EcoRI site shown in parentheses is present only in the CaMEP2-1 allele. 
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The strains MEP2M4A and MEP2M4B served as hosts for the generation of two 
independent, prototrophic, homozygous ∆mep2 mutant MEP2M5A and MEP2M5B (Fig. 6B, 
bottom and Fig. 7, lanes 10 and 11) and the corresponding complemented strains 
MEP2MK2A and MEP2MK2B (Fig. 6B, top and Fig. 7, lanes 12 and 13) by reintroduction of 
the URA3 selection marker alone or a complete copy of the CaMEP2 gene into one of the 
inactivated ∆mep2 alleles. 
 
 
 
 
 
 
 
 
 
 
  
 
 
Fig. 7. Southern hybridization of EcoRI-digested genomic DNA of the parent strain CAI4 and mutant 
derivatives with a CaMEP2-specific probe shown in Fig. 6A. The sizes of the hybridizing fragments (in kb) are 
given on the left side of the blot and their identities are indicated on the right. 
 
 
 
CaMEP1 gene was deleted using a similar procedure to generate ∆mep1 single as well 
as ∆mep1 ∆mep2 double mutants. A deletion cassette in which the whole CaMEP1 coding 
sequence had been replaced by the URA3 flipper (see section 3.2 and Fig. 8A) was 
constructed. The construction of ∆mep1 single mutants has been documented in Fig. 8 and 
Fig. 9.  The parental strain CAI4 was used to generate ∆mep1 single mutants. The two 
CaMEP1 alleles of CAI4 and its derivatives could be distinguished by ClaI restriction site 
polymorphism and were arbitrarily assigned a suffix (e.g., MEP1-1 and MEP1-2). Two 
transformants in which the URA3 flipper was integrated into either the CaMEP1-1 allele 
(MEP1M1A, Fig. 9, lanes 2)  or into the CaMEP1-2 allele (MEP1M1B, Fig. 9, lanes 3) were 
selected and the URA3 flipper was excised by FLP-mediated recombination to generate the 
uridine-auxotrophic strains MEP1M2A and MEP1M2B (Fig. 9, lanes 4 and 5). These strains 
were then again transformed with the same deletion cassette and the integrations were 
5.6
4.1
∆ mep2- 1:: URA3
∆ mep2- 1:: URA3 - FLIP
MEP2 -2
CA
I4
M
EP
2M
1A
M
EP
2M
1B
M
EP
2M
2A
M
EP
2M
2B
M
EP
2M
3A
M
EP
2M
3B
M
EP
2M
4A
M
EP
2M
4B
M
EP
2M
5A
M
EP
2M
5B
M
EP
2M
K1
A
M
EP
2M
K1
B
1     2     3     4     5    6     7    8     9   10   11   12  13
∆ mep2-2 ::FRT
MEP2 -1
∆ mep2- 2:: URA3 - FLIP
∆ mep2- 2:: URA3
MEP2 -1:: URA3
∆ mep2- 1:: FRT
MEP2- 2 ::URA3
2.8
4.3
2.6
1.6
3.1
4.6
1     2      3     4     5     6      7     8     9   10   11   12    13
  Results 
 
 56 
successfully targeted to the remaining wild-type CaMEP1 allele in several transformants of 
both parent strains. The URA3 flipper was excised again from the two independent 
homozygous ∆mep1 mutants MEP1M3A and MEP1M3B (Fig. 9, lanes 6 and 7), generating 
the uridine-auxotrophic derivatives MEP1M4A and MEP1M4B (Fig. 9, lanes 8 and 9).  
 
 A. 
Fig.  8. (A) Structure of the deletion 
cassette from plasmid pMEP1M2 (top) 
and genomic structure of the CaMEP1 
locus in the parent strain CAI4 
(bottom). The CaMEP1 coding region 
is represented by the white arrow, and 
the upstream and downstream 
sequences by the solid lines. The 
34 bp FRT sites are not drawn to scale. 
The probe used for Southern 
hybridization analysis of the mutants 
is indicated by the black bar. (B) 
Structure of the DNA fragments from 
pMEP1K1 (top) and pMEP1M4 
(bottom), which were used for 
reintegration of an intact CaMEP1 
copy (white arrow) or only the URA3 
marker (grey arrow), respectively, into 
one of the inactivated ∆mep1 alleles 
(middle). The ACT1 transcription 
termination sequence (ACT1T) is 
indicated by the black diamond. Only 
relevant restriction sites are given. Bg, 
BglII; C, ClaI; K, KpnI; P, PstI; ScI, 
SacI; Xh, XhoI. The ClaI site shown in 
parentheses is present only in the 
CaMEP2-1 allele. 
 
 
 
   
To generate the prototrophic ∆mep1 mutants the URA3 selection marker alone was 
integrated into either of the two inactivated ∆mep1 alleles (see section 3.2 and Fig. 8B, 
bottom) of the homozygous ∆mep1 mutants MEP1M4A and MEP1M4B, resulting to the 
generation of the strains MEP1M5A and MEP1M5B (Fig. 9, lanes 10 and 11). For the 
reintroduction of the complete copy of the CaMEP1 gene (see section 3.2 and Fig. 8B) along 
with the URA3 marker, an intact CaMEP1 copy was integrated into either of the inactivated 
∆mep1 alleles in strains MEP1M4A and MEP1M4B to generate the complemented strains 
MEP1MK1A and MEP1MK1B (Fig. 9, lanes 12 and13). 
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Fig. 9. Southern hybridization of ClaI-digested genomic DNA of the parent strain CAI4 and mutant derivatives 
with a CaMEP1-specific probe shown in Fig. 8A. The sizes of the hybridizing fragments (in kb) are given on the 
left side of the blot and their identities are indicated on the right.  
 
 
 
To construct ∆mep1 ∆mep2 double mutants the ∆mep2 mutants, MEP2M4A and 
MEP2M4B (see section 3.3) were transformed with the CaMEP1 deletion cassette. From each 
parent strains, one transformant in which the URA3 flipper was integrated into either the 
CaMEP1-1 allele of strain MEP2M4A (MEP12M1A, Fig. 10, lanes 4) or into the CaMEP1-2 
allele of strain MEP2M4B (MEP12M1B, Fig. 10, lanes 5) was selected. The URA3 flipper 
was excised from these strains by FLP-mediated recombination, resulting in the uridine-
auxotrophic strains MEP12M2A and MEP12M2B (Fig. 10, lanes 6 and 7). Deletion of the 
remaining CaMEP1 wild-type alleles in a second round of insertion/excision of the URA3 
flipper generated strains MEP12M3A and B (Fig. 10, lanes 8 and 9) and their ura3-negative 
derivatives MEP12M4A and B (Fig. 10, lanes 10 and 11). The homozygous ∆mep1 ∆mep2 
double mutants (MEP12M4A and B) then served as host strains for reintroduction of an intact 
CaMEP1 copy with the help of the URA3 marker (Fig. 8B, top) into either of the two 
inactivated ∆mep1 alleles, resulting in strains MEP12MK1A and B (Fig. 10A, lanes 16 and 
17), or of an intact CaMEP2 copy into either of the two inactivated ∆mep2 alleles, resulting in 
strains MEP12MK2A and B (Fig. 10B, lanes 18 and 19). To obtain appropriate control 
strains, the URA3 marker alone was inserted in the identical way (see Fig. 8B, bottom and 
Fig. 6B, bottom) into either of the four possible alleles, thereby generating the prototrophic, 
homozygous ∆mep1 ∆mep2 double mutants MEP12M5A and B and MEP12M6A and B 
(Fig. 10A and B, lanes 12 to 15).  
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A. 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Construction of C.albicans ∆mep1 ∆mep2 double mutants and complemented strains. (A) Southern 
hybridization of ClaI-digested genomic DNA of the wild-type strain CAI4, the ∆mep2 parental strains 
MEP2M4A and B, and mep1 mutant derivatives with a CaMEP1-specific probe shown in Fig. 8A. The sizes of 
the hybridizing fragments (in kb) are given on the left side of the blot and their identities are indicated on the 
right. (B) Southern hybridization of EcoRI-digested genomic DNA of the same strains with the CaMEP2-
specific probe shown in Fig. 6A. 
 
 
4.1.4. CaMep1p and CaMep2p are functional ammonium permeases 
The ability of all mep mutants to grow on media containing various ammonium 
concentrations as the sole nitrogen source (Fig. 11) was tested.  Strains lacking both the Mep 
proteins showed a severe growth defect on media containing less than 5 mM ammonium. At 
high ammonium concentrations (76 mM) the ∆mep1 ∆mep2 double mutants grew well, 
presumably because under these conditions sufficient ammonium can diffuse across the 
cytoplasmic membrane in an unmediated manner fast enough to allow optimal growth (Marini 
et al., 1997; Soupene et al., 2001). Compared to the wild-type strain, cells with a single MEP 
gene deletion were not affected for growth on all ammonium concentrations tested (data not 
shown). In contrast to the double mutants, cells expressing a single Mep protein were able to 
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complement the growth defect at low ammonium concentrations. Uridine-auxotrophic strains 
behaved like their prototrophic counterparts (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11. Growth of the wild-type strain SC5314, the ∆mep1 ∆mep2 double mutants MEP12M5 and MEP12M6, 
and the complemented strains MEP12MK1 and MEP12MK2 in which an intact copy of CaMEP1 or CaMEP2, 
respectively, was reintroduced, on YNB agar plates containing the indicated ammonium concentrations. The 
plates were incubated at 30°C for 4 days. The strain pairs A and B behaved identically and only one of them is 
shown in each case. The ∆mep1 and ∆mep2 single mutants grew as well as the wild-type strain and are not 
included in the figure. 
 
 
 
The ability of ∆mep mutants to extract the ammonium from minimal proline medium 
containing 1mM ammonium (see section 3.9) was then examined. In comparison to the wild-
type strain and strains expressing either of the Mep proteins, ∆mep1 ∆mep2 double mutants 
exhibited no ammonium uptake capacity (Fig. 12). Cells expressing either of the Mep proteins 
did not exhibit any difference in the ammonium uptake capacity compared to the wild-type. 
These findings are consistent with the growth of these strains on ammonium limiting medium. 
These results provide experimental evidence that both these proteins are functional 
ammonium permeases and the expression of either of the two permeases is sufficient to allow 
growth of C.albicans under low ammonium conditions. 
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Fig. 12. Ammonium uptake from the medium by the wild-type strain SC5314, the ∆mep1 ∆mep2 double mutants 
MEP12M5A/B and MEP12M6A/B, and the complemented strains MEP12MK1A/B (∆mep1 ∆mep2 + CaMEP1) 
and MEP12MK2A/B (∆mep1 ∆mep2 + CaMEP2). For experimental details see section 3.9. 
 
 
 
4.1.5. The CaMep2 ammonium permease is required for nitrogen starvation induced 
filamentous growth 
To test whether these two ammonium permeases affect filamentous growth in low 
nitrogen medium, the morphology of a series of mep mutants was tested after growth for 6 
days at 37°C on plates containing 100 µM ammonium (Fig. 13). Strains lacking Mep2 
showed a severe defect in filamentation in low nitrogen medium, however, these strains had 
no apparent growth defect. In contrast, deletion of CaMEP1 had no effect on hyphal growth 
as noted above. Strains lacking both ammonium permeases showed severe growth defect on 
low nitrogen medium, but when these strains were complemented either with CaMEP1 or 
CaMEP2, the growth defect was complemented. However, the filamentation defect was 
complemented only when CaMEP2 was reintroduced (Fig. 13, first row). 
In S.cerevisiae, ScMEP2 is essential for pseudohyphal growth at low ammonium 
concentrations, but ScMEP2 deletion does not affect pseudohyphae formation when limiting 
concentrations of other nitrogen sources, like amino acids are present instead of ammonium, 
which led to the current model that ScMep2p is an ammonium sensor regulating 
pseudohyphal differentiation (Lorenz and Heitman, 1998a). Therefore, whether CaMEP2 is 
involved in the induction of filamentous growth of C.albicans by other environmental signals 
was tested. The ∆mep1 ∆mep2 strains did not show any growth defect when the media contain 
limiting concentrations of urea or amino acids like glutamine, proline, glutamate, histidine, or 
 
minutes
A 3
40
SC5314
MEP12M5A
MEP12M5B
MEP12M6A
MEP12M6B
MEP12MK1A
MEP12MK1B
MEP12MK2A
MEP12MK2B
0
0,05
0,1
0,15
0,2
0 30 60 90 120
A 3
40
  Results 
 
 61 
arginine as the sole nitrogen source. However, except when arginine was used, in all other 
conditions the capacity to switch from yeast to filamentous growth depended on the presence 
of a functional CaMEP2 gene (Fig. 13). All those phenotypes were seen in both URA3 and 
ura3 mutants when the mutants were compared with their respective control strains (data not 
shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13. CaMEP2 is required for nitrogen starvation induced filamentous growth of C.albicans. (A) YPD 
precultures of the strains were appropriately diluted and spread on YNB plates containing the indicated nitrogen 
sources at a concentration of 100 µM. Individual colonies were photographed after incubation for 6 days at 
37°C. The small colonies produced by the ∆mep1 ∆mep2 double mutants on plates containing 100 µM 
ammonium (SLAD) are due to residual growth after transfer from rich medium and no growth was observed 
when these strains were restreaked on the same plates. The following strains were used: wild-type, SC5314; 
∆mep1, MEP1M5A and B, ∆mep2, MEP2M5A and B, ∆mep1 ∆mep2, MEP12M5A and B and MEP12M6A and 
B; ∆mep1 ∆mep2 + MEP1, MEP12MK1A and B; ∆mep1 ∆mep2 + MEP2, MEP12MK2A and B. Independently 
constructed mutants and complemented strains behaved identically and only one of them is shown in each case. 
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Apart from nitrogen starvation, filamentous growth of C.albicans can be induced by 
many other environmental factors, like the presence of serum, a shift from acidic to neutral 
pH, or embedding in agar. When the mutant strains were incubated in other hyphal inducing 
media, like on serum containing plates or after embedding in agar, they showed no defect in 
hyphal formation (Fig. 14). Moreover, ∆mep2 mutants had no defect in hyphal induction in 
any of the liquid hyphal inducing media tested,  which indicates that CaMEP2 has no role in 
hyphal induction under those conditions (Fig. 15). 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14. Hyphal growth was induced in plates containing 10% serum (top row) or by embedding the cells in YPS 
agar (bottom row). Photographs were taken after 6 days of growth at 37°C (serum) or at 25°C (YPS). Deletion of 
CaMEP2 did not affect hyphal growth under these conditions. The following strains were used: wild-type, 
SC5314; ∆mep1, MEP1M5A and B, ∆mep2, MEP2M5A and B, ∆mep1 ∆mep2, MEP12M5A and B and 
MEP12M6A and B; ∆mep1 ∆mep2 + MEP1, MEP12MK1A and B; ∆mep1 ∆mep2 + MEP2, MEP12MK2A and 
B. Independently constructed mutants and complemented strains behaved identically and only one of them is 
shown in each case. 
 
 
 
 
  
 
 
 
 
 
 
 
 
Fig. 15. Filamentous growth of cells in liquid culture. YPD grown cells were diluted 1:100 in the hyphal 
inducing media and photographs were taken after 6 hours incubation at 37°C. Deletion of CaMEP2 had no effect 
in hyphal induction in these media. The following strains were used: wild-type, SC5314; ∆mep2, MEP2M5A. 
Independently constructed mutants and complemented strains behaved identically. 
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4.1.6. Regulation of CaMEP1 and CaMEP2 expression 
The physiological role of ammonium permeases is to scavenge external ammonium 
for use as a nitrogen source. The results above demonstrated that CaMEP1 and CaMEP2 are 
functional ammonium permeases, but CaMEP2 has an additional function in the switch from 
yeast to filamentous growth under nitrogen starvation conditions. In order to understand these 
functional differences, the regulation of CaMEP1 and CaMEP2 expression by nitrogen 
availability was investigated.  
Northern hybridization using RNA from the wild-type strain SC5314, grown at 
different concentrations of ammonium or other nitrogen sources, showed a single band 
hybridizing with the probe used to detect CaMEP2 transcript. The intensity of the signal 
varied according to the nitrogen sources available in the medium. No or very low amounts of 
CaMEP2 RNA were detected when cells were grown at 20 mM or higher concentrations of 
ammonium, but CaMEP2 expression was strongly induced when the ammonium 
concentration was decreased to 10 mM and below (Fig. 16, lanes 1-4). Comparable levels of 
CaMEP2 mRNA were detected when 100 µM of urea or different amino acids were used as 
the sole source of nitrogen (Fig. 16, lanes 5-10), indicating that the presence of ammonium is 
not required to induce CaMEP2 expression under nitrogen limiting conditions. In several 
repeat experiments no CaMEP1 transcript could be detected in any of the conditions tested, 
even in a ∆mep2 background (data not shown). However, the phenotype of ∆mep1 ∆mep2 
double mutants demonstrates that at least under low ammonium conditions sufficient 
expression of CaMEP1 must occur to support growth. 
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Fig.  16. Detection of CaMEP2 mRNA by Northern hybridization analysis of the wild-type strain SC5314 grown 
at 30°C to log phase in liquid YNB medium containing the indicated concentrations of ammonium, urea, or 
amino acids (see section 3.6.1 for growth conditions). 
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Since no good quality RNA could be isolated from cells growing as agar invading 
filaments on plates, lacZ reporter fusions were used to analyze expression of the CaMEP1 and 
CaMEP2 promoters on solid media containing different ammonium concentrations. At 10 
mM or lower concentrations of ammonium the CaMEP2 promoter was strongly induced, 
producing intense blue stained colonies in X-Gal agarose overlay assay (see section 3.10), 
whereas on plates containing 20 mM or higher concentrations of ammonium the CaMEP2P-
lacZ fusion produced β-galactosidase acitivity that was only slightly above the background 
(Fig. 17, last row). This result indicates that the regulation of CaMEP2 expression by 
ammonium levels on the solid media is similar to that seen in liquid media. At high 
ammonium concentrations, colonies of strains carrying a CaMEP1P-lacZ fusion showed a 
somewhat stronger color production than those expressing lacZ from the CaMEP2 promoter, 
but the CaMEP1 promoter was also clearly induced when ammonium levels decreased to 10 
mM or below (Fig. 17, third row). These results indicate that both CaMEP1 and CaMEP2 are 
induced when ammonium levels become limiting and require transporter mediated uptake. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17. Induction of the CaMEP1 and CaMEP2 promoters on solid media with varying ammonium 
concentrations. Strains carrying MEP1P-lacZ or MEP2P-lacZ reporter fusions were grown on YNB agar plates 
containing the indicated concentrations of ammonium and β-galactosidase activity was measured using an X-Gal 
agarose overlay assay (see section 3.10). Individual colonies were photographed. The strain pairs CLACZ1A/B 
(MEP1P-lacZ) and CLACZ2A/B (MEP2P-lacZ) behaved identically and only one of them is shown in each 
case. Strain CALACZ1, which carries a ACT1P-lacZ fusion (Uhl and Johnson, 2001), served as a positive 
control, and the wild-type strain SC5314 was used as a negative control. 
 
 
 
Since the lacZ reporter fusion experiment did not detect differences in the expression 
levels of the two permeases at low ammonium concentrations, which was in contrast to the 
results of the Northern analysis, strains expressing GFP-tagged CaMep1p or CaMep2p (see 
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section 3.3) were used to compare the expression of CaMEP1 and CaMEP2 in different 
growth conditions. When expressed in a ∆mep1 ∆mep2 double mutant background, the GFP-
tagged CaMEP1 and CaMEP2 genes restored ammonium uptake and growth on SLAD plates 
(see section 4.1.7), demonstrating that they encode functional ammonium permeases.  
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18. Expression of GFP-tagged CaMep1p (A) or CaMep2p (B) after 6 days of growth at 37°C on YNB agar 
plates containing the indicated concentrations of ammonium. Fluorescence of the cells was observed by confocal 
microscopy. The strain pairs CMEP1GA/B (MEP1-GFP) and CMEP2GA/B (MEP2-GFP) behaved identically 
and only one of them is shown in each case.  
 
 
Expression of the GFP-tagged CaMep2p could be detected by fluorescence of the cells 
at their peripheries when the reporter strains were grown at low ammonium concentrations, 
whereas no fluorescence was detected at higher ammonium concentrations (Fig. 18B). In 
accordance with the results of Northern hybridization experiments (Fig. 16) no significant 
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difference in expression of the CaMep2p-GFP fusion was detected during logarithmic growth 
in liquid medium containing 100 µM or 10 mM ammonium (Fig. 19). On solid medium, cells 
grown at 100 µM ammonium exhibited stronger fluorescence than cells grown at 10 mM 
ammonium, suggesting CaMEP2 is expressed at higher levels when C.albicans switches from 
yeast to filamentous growth (Fig. 18B). No fluorescence of cells carrying the CaMEP1-GFP 
fusion was detectable at any ammonium concentration (Fig. 18A), which is in line with the 
results of the Northern hybridization experiments. Altogether these results showed that at low 
ammonium concentrations the promoters of both CaMEP1 and CaMEP2 are induced (as seen 
from the lacZ reporter fusions) but CaMEP2 is expressed much more strongly than CaMEP1 
(as judged the amounts of mRNA and GFP-tagged proteins). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19. Expression of CaMep2-GFP fusion protein in cells grown at 30°C to log phase in liquid YNB medium 
containing 100 µM or 10 mM ammonium. Fluorescence of the cells was observed by confocal microscopy. The 
two independently constructed reporter strains MEP12MG2A and B behaved identically and only one of them is 
shown. 
 
 
 
4.1.7. Nitrogen starvation induced filamentous growth depends on high CaMEP2 
expression levels 
To investigate whether the differences in the expression level of the two ammonium 
permeases determine their different role in filament induction, both genes were expressed 
under the control of the strong ADH1 promoter. In addition, promoter swapping experiments 
were also performed, where CaMEP1 was expressed from the CaMEP2 promoter and vice 
versa (Fig. 20A and B).  
Expression of CaMEP1 from the ADH1 promoter rescued the growth defect of ∆mep1 
∆mep2 double mutants on SLAD plates and restored ammonium uptake to wild-type levels, 
but did not result in filamentous growth. When CaMEP1 was expressed under the control of 
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CaMEP2 promoter, ammonium uptake and growth on SLAD plates were also restored, and a 
minor percentage of the colonies even showed a weak filamentation. In contrast, the defects in 
ammonium uptake and growth on SLAD plates of ∆mep1 ∆mep2 double mutants were only 
partially rescued when CaMEP2 was expressed from the ADH1 or the CaMEP1 promoter. 
Importantly, these strains were also unable to filament on SLAD plates (Fig. 20A and B). 
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Fig. 20. Growth and ammonium uptake of strains expressing a single copy of CaMEP1 or CaMEP2 under 
control of the CaMEP1, CaMEP2, or ADH1 promoter. (A) ∆mep1 ∆mep2 double mutants carrying the indicated 
fusions were grown for 6 days at 37°C on SLAD plates. All colonies are shown at the same magnification. 
Transformants of the independently generated ∆mep1 ∆mep2 mutants MEP12M4A and B behaved identically 
and only one of them is shown in each case. The wild-type strain SC5314 and a ∆mep1 ∆mep2 double mutant 
were included for comparison. (B) Ammonium uptake of the same strains was measured as described in 
Materials and methods. The following strains were used: ∆mep1 ∆mep2, MEP12M5A and MEP12M6A; 
MEP1P-MEP1, MEP12MK1A and B; MEP2P-MEP1, MEP12MK3A and B; ADH1P-MEP1, MEP12ME1A and 
B; MEP1P-MEP2, MEP12MK4A and B; MEP2P-MEP2, MEP12MK2A and B; ADH1P-MEP2, MEP12ME2A 
and B. 
 
 
In order to relate the phenotypes of strains to the expression levels of the ammonium 
permeases, expressions of CaMEP1 and CaMEP2 from the CaMEP1, CaMEP2, or ADH1 
promoters were monitored using the GFP fusions. The amounts of mRNA levels were 
compared using GFP as a probe in Northern hybridizations of cells grown in SLAD medium.  
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promoter, but the CaMEP1-GFP transcript was readily observed when expressed under 
control of the CaMEP2 promoter, and mRNA levels increased further when it was expressed 
from the ADH1 promoter (Fig. 21, lanes 1-3). The same hierarchy of promoter strength was 
observed for CaMEP2-GFP expression (Fig. 21, lanes 4-6). Of note, the levels of CaMEP2-
GFP mRNA were always higher than those of the CaMEP1-GFP transcript expressed from 
the same promoter. These results demonstrate that under nitrogen starvation conditions the 
CaMEP2 promoter is more strongly induced than the CaMEP1 promoter and also suggest that 
the CaMEP2 transcript is more stable than the CaMEP1 mRNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21. Expression of CaMEP1-GFP or CaMEP2-GFP fusions under control of the CaMEP1, CaMEP2, or 
ADH1 promoter in a wild-type background. The strains were grown to log phase in liquid SLAD medium at 
30°C and then used for RNA isolation and Northern hybridization analysis with a GFP-specific probe. The 
following strains were used: MEP1P-MEP1-GFP, CMEP1GA and B; MEP2P-MEP1-GFP, CMEP1G2A and B; 
ADH1P-MEP1-GFP, CMEP1EGA and B; MEP1P-MEP2-GFP, CMEP2G1A and B; MEP2P-MEP2-GFP, 
CMEP2GA and B; ADH1P-MEP2-GFP, CMEP2EGA and B. Independent transformants gave identical results 
and only one of them is shown in each case. 
 
 
Analysis of the strains by fluorescence microscopy confirmed that the GFP-tagged 
ammonium permeases were more strongly expressed from the CaMEP2 promoter than from 
the CaMEP1 promoter and the fluorescence of cells expressing CaMEP2-GFP was much 
stronger than that of cells expressing CaMEP1-GFP from the same promoter (Fig. 22). In 
contrast, the high transcript levels produced from the ADH1 promoter did not result in high 
amounts of protein (Fig. 21 and Fig. 22). Expression of the CaMEP1-GFP either from the 
GFP
rRNA
M
EP
1P
-
M
EP
1-
GF
P
M
EP
2P
-
M
EP
1-
GF
P
AD
H1
P-
M
EP
1-
GF
P
M
EP
1P
-
M
EP
2-
GF
P
M
EP
2P
-
M
EP
2-
GF
P
AD
H1
P-
M
EP
2-
GF
P
1        2        3        4        5        6
  Results 
 
 69 
ADH1 or CaMEP2 promoter resulted in comparable fluorescence, and fluorescence of cells 
expressing GFP-tagged CaMep2p from ADH1 promoter was even weaker than when it was 
expressed from the CaMEP2 promoter, suggesting that the translation of the CaMEP1-GFP 
and CaMEP2-GFP transcripts carrying the ADH1 upstream region was relatively inefficient. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.  22. Expression of CaMEP1-GFP or CaMEP2-GFP fusions under control of the CaMEP1, CaMEP2, or 
CaADH1 promoter in a wild-type background. The strains were grown to log phase in liquid SLAD medium at 
30°C and then fluorescence of the cells was examined by confocal microscopy. The following strains were used: 
MEP1P-MEP1-GFP, CMEP1GA and B; MEP2P-MEP1-GFP, CMEP1G2A and B; ADH1P-MEP1-GFP, 
CMEP1EGA and B; MEP1P-MEP2-GFP, CMEP2G1A and B; MEP2P-MEP2-GFP, CMEP2GA and B; 
ADH1P-MEP2-GFP, CMEP2EGA and B. Independent transformants gave identical results and only one of 
them is shown in each case. 
 
 
 
The phenotypes of cells expressing the GFP-tagged CaMEP genes from the different 
promoters were comparable to those expressing the untagged genes from the same promoters 
(compare Fig. 20A and B with Fig. 23A and B). Expression of CaMEP1-GFP from either of 
the promoters in a ∆mep1∆mep2 double mutant resulted in wild type levels ammonium 
uptake and growth on SLAD plates, including the weak filamentation of some colonies of 
strains carrying the fusion under control of the CaMEP2 promoter (Fig. 23A and B). The 
reduced expression of CaMep2p-GFP from the ADH1 and CaMEP1 promoters as compared 
with the CaMEP2 promoter correlated with inefficient ammonium uptake, reduced growth on 
SLAD plates, and defective filamentation under nitrogen limiting conditions. These data 
showed that CaMEP2 needs to be expressed at high levels (as from its own promoter) to 
mediate efficient ammonium uptake and to support optimal growth and strong filamentation 
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under low ammonium conditions. In contrast, the low levels of CaMEP1 expression seem to 
be sufficient to support ammonium uptake and optimal growth at limiting ammonium 
concentrations, indicating that CaMep1p is more efficient permease than CaMep2p. When 
artificially expressed at higher levels, CaMEP1 could even partially rescue the filamentation 
defect of ∆mep2 mutants. Therefore, it can be concluded that the specific role of CaMEP2 in 
nitrogen starvation induced filamentous growth results at least in part from its high expression 
as compared with CaMEP1. 
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Fig. 23. Growth and ammonium uptake of strains expressing a single copy of CaMEP1-GFP or CaMEP2-GFP 
fusion under control of the CaMEP1, CaMEP2, or CaADH1 promoter. (A) ∆mep1 ∆mep2 double mutants 
carrying the indicated fusions were grown for 6 days at 37°C on SLAD plates. All colonies are shown at the 
same magnification. Transformants of the independently generated ∆mep1 ∆mep2 mutants MEP12M4A and B 
behaved identically and only one of them is shown in each case. The wild-type strain SC5314 and a ∆mep1 
∆mep2 double mutant are shown for comparison. (B) Ammonium uptake of the same strains was measured as 
described in section 3.9. The following strains were used: ∆mep1 ∆mep2, MEP12M5A and MEP12M6A; 
MEP1P-MEP1-GFP, MEP12MG1A and B; MEP2P-MEP1-GFP, MEP12MG3A and B; ADH1P-MEP1-GFP, 
MEP12MEG1A and B; MEP1P-MEP2-GFP, MEP12MG5A and B; MEP2P-MEP2-GFP, MEP12MG2A and B; 
ADH1P-MEP1-GFP, MEP12MEG2A and B. 
 
wild-type
∆mep1 ∆mep2
MEP2P-MEP1-GFP
ADH1P-MEP1-GFP
MEP1P-MEP1-GFP
96% 4%
MEP1P-MEP2-GFP
MEP2P-MEP2-GFP
ADH1P-MEP2-GFP
minutes
A 3
40
0
0,05
0,1
0,15
0,2
0,25
0 60 120 180
A 3
40
∆mep1 ∆mep2
ADH1P-MEP2-GFP
MEP2P-MEP2-GFP
MEP1P-MEP2-GFP
ADH1P-MEP1-GFP
MEP2P-MEP1-GFP
MEP1P-MEP1-GFP
  Results 
 
 71
4.1.8. The C-terminal tail of CaMep2p contains a region important for filamentation 
As CaMep2p is a transmembrane protein and was predicted to have a cytoplasmic tail 
of about 74 amino acids, it was hypothesized that the C-terminal cytoplasmic tail of CaMep2p 
might have a signaling function. This hypothesis was tested by expressing C-terminally 
truncated versions of CaMep2p in a ∆mep1 ∆mep2 double mutant background. It was found 
that deletion of the last 57 amino acids of CaMep2p abolished filamentation without affecting 
the transport function of the protein, because cells expressing CaMEP2∆C423 showed wild-
type ammonium uptake rates (Fig. 25) and grew on SLAD plates as well as cells expressing 
wild-type CaMEP2, but only in the yeast form (Fig. 24, No.3). Therefore the functions of 
CaMep2p in ammonium transport and filamentous growth are separable. Deletion of 74 
amino acids from the C-terminus of CaMep2p resulted in a non-functional protein, since the 
cells expressing CaMEP2∆C406 were unable to grow on SLAD plates and behaved like 
∆mep1 ∆mep2 double mutants (Fig. 24, No.5). An analogous truncation of CaMep1p (∆C404) 
also rendered the cells unable to grow in limiting ammonium conditions (Fig. 24, No. 8). 
Depending on the algorithm used, the last amino acids in these truncated proteins are 
predicted to be located either directly behind (Marini et al., 2000b) (see also Fig. 4) or within 
their last transmembrane domains (Marini and Andre, 2000). When 67 amino acids from the 
C-terminus of CaMep2p were deleted, resulting a slightly longer CaMep2p than the non-
functional truncated version of CaMep2p, the growth defects of ∆mep1 ∆mep2 double mutant 
were partially rescued, but the colonies had an irregular shape (Fig. 24, No.4), probably 
because ammonium uptake capacity of the truncated permease was still impaired (Fig. 25). 
 An interesting phenotype was observed in cells expressing a truncated CaMep2p from 
which only the last 40 amino acids were removed (∆C440). These cells exhibited a 
hyperfilamentous phenotype on SLAD plates (Fig. 24, No.2). Northern analysis showed that 
CaMEP2∆C440 transcript levels were strongly increased as compared with wild-type CaMEP2 
mRNA (Fig. 26, lane 3), indicating that the hyperfilamentous phenotype was not caused by 
the removal of the C-terminal 40 amino acids but resulted from overexpression of the 
truncated CaMEP2 due to increased mRNA stability. A similar truncated version of CaMep1p 
(∆C438) retained its transporter function but did not induce filamentous growth (Fig. 24, 
No.7) and expression of CaMEP1∆C438 remained below the detection limit by Northern 
hybridization (not shown). Importantly, the truncated CaMEP2∆C423 allele, which did not 
restore filamentation, was overexpressed to the same extent as the CaMEP2∆C440 allele that 
produced the hyperfilamentous phenotype (Fig. 26, lane 4). These results demonstrate that at 
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least some residues in the region between amino acids 423 and 440 of CaMep2p are essential 
for inducing hyphal growth in response to nitrogen starvation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 24. Ability of C-terminally truncated versions and hybrid proteins of CaMep1p and CaMep2p to mediate 
growth and filamentation under ammonium starvation conditions. The names of the plasmids containing the 
various constructs are given on the left. Promoters and coding regions are symbolized by the thin and thick 
arrows, respectively. Regions derived from CaMEP1 and CaMEP2 are represented by white and hatched 
staining, respectively. + and  indicate growth/filamentation and no growth/filamentation, respectively, on 
SLAD plates. ++: hyperfilamentous growth; +/-: only some colonies showed a weak filamentation (the 
percentage of smooth and filamentous colonies is given). The appearance of the colonies after 6 days of growth 
on SLAD plates at 37°C is shown on the right. All constructs were expressed in ∆mep1 ∆mep2 double mutant 
backgrounds. The following strains were used: MEP2P-MEP2, MEP12MK2A and B; MEP2P-MEP2∆C440, 
MEP12MK2A∆C2 and MEP12MK2B∆C2; MEP2P-MEP2∆C423, MEP12MK2A∆C3 and MEP12MK2B∆C3; 
MEP2P-MEP2∆C413, MEP12MK2A∆C4 and MEP12MK2B∆C4; MEP2P-MEP2∆C406, MEP12MK2A∆C1 and 
MEP12MK2B∆C1; MEP1P-MEP1, MEP12MK1A and B; MEP1P-MEP1∆C438, MEP12MK1A∆C2 and 
MEP12MK1B∆C2; MEP1P-MEP1∆C404, MEP12MK1A∆C1 and MEP12MK1B∆C1; MEP2P-MEP21-418-
MEP1417-534, MEP12MK21H2A and B; MEP1P-MEP11-416-MEP2419-480, MEP12MK12H2A and B; MEP2P-
MEP11-416-MEP2419-480, MEP12MK12H3A and B; MEP2P-MEP11-416-MEP2419-440, MEP12MK12H4A and B. 
Transformants of the independently generated ∆mep1 ∆mep2 mutants MEP12M4A and B behaved identically 
and only one of them is shown in each case.  
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To test whether the C-terminal cytoplasmic domain of CaMep2p is sufficient to confer 
signaling activity upon an ammonium permease, a fusion protein was generated in which the 
last 62 amino acids of CaMep2p were substituted for the corresponding part of CaMep1p (see 
section 3.2 and Fig. 24, No.10). This hybrid protein complemented the growth defect of 
∆mep1 ∆mep2 double mutants on low ammonium medium (100 µM), consistent with the 
restoration of ammonium transport (Fig. 24, No.10), but failed to restore the filamentation 
defect of the double mutants. Expression of this fusion protein from the CaMEP2 promoter 
resulted the same phenotype as overexpression of the wild-type CaMEP1 gene from the 
CaMEP2 promoter, i.e., a weak filamentation of the minority of the colonies (Fig. 24, No.11). 
Removal of the last 40 amino acids from the CaMep2p part did not increase filamentation of 
the cells expressing the hybrid protein (Fig. 24, No.12). Therefore, although the C-terminal 
cytoplasmic domain of CaMep2p is essential for signaling, its substitution for the 
corresponding domain in CaMep1p did not increase the signaling efficiency of the CaMep1p. 
Conversely, substitution of the C-terminal cytoplasmic domain of CaMep1p for the 
corresponding region of CaMep2p abolished hyphae formation on SLAD plates (Fig. 24, 
No.9), although the amount of the hybrid CaMEP21-418-CaMEP1417-534 mRNA was 
comparable to the wild-type CaMEP2 mRNA (Fig. 26, lanes 1 and 2). These results 
suggested that specific interactions between the signaling and transporter domains of 
CaMep2p are required to efficiently induce filamentous growth under nitrogen starvation 
conditions.  
 
 
 
 
Fig. 25. Ammonium uptake of strains expressing 
full-length and C-terminally truncated CaMEP1 and 
CaMEP2 ORFs from their native promoters in a 
∆mep1 ∆mep2 double mutant background. For 
experimental details see section 3.9. The following 
strains were used: MEP2, MEP12MK2A and B; 
MEP2∆C440, MEP12MK2A∆C2 and 
MEP12MK2B∆C2; MEP2∆C423, MEP12MK2A∆C3 
and MEP12MK2B∆C3; MEP2∆C413, 
MEP12MK2A∆C4 and MEP12MK2B∆C4; 
MEP2∆C406, MEP12MK2A∆C1 and 
MEP12MK2B∆C1; MEP1, MEP12MK1A and B; 
MEP1∆C438, MEP12MK1A∆C2 and 
MEP12MK1B∆C2; MEP1∆C404, MEP12MK1A∆C1 
and MEP12MK1B∆C1. 
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Fig. 26. Expression of full length, truncated, and hybrid 
CaMEP2 ORFs. ∆mep1 ∆mep2 double mutants carrying the 
indicated CaMEP2 versions were grown to log phase in 
liquid SLAD medium at 30°C and CaMEP2 mRNA was 
detected by Northern hybridization with a CaMEP2-specific 
probe. The following strains were used: MEP2, 
MEP12MK2A and B; MEP21-418-MEP1417-534, 
MEP12MK21H2A and B; MEP2∆C440, MEP12MK2A∆C2 
and MEP12MK2B∆C2; MEP2∆C423, MEP12MK2A∆C3 and 
MEP12MK2B∆C3. Transformants of the independently 
generated ∆mep1 ∆mep2 mutants MEP12M4A and B 
behaved identically and only one of them is shown in each 
case. 
 
 
 
 
4.1.9. Regulation of filamentation by CaMEP2 is dependent on both the MAP kinase 
cascade and the cAMP pathway 
The results shown above demonstrated that nitrogen starvation induces CaMEP2 
expression, which in turn induces the cells to switch from yeast to filamentous growth. In 
C.albicans two pathways regulate the filament formation: A MAP kinase cascade that ends in 
the transcription factor Cph1p and a cAMP-dependent signaling pathway that ends in the 
transcription factor Efg1p. Several components of these two pathways have been shown to be 
required for filamentous growth of C.albicans in response to low ammonium concentrations 
(Bahn and Sundstrom, 2001; Csank et al., 1998; Rocha et al., 2001; Sanchez-Martinez and 
Perez-Martin, 2002). To test whether CaMep2p induces filamentous growth by activating one 
of these pathways, the hyperactive CaMEP2∆C440 allele was substituted for one of the 
resident CaMEP2 alleles in the wild-type strain CAI4 and in mutants deleted for the 
transcription factor CPH1, which is activated by the MAP kinase cascade, or the EFG1 and 
TEC1 transcription factors, which are involved in the cAMP-dependent pathway (Lane et al., 
2001a). A control construct with the full length CaMEP2 ORF was integrated in an identical 
manner. As compared with the wild-type, the ∆cph1, ∆efg1, and ∆tec1 mutants displayed a 
filamentation defect on SLAD plates (Fig. 27).  Expression of the hyperactive CaMEP2∆C440 
allele restored filamentous growth in all three mutants, although the hyperfilamentation 
caused by the CaMEP2∆C440 allele was stronger in a wild-type background. In contrast, the 
filamentous growth defect of a ∆cph1 ∆efg1 double mutant could not be rescued by 
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expression of the CaMEP2∆C440 allele (Fig. 27). These results suggested that CaMep2p 
activates both the Cph1p- and the Efg1p-dependent signaling pathways and that 
hyperactivation of one of these pathways by the CaMEP2∆C440 allele is sufficient to induce 
filamentous growth in response to nitrogen starvation. In contrast, in a wild-type background 
both pathways are required for filamentation under these conditions. 
 
 
 
  
 
 
 
 
 
Fig. 27. The hyperactive CaMEP2∆C440 allele rescues the filamentation defect of some signal transduction 
mutants. The CaMEP2∆C440 allele or a control construct with the wild-type CaMEP2 ORF was substituted for 
one of the resident CaMEP2 alleles in the indicated mutants. Shown are representative colonies of the various 
strains after six days of growth at 37°C on SLAD plates. Independent transformants gave identical results and 
only one of them is shown in each case. 
 
 
 
 
The G-proteins Ras1p and Gpa2p have been reported to induce filamentous growth in 
C.albicans by activating both the MAP kinase and the cAMP signaling pathways (Feng et al., 
1999; Leberer et al., 2001; Miwa et al., 2004; Sanchez-Martinez and Perez-Martin, 2002). To 
investigate if these proteins are required for signaling by CaMep2p, the hyperactive 
CaMEP2∆C440 allele was expressed in ∆ras1 and ∆gpa2 mutants and also in a ∆cdc35 mutant 
lacking adenylyl cyclase, which has been shown to be required for filamentous growth of 
C.albicans under all conditions tested (Rocha et al., 2001). Expression of hyperactive 
CaMEP2∆C440 allele partially suppressed the filamentation defect of the ∆gpa2 mutant, 
whereas ∆ras1 and ∆cdc35 were still unable to filament on SLAD plates (Fig. 27). These 
results suggested that upon nitrogen starvation CaMep2p may activate the MAP kinase and 
the cAMP signaling pathways through Ras1p, but Gpa2p is also required for full induction of 
filamentous growth under these conditions. The fact that the hyperactive CaMEP2∆C440 allele 
could rescue the filamentation defect of a ∆efg1 mutant but not of a ∆cdc35 mutant supported 
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the previous suggestion that both Efg1p and components of the MAP kinase cascade depend 
on adenylyl cyclase activity to induce the switch from yeast to filamentous growth (Rocha et 
al., 2001). 
 
4.1.10. Ammonium suppresses CaMep2p signaling 
The results obtained with the hyperactive CaMEP2∆C440 allele suggested that 
CaMep2p induces filamentous growth by activating the MAP kinase and the cAMP signaling 
pathways in response to nitrogen limitation. Therefore, artificial activation of downstream 
components of these pathways should bypass the requirement of CaMEP2 for filamentation. 
Indeed, the expression of dominant active alleles of GPA2 or RAS1 in ∆mep2 mutants 
restored their ability to switch to filamentous growth at low ammonium concentrations 
(Fig. 28, upper panels). Similarly, the addition of exogenous cAMP rescued the filamentous 
growth defect of ∆mep2 mutants on SLAD plates, but did not increase filamentation of the 
wild-type strain SC5314 under these conditions (Fig. 29A).  
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Fig. 28. Dominant active GPA2Q354L or RAS1G13V alleles suppress the filamentation defect of ∆mep2 mutants on 
SLAD plates (100 µM NH4+, top panels) but do not induce filamentous growth under ammonium-replete 
conditions (10 mM NH4+, bottom panels). The plates were incubated at 37°C for 6 days. 
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Interestingly, however, increasing the ammonium concentration in the plates to 
10 mM suppressed filamentous growth even in cells expressing the dominant active 
GPA2Q354L or RAS1G13V alleles (Fig. 28, lower panel), or in cells expressing the hyperactive 
CaMEP2∆C440 allele (Fig. 29B). In addition, exogenous cAMP did not induce filamentous 
growth in ammonium-replete conditions (Fig. 29A). These results demonstrated that 
ammonium suppresses the CaMep2p-dependent filamentous growth of C.albicans even when 
components of the signaling pathways are artificially activated. 
 
 
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 29. (A) Exogenous cAMP rescues the filamentation defect of ∆mep2 mutants on SLAD plates (left)  but 
does neither increase filamentation in the wild-type (middle) nor induce filamentous growth under ammonium-
replete conditions (right). (B) The hyperactive CaMEP2∆C440 allele does not induce filamentation at 10 mM 
ammonium concentration. All plates were incubated at 37°C for 6 days. The following strains were used: wild-
type, SC5314; ∆mep2, MEP2M5A or B; MEP2, MEP12MK2A or B; MEP2∆C440, MEP12MK2A∆C2 or 
MEP12MK2B∆C2. Independent transformants gave identical results and only one of them is shown. 
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4.2. Evaluation of putative essential genes as potential targets for antifungal 
drug development 
 
C.albicans infections in immunocompromised patients have become a major medical 
problem because of the limited availability of clinically useful antifungal drugs. There are 
four classes of licensed drugs for the therapy of the Candida infections. These include 
polyenes (e.g. the various formulations of amphotericin B), nucleoside analogs (flucytosine), 
azoles (fluconazole, itraconazole, and voriconazole), and echinocandins (caspofungin). But, 
with the increasing resistance of Candida to theses drugs, the demand to increase the arsenal 
of the anti-fungal drugs is great. For the past several decades, drug discovery has focused 
primarily on a limited number of families of ‘druggable’ genes against which medicinal 
chemists could readily develop compounds with a desired biochemical effect. However, 
nowadays the genomics approach has undoubtedly increased the opportunities to developing 
new therapies and the characterization of genes essential for fungal growth will be an 
important step in the identification and development of novel antifungal drugs. But the targets 
should be prioritized based on their conservation among most pathogenic fungi and 
significant divergence in higher eukaryotes. Using those criteria RAP1, a repressor-activator 
protein; CBF1, a centromere binding factor and YIL19, a previously uncharacterized gene 
were selected and characterized to test their potential as putative targets in this study. 
 
 
4.2.1. Repressor/activator protein 1 
The repressor/activator protein 1 (Rap1p), an essential transcription factor in 
S.cerevisiae is a multifunctional protein involved in transcriptional activation, transcriptional 
silencing, and telomere function (Shore and Nasmyth, 1987; Conrad et al., 1990; Lustig et al., 
1990; Kurtz and Shore, 1991; Shore, 1994). Rap1p consists of 827 amino acids and can be 
divided into three regions, a central DNA binding domain, a N-terminal domain that is 
associated with DNA bending and a C-terminal domain which contains both a transcriptional 
activation domain and domains involved in telomere function and silencing. Among these 
three domains only the DNA binding domain is essential for cell viability (Graham et al., 
1999). The N-terminus of the protein is dispensable for cell viability, although it may be 
involved in regulating the activity of Rap1p through the putative BRCT domain (Callebaut 
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and Mornon, 1997). This region has been shown also to potentiate DNA bending in vitro 
(Muller et al., 1994). The C terminus is the target for all of the protein-protein interactions 
involving Rap1p characterized to date, including interactions with the Sir proteins Sir3p and 
Sir4p and competing  interactions with the Rif proteins Rif1p and Rif2p (Hardy et al., 1992; 
Hecht et al.,  1996; Moretti et al., 1994; Wotton and Shore, 1997). Rap1p binds to (C1-3A)n 
repeats at chromosome ends and regulates telomere length by recruiting the Rap1p interacting 
factors Rif1p and Rif2p whereas the interaction of Rap1p with Sir2p, Sir3p, and Sir4p 
represses telomeric transcription (Moretti et al., 1994). The Rap-Sir complex also represses 
transcription at the silent mating type loci HML and HMR. (Aparicio et al., 1991). Apart from 
its interaction at telomere and silent mating type loci Rap1p also acts as a transcriptional 
regulator of many essential S.cerevisiae genes, including genes encoding ribosomal proteins 
and glycolytic enzymes (Warner, 1999). The function of Rap1p in regulating the 
transcriptional program of S.cerevisiae is still unclear mainly because the mutations that 
abolish DNA Binding are lethal (Graham et al., 1999 ) and overexpression of Rap1p is toxic ( 
Freeman et al., 1995 ). 
RAP1 homologues have been identified in other yeasts like Kluyveromyces lactis, 
Candida glabrata , and Saccharomyces castelli. RAP1 from C.glabrata and S.castelli but not 
from K.lactis are able to complement the temperature sensitivity of S.cerevisiae rap1 mutants 
(Larson et al., 1994; Haw et al., 2001; Wahlin and Cohn, 2002). A human Rap1p homolog 
was shown to be localized to chromosome ends and to be involved in telomere length 
regulation, but its function in transcriptional regulation is not known (Li et al., 2000). 
However the low overall sequence similarity of human Rap1p to the yeast proteins suggests 
that Rap1p could serve as a specific target to inhibit an essential function of fungal pathogens. 
               
 
4.2.1.1. Identification of the C.albicans RAP1 gene 
A BLAST search identified an open reading frame in the genome sequence of 
C.albicans strain SC5314 with significant similarity to the S.cerevisiae Rap1 protein 
(ScRap1p). The corresponding gene has been annotated as RAP1 at the Stanford Genome 
Technology Center (http://www-sequence.stanford.edu/group/candida/). The encoded protein 
(CaRap1p) is much shorter than ScRap1p and contains only 430 amino acids (Fig. 30 and Fig. 
31). The overall identity of CaRap1p to ScRap1p is 24%. Significant similarity to ScRap1p 
was found only in the C-terminal part of CaRap1p, which corresponds to the DNA binding 
domain of ScRap1p. Two regions of high similarity are present in this region, from amino 
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acid positions 255 to 353 of CaRap1p (65% similarity, 44% identity), and from positions 375 
to 417 (55% similarity, 41% identity). In contrast, the N-terminal region of CaRap1p did not 
exhibit similarity to ScRap1p, and the C-terminal region of ScRap1p was absent from the 
C.albicans protein. Polymerase chain reaction (PCR) amplification with different sets of 
primers (see section 3.2 and section 3.4) and sequencing of the corresponding region from 
C.albicans SC5314, confirmed the presence of a stop codon at position 1291-1293 of 
CaRAP1, and the downstream sequence also did not exhibit sequence similarity to the C-
terminal part of ScRap1p, confirming that RAP1 in C.albicans is truncated in comparison to 
its counterpart in S.cerevisiae. 
 
 
Fig. 30. Schematic comparison of Rap1p 
from S.cerevisiae (ScRap1p) and 
C.albicans (CaRap1p). The amino acid 
positions delineating the borders of the 
different regions in the proteins are 
indicated. The two blocks with the highest 
similarity in the region corresponding to 
the DNA binding domain of ScRap1p are 
bracketed by the stippled lines, and the 
percent similarity (65% and 55%) is given 
in the C.albicans protein. 
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ScRap1p          ASITSGGHNDLVQIEQPQKDTSNNNNSNVNDEDNDLLTQDNNPQTADEGNASFQAQRSMI 
CgRap1p          ------------KRDIPTKKVSANTG---------------------------------- 
ScasRap1p        NAAQQQTEEQLRLLQEHAQEVNQQAEPSNVSDEDVN-----------------YEERAYM 
KlRap1p          EVKMSSKDDEIASHDQQQQLTHTDVDDAN---------------------------DLIL 
CaRap1p          -------------PHQQQRSIDAFPNPNIN------------------------------ 
                               .   :                                          
 
ScRap1p          SRGALPSHNKASFTDEEDEFILDVVRKNPTRRTTHTLYDEISHYVPN--HTGNSIRHRFR 
CgRap1p          -------VSKTSFTEEEDEFILDVVRKNPMRRTTHTLFDEISHYVPN--HTGNSIRHRFR 
ScasRap1p        MRAALPSHNKASFTEAEDEFILDVVRKNPTRRTTHTLYDEISHYVPN--HTGNSIRHRFR 
KlRap1p          HEQASSSHNKSSFTKEEDEFILDVVRKNPTKRTTHTLYDEISHYVPN--HTGNSIRHRFR 
CaRap1p          --NARRGSSGHRFTIEQDEFILEHIRRKPRFRQSQKFYAQLALLEPLRGHTGNSIRSRFR 
                         .   **  :*****: :*::*  * ::.:: :::   *   ******* *** 
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                  :*..**:::*:.*. .:*:**: *****   . :*  :*.**:.::** *. .  : :  
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CgRap1p          KQFTENHPTHTESAWRDRFRKFLLEYG-VDKYIEYYETQKANNDEPEAMKNLTIRTKRDN 
ScasRap1p        KSFADANVSHSENAWRDRFRKFLLTFG-VDHYIEYFEQETNAGRKPEPMKNLTNRPRRKA 
KlRap1p          KLFALEVPTHSENAWRDRFRKFILPYG-IDSYISYYEKCMEEGIEPESIKNMTNRPKRE- 
CaRap1p          DGMYRKYRNHTLQSWRDRFRKYIRDKSDLVDYKEYYENCEKVGMAPRCLTRIAP------ 
                 . :      *: .:*******::   . :  * .*:*     .  *. :..::        
 
ScRap1p          VPTPGNYNSAAKRARNYSSQRNVQPTANAASANAAAAAAAAASN---------SYAIPEN 
CgRap1p          FPTPGNYGNAAKRQKYEVSSN-------------VENTLKSKGQ---------AGDIPDA 
ScasRap1p        GITPGNYNSAIKRQRAYSISKAVHDQNSNISNAAVVAAANAASGDNTDTHSTPSYPIPEN 
KlRap1p          GPSPGNYNTTLKKSKRSTEGG-------------TQQSTDTSLN---------------D 
CaRap1p          ------------------------------------------------------------ 
                                                                             
 
ScRap1p          ELLDEDTMNFISSLKNDLSNISN-------SLPFEYPHEIAERIRSDFSNE-DIYDNIDP 
CgRap1p          ELLDEDTMKFISSLKNDLSKIDN-------NFGFDYTNEIAEAIRNDFSEEEAIYDNIDP 
ScasRap1p        ELLDEETMNFISNLKNDLSKLESNNSGNNNNLPFEYSPEIAEAIRNDFDNEGKEFDNIDP 
KlRap1p          FFLESDAFDLIDGIRRDLHAAETQQE---EQARSLYADDVAERIRHQVALEHEEYDNYDF 
CaRap1p          ------------------------------------------------------------ 
                                                                             
 
ScRap1p          DTISFPPKIATTD-LFLPLFFHFGSTRQFMDKLHEVISGDYEPSQAEKLVQDLCDETGIR 
CgRap1p          NTIPFPPPIATID-LFLPQFFRMSSTQEFIEKIREIIQRDYEPSQAELLMQDLNDEAGIR 
ScasRap1p        DTIKFPPEIATID-LFLPIFFQFGSTRNFLEKVENVIKRDYEPSQAEKLVEDLCDEAGVR 
KlRap1p          DSIPFPPKLADNDDFFDHTFFNFRSTKEFIQKLEEIITREYDESQADVLVHDLDVECGIR 
CaRap1p          ------------------------------------------------------------ 
                                                                             
 
ScRap1p          KNFSTSILTCLSGDLMVFPRYFLNMFKDNVNPPPNVPGIWTHDDDESLKSNDQEQIRKLV 
CgRap1p          KTFTSSILGSLSGDLMVLPRYFLNMFSKNQNPPIDIPGIWTSGDDDILRRGDEAEVSKLV 
ScasRap1p        RGFSTSILTALSGDLMIFPRYFLNMFKNNVNPPLNVPGIWTHEDDAMLSSNDSEDLRHLE 
KlRap1p          KKYATSVLTALTGDISLFPRYILTSFKYGVHLPQNVPGIWTKEDDVILRSKNPDGMKMLE 
CaRap1p          ------------------------------------------------------------ 
                                                                             
 
 
ScRap1p          KKHGTGRMEMRKRFFEKDLL 
CgRap1p          KRQGAGRVEMRKKFLERNLI 
ScasRap1p        KKHGAARIAIRRRFVERDLV 
KlRap1p          KKHGIARMQMRIRFQENNLV 
CaRap1p          -------------------- 
 
 
Fig. 31. ClustalW (http://www.ebi.ac.uk/clustalw/#) analysis of CaRap1p with ScRap1p, Rap1 from C.glabrata 
(CgRap1p), S.castelli (ScasRap1p) and K.lactis (KlRap1p). Identical and similar amino acids are indicated by 
asterisks and colons, respectively. DNA binding domains of the proteins are indicated in red. 
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4.2.1.2. Expression of CaRAP1 in temperature-sensitive S.cerevisiae rap1 mutants 
 Certain temperature-sensitive alleles of ScRAP1 render S.cerevisiae nonviable at 37°C 
(Kurtz and Shore, 1991). To test whether CaRAP1 can complement the temperature-sensitive 
phenotype of S.cerevisiae rap1 mutants, CaRAP1 was cloned under its own promoter in the 
vector pRS426 (see section 3.2). The resulting plasmid was named pRS-RAP1. S.cerevisiae 
strains YDS 407 (rap1-1) and YDS 408 (rap1-2) were transformed with the plasmid pRS-
RAP1 and the empty control vector pRS426. Uridine-prototrophic transformants were 
selected on SD agar plates without uracil at room temperature (permissive conditions). The 
transformants were then restreaked on SD agar plates and allowed to grow at both 25°C and 
37°C. Neither of the transformants grew at 37°C, suggesting that CaRAP1 does not 
complement a defect in ScRAP1 (Fig. 32). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32. Expression of CaRAP1 in temperature-sensitive rap1 mutants of S.cerevisiae. The strains were streaked 
on SD agar plates and incubated at room temparature or 37°C for 4 days. 
 
 
4.2.1.3. Construction of C.albicans rap1 deletion mutants 
  In order to find out whether RAP1 is an essential gene also in C.albicans, an attempt 
was taken to knock-out both CaRAP1 alleles of this diploid yeast by targeted gene deletion 
using the URA3-flipping strategy (see section 4.1.3). The ura3-negative strain CAI4 was 
transformed with a deletion cassette in which almost all of the CaRAP1 coding sequence had 
been replaced by the URA3 flipper (see section 3.2 and Fig. 33A).  
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A.       B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 33. (A) Structure of the deletion cassette from plasmid pRAP1M2 and genomic structure of the CaRAP1 
locus in the parent strain CAI4. The CaRAP1 coding region is represented by the white arrow, and the upstream 
and downstream sequences by the solid line. The 34 bp FRT sites (black arrows) are not drawn to scale. (B) 
Structure of the DNA fragments from pRAP1K1 (upper part) and pRAP1M4 (lower part), which were used for 
reintegration of an intact CaRAP1 copy (white arrow) or only the URA3 marker (grey arrow), respectively, into 
one of the inactivated rap1 alleles (middle). The ACT1 transcription termination sequence (ACT1T) is indicated 
by the black diamond. Only relevant restriction sites are given. B, BamHI; Bg, BglII; K, KpnI; N, NsiI; P, PstI; 
ScI, SacI; Sl, SalI; Xh, XhoI. The BamHI and BglII sites shown in parenthesis were destroyed by the cloning 
procedure. The probe used for Southern hybridization analysis of the mutants is indicated by the thick bar. 
 
 
 
From two transformants in which the deletion cassette had been correctly inserted in 
one of the CaRAP1 alleles (strains RAP1M1A and RAP1M1B, Fig. 34, lanes 2 and 3) the 
URA3 flipper was excised again by FLP-mediated recombination, resulting in the ura-
auxotrophic strains RAP1M2A and RAP1M2B (Fig. 34, lanes 4 and 5). When these strains 
were transformed again with the same deletion cassette, integration was successfully targeted 
to the remaining wild-type CaRAP1 allele in several transformants of both parent strains, 
demonstrating that CaRAP1 is not an essential gene in C.albicans. The URA3 flipper was 
excised again from the two independent homozygous rap1 mutants RAP1M3A and 
RAP1M3B (Fig. 34, lanes 6 and 7), generating the ura-auxotrophic derivatives RAP1M4A 
and RAP1M4B (Fig. 34, lanes 8 and 9). These strains served as hosts for reintroduction of a 
complete copy of the CaRAP1 gene or the URA3 selection marker alone into one of the 
inactivated ∆rap1 alleles (see section 3.2 and Fig. 33B). This resulted in the generation of the 
two independent, prototrophic, homozygous rap1 mutants RAP1M5A and RAP1M5B (Fig. 
34, lanes 10 and 11) and the corresponding complemented strains RAP1MK1A and 
RAP1MK1B (Fig. 34, lanes 12 and 13). 
 
5`RAP1                             URA3-FLIP                                     3`RAP1
N                                   N                           N
RAP1
K      Xh      N                                                (Bg/B)    ScII
1 kbprobe
1 kb
N                                                               N
∆rap1
RAP1            ACT1T      URA3            3 R´AP1
K                    N    (B/Bg) Sl                         P   ScI
5´RAP1  ACT1T     URA3           3 R´AP1
K  (B/Bg) Sl                         P          ScI
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Fig. 34. Southern hybridization of NsiI-digested genomic DNA of the parent strain CAI4 and mutant derivatives 
with a CaRAP1-specific probe shown in Fig. 33A. The sizes of the hybridizing fragments (in kb) are given on 
the left side of the blot and their identities are indicated on the right. 
 
 
4.2.1.4. Growth analysis of the rap1 deletion mutants 
  Since CaRAP1 was not essential for viability of C.albicans it was tested 
whether its deletion conferred some growth defect upon the cells. However, the rap1 deletion 
mutants RAP1M5A and RAP1M5B grew  as well as wild-type strain SC5314 and the 
complemented strains RAP1MK1A and RAP1MK1B in rich medium (YPD) and also at 
defined medium (SD) at 30°C, 37°C and 42°C (Fig. 35 and data not shown). Similarly, the 
ura3-negative rap1 mutants RAP1M4A and RAP1M4B grew equally well as the ura3-
negative CaRAP1 wild-type strain CAI4 in media supplemented with uridine (data not 
shown). 
 
 
Fig. 35. Growth curves of 
∆rap1 mutants and control 
strains in YPD liquid medium 
at 30°C. Cells from a YPD 
overnight culture were diluted 
in fresh medium and incubated 
at 30°C. Growth was followed 
by measuring the increase in 
optical density over time. 
 
 
 
 
When grown on YPD or SD agar plates at 30°C, the rap1 deletion mutants formed 
slightly smaller colonies with an irregular fringe, in contrast to the wild-type and 
complemented strains, which grew as round colonies under these conditions (Fig. 36A, upper 
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row). This phenotype was seen with both URA3 and ura3 strains when the mutants were 
compared with the respective control strains. Microscopic analysis of the cells from these 
colonies showed that colonies of rap1 deletion mutants consisted of both yeast cells and short 
pseudohyphae, whereas the colonies of wild-type and complemented strains contained only 
yeast cells (Fig. 36A, lower row). Pseudohyphal growth of the ∆rap1 mutants was also 
observed in YPD liquid medium, in which the wild-type and complemented strains grew 
almost exclusively as budding yeasts. In contrast, in cultures of ∆rap1 mutants many cells 
with a pseudohyphal phenotype were observed in addition to yeast cells (Fig. 36B, and Table 
5). 
 
 
A. 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
Fig. 36. Phenotype of wild-type strain SC5314, the homozygous ∆rap1 mutants, and complemented strains on 
YPD agar and in YPD liquid medium. (A) Colony appearance on YPD agar plates of the wild-type strain 
SC5314, the homozygous ∆rap1 mutants, and complemented strains (upper row). Photographs were taken after 
two days of growth at 30°C. The lower row shows the morphology of resuspended cells within the colonies, 
visualized by phase contrast microscopy using a 40x objective. The strain pairs RAP1M5A/B and 
RAP1MK1A/B looked identical and only one of them is shown. (B) Microscopic appearance of the wild-type 
strain SC5314, the homozygous ∆rap1 mutants, and complemented strains after overnight growth in YPD liquid 
medium at 30°C. Shown are phase contrast micrographs of the cells taken with a 40x objective (upper row). The 
strain pairs RAP1M5A/B and RAP1MK1A/B looked identical and only one of them is shown. 
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Table 5.  
 
Frequency of pseudohyphal cells in YPD cultures of C.albicans ∆rap1 mutants and control strains. 
 
 
Strain Genotype no. of cells 
counted 
no. of yeast 
cells 
no. of 
pseudohyphal 
cells 
% 
pseudohyphal 
cells 
 URA3     
SC5314 RAP1/RAP1 8,757 8,754 3 0.03 
RAP1M5A ∆rap1/∆rap1 3,275 3,096 179 5.47 
RAP1M5B ∆rap1/∆rap1 2,403 2,275 128 5.33 
RAP1MK1A ∆rap1/∆rap1 + RAP1 7,032 7,030 2 0.03 
RAP1MK1B ∆rap1/∆rap1 + RAP1 6,643 6,641 2 0.03 
 ura3     
CAI4 RAP1/RAP1 7,438 7,433 5 0.07 
RAP1M4A ∆rap1/∆rap1 948 896 52 5.49 
RAP1M4B ∆rap1/∆rap1 976 923 53 5.43 
 
 
 
When the cell suspensions were stained either with CFDA (5, [6]-carboxyfluorescein 
diacetate) which stains live cells, or with DiBAC (bis-[1,3-dibutylbarbituric acid] trimethine 
oxonol) which stains dead cells, it was found that the pseudohypha like cells are alive and this 
morphology was not due to death of the cells (Fig. 37A). The esterase activity of viable cells 
cleaves the acetate moieties from CFDA to produce free carboxyfluorescein, which is retained 
in cells whose membranes are intact. DiBAC is a member of the oxonol class of dyes that 
exhibit intense fluorescence upon binding to phospholipids. Normal membrane potential, 
which collapses with mortal injury upon cell death, prevents access of DiBAC to the inside of 
the cell (Bowmann et al., 2002). Staining of cell wall chitin with calcofluor and nuclear 
staining with Hoechst dye demonstrated that the individual cellular compartments of the 
∆rap1 pseudohyphal cells usually were separated by chitin containing constrictions and 
contained one nucleus, as is typical for C.albicans pseudohyphae (Fig. 37B). 
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 A.       B. 
 
             
 
 
 
 
 
 
 
 
Fig. 37. (A) The homozygous ∆rap1 mutants were grown in YPD at 30°C till mid log phase and stained either 
with CFDA to visualize live cells or with DiBAC to visualize dead cells. Shown are the corresponding 
fluorescence (top) and phase contrast (bottom) micrographs. (B) Fixed cells of ∆rap1 mutants were stained with 
either calcofluor to visualize chitin in the septae (left), or with Hoechst dye 33258 to visualize nuclei (right). 
Shown are the corresponding fluorescence (top) and phase contrast micrographs (bottom). The strain pairs 
RAP1M5A/B behaved identically and only one of them is shown 
 
 
4.2.1.5. Phenotypic analysis of ∆rap1 mutants in hyphal growth induction medium  
Since the ∆rap1 mutants grew as a mixture of yeast and short pseudohyphae in   
hyphal non-inducing conditions, it was tested whether there was any change in the 
morphology of the ∆rap1 mutants under conditions that induce hyphal growth in C.albicans 
(growth on SPIDER, Lee´s and SLAD agar plates, growth in liquid SPIDER medium, Lee´s 
medium, or RPMI + 10% serum). In all those conditions ∆rap1 mutants formed germ tubes 
and hyphae as efficiently as the wild-type and complemented strains (Fig. 38 and data not 
shown). Occasional yeast and pseudohyphal cells were also seen when ∆rap1 mutants were 
grown in RPMI medium +10% serum in which all cells of the control strains formed true 
hyphae. 
 
 
 
 
Fig. 38. Hyphal growth of the wild-type 
strain SC5314, the homozygous ∆rap1 
mutants, and complemented strains. The 
upper row shows colonies grown for 10 days 
on Lee´s medium at 37°C. The middle row 
shows the colonies grown for 6 days on 
SLAD medium at 37°C. The lower row 
shows phase contrast micrographs of the cells 
after 4 hours of growth in RPMI 1640 with 
10% serum at 37°C. The strain pairs 
RAP1M5A/B and RAP1MK1A/B looked 
identical and only one of them is shown.  
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4.2.2. Centromere Binding Factor 1 
 
Centromeres are specific regions of eukaryotic chromosomes that provide attachment 
sites for the spindle microtubules that transport chromatids during anaphase. In contrast to the 
large regional centromeres of humans that span several kilobases of DNA, centromeric DNA 
sequences in budding yeasts such as S.cerevisiae are contained within 125-400 bp and are 
called ‘point’ centromeres (Clarke and Carbon, 1980). Regional centromeres often are 
associated with short nucleosome-length satellite repeats (such as the α satellite of humans) 
present within an untranscribed (AT)-rich region of DNA, whereas point centromeres have 
conserved DNA sequence elements and an (AT)-rich core (Choo, 1997). In the yeast 
S.cerevisiae, a centromere consists of three conserved regions, named as centromeric DNA 
elements (CDEI, CDEII, and CDEIII). Single base pair changes in CDEI and CDEIII result in 
chromosome loss and several proteins that bind to CDEI and CDEIII have been identified 
(Baker et al., 1989; Bram and Kornberg, 1987; Cai and Davis, 1990). These proteins are 
named as centromere binding factors (Cbf) and assemble into a centromere complex.  
Centromere binding factor 1 (Cbf1; also called Cp1 and Cpf1) has been well studied in 
S.cerevisiae (Baker and Masison 1990; Cai and Davis, 1990; Mellor et al., 1990) and is an 
abundant basic-helix-loop-helix leucine zipper protein which binds as a homodimer to the 
consensus sequence CACGTG (the CDEI region of the centromere) (Baker et al., 1989; Bram 
and Kornberg, 1987; Jiang and Phillipsen, 1989). S.cerevisiae ∆cbf1 mutants show an 
increased rate of chromosome and plasmid loss and have a slow growth phenotype. In 
addition to its centromere binding function, ScCbf1p is also a transcription factor that is 
necessary for the expression of genes involved in methionine biosynthesis, and deletion of 
CBF1 renders S.cerevisiae methionine auxotrophic. The role of ScCbf1p in methionine 
prototrophy is due to its binding to a CDEI motif in the promoter region of the genes of the 
sulphate assimilation pathway, a part of the sulphur amino acids biosynthetic pathway, 
facilitating the transcriptional activation of these genes (Kuras and Thomas, 1995). Analysis 
of CBF1 alleles with mutations revealed that its role as a centromere binding protein and as a 
transcription factor is separable. The N-terminal 209 amino acids of Cbf1p are required for 
optimal binding to centromeric DNA (Wieland et al., 2001) and residues 210 to 351 are 
sufficient to relieve methionine auxotrophy of cbf1 null mutants (Kuras et al., 1997). 
In contrast to S.cerevisiae, deletion of the CBF1 gene is lethal in the related yeast 
Kluyveromyces lactis, and recently it was shown that CBF1 also is an essential gene in the 
pathogenic yeast Candida glabrata (Mulder et al., 1994; Stoyan et al., 2001). These findings 
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suggested that Cbf1p might serve as a target for the inhibition of an essential cellular function 
in fungal pathogens. 
The CBF1 gene has recently been cloned from Candida albicans (Eck et al., 2001). 
When expressed in S.cerevisiae CaCBF1 complemented the slow growth, methionine 
auxotropy, and plasmid instability phenotypes of ∆cbf1 mutants. However, the role of 
CaCBF1 for growth and viability of C.albicans itself has not been investigated so far. 
Therefore, this gene was functionally characterized by the construction and analysis of 
C.albicans ∆cbf1 mutants. 
 
4.2.2.1. Construction of C.albicans cbf1 deletion mutants 
 For inactivation of the CBF1 gene in the diploid C.albicans the URA3-flipping 
strategy was used (see section 4.1.3) . The ura3-negative strain CAI4 was transformed with a 
deletion cassette in which the whole CaCBF1 coding sequence had been replaced by the 
URA3 flipper (see section 3.2 and Fig. 39A). From two transformants in which the deletion 
cassette had been correctly inserted in one of the CaCBF1 alleles (strains CBF1M1A and 
CBF1M1B, Fig. 40, lanes 2 and 3) the URA3 flipper was excised again by FLP-mediated 
recombination, resulting in the uridine-auxotrophic strains CBF1M2A and CBF1M2B (Fig. 
40, lanes 4 and 5). When these strains were transformed again with the same deletion cassette, 
integration was successfully targeted to the remaining wild-type CaCBF1 allele in several 
transformants of both parent strains, demonstrating that CaCBF1 is not an essential gene in 
C.albicans. The URA3 flipper was excised from the two independent homozygous cbf1 
mutants CBF1M3A and CBF1M3B (Fig. 40, lanes 6 and 7), generating the uridine-
auxotrophic derivatives CBF1M4A and CBF1M4B (Fig. 40, lanes 8 and 9). These strains 
served as hosts for reintroduction of a complete copy of the CaCBF1 gene or the URA3 
selection marker alone into one of the inactivated ∆cbf1 alleles (see section 3.2 and Fig. 39B). 
This resulted in the generation of the two independent, prototrophic, homozygous ∆cbf1 
mutants CBF1M5A and CBF1M5B (Fig. 40, lanes 10 and 11) and the corresponding 
complemented strains CBF1MK1A and CBF1MK1B (Fig. 40, lanes 12 and 13). 
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A.  
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 39. (A) Structure of the deletion cassette from plasmid pCBF1M2 (top) and genomic structure of the 
CaCBF1 locus in the parental strain CAI4 (bottom). The CaCBF1 coding region is represented by the white 
arrow, and the upstream and downstream sequences by the solid lines. The 34 bp FRT sites (black arrows) are 
not drawn to scale. The probe used for Southern hybridization analysis of the mutants is indicated by the thick 
bar. (B) Structure of the DNA fragments from pCBF1K1 (top) and pCBF1M4 (bottom), which were used for 
reintegration of an intact CaCBF1 copy (white arrow) or only the URA3 marker (grey arrow), respectively, into 
one of the inactivated CaCBF1 alleles (middle). The ACT1 transcription termination sequence (ACT1T) is 
indicated by the black diamond. Only relevant restriction sites are given. Bg, BglII; H, HindIII; K, KpnI; P, PstI; 
ScI, SacI; Xh, XhoI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 40. Southern hybridization of HindIII-digested genomic DNA of the parental strain CAI4 and mutant 
derivatives with a CaCBF1-specific probe shown in Fig. 39A. The sizes of the hybridizing fragments (in kb) are 
given on the left side of the blot and their identities are indicated on the right. 
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4.2.2.2. Growth and phenotypic analysis of ∆cbf1 mutants 
Since CaCBF1 was not essential for viability of C.albicans, it was tested whether its 
deletion conferred some growth defect upon the cells. When grown on rich medium YPD at 
30°C or 37°C, the ∆cbf1 mutants CBF1M5A and CBF1M5B grew very slowly, similar to 
what has been described for S. cerevisiae ∆cbf1 mutants (Fig. 41). In addition, the C.albicans 
∆cbf1 mutants were temperature-sensitive, since no growth was observed at 42°C. The same 
phenotypes were seen for the ura3-negative ∆cbf1 mutants CBF1M4A and CBF1M4B (data 
not shown).The slow growth phenotype was also observed in SD medium. Reintroduction of 
a functional CaCBF1 copy in the complemented strains CBF1MK1A and CBF1MK1B 
restored normal growth (Fig. 41). 
 
 
 
 
 
 
 
 
 
 
Fig. 41. C.albicans ∆cbf1 mutants have a slow growth phenotype and are temperature-sensitive. Strains were 
streaked on YPD agar plates and grown for 3 days at 30°C or 37°C, or for 6 days at 42°C. The strain pairs 
CBF1M5A/B and CBF1MK1A/B behaved identically and only one of them is shown in each case. 
 
 
 
Microscopic examination of cells grown in YPD medium demonstrated that a 
significant number of ∆cbf1 mutant cells were abnormally large and the cells tended to 
aggregate, a phenotype that was reverted by reintroduction of a functional CaCBF1 copy (Fig. 
42, upper row). The ∆cbf1 mutants were able to form hyphae upon induction by serum, 
although hyphae formation was delayed in comparison with the wild-type and complemented 
strains because of their slow growth phenotype. In addition, and in contrast to the control 
strains, not all cells of the ∆cbf1 mutants formed hyphae under these conditions but some 
grew as unusually large yeast cells (Fig. 42, lower row). 
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Fig. 42. Yeast and hyphal growth of C.albicans ∆cbf1 mutants. Strains were grown at 30°C in YPD liquid 
medium to promote growth as budding yeast, or at 37°C in RPMI 1640 medium containing 10% serum to induce 
hyphal growth. The strain pairs CBF1M5A/B and CBF1MK1A/B behaved identically and only one of them is 
shown in each case. 
 
 
 
4.2.2.3. C.albicans ∆cbf1 mutants are methionine and cysteine auxotrophic 
  In contrast to the wild-type strain, the ∆cbf1 mutants CBF1M5A and CBF1M5B were 
unable to grow on unsupplemented SD minimal medium. When methionine or cysteine were 
added to this unsupplemented minimal medium, the slow growth phenotype of the mutants 
was restored. The same phenotype was observed when ura3 mutant strains CBF1M4A and 
CBF1M4B or URA3 mutant strains CBF1M5A and CBF1M5B were checked. Reintroduction 
of a functional copy of CaCBF1 into the mutant strains suppressed this auxotrophic 
phenotype (Fig. 43). These results suggest that CaCBF1 is required for the biosynthesis of 
sulphur amino acids in C.albicans. 
 
 
 
 
 
 
 
 
 
 
Fig. 43. C.albicans ∆cbf1 mutants are auxotrophic for sulphur amino acids. Strains were grown for 3 days at 
30°C on SD agar plates without CSM, supplemented (+) or not (-) with methionine (Met) or cysteine (Cys). The 
strain pairs CBF1M5A/B and CBF1MK1A/B behaved identically and only one of them is shown in each case. 
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4.2.2.4. Chromosome stability in C.albicans ∆cbf1 mutants 
In C.glabrata, where CBF1 is essential, depletion of Cbf1p results in the generation of 
enlarged cells with unseparated or undetectable nuclei (Stoyan et al., 2001). Similarly, the 
formation of enlarged cells arrested in the large-budded stage was recently described for 
C.albicans mutants depleted for the essential centromere protein Cse4p (Sanyal and Carbon, 
2002). The observation of the presence of the unusually large cells in the C.albicans ∆cbf1 
mutants, together with the known centromere function of Cbf1p in other yeasts, pointed to a 
possible role of CaCBF1 in mitosis. 
Nuclear staining showed that many of the unusually large cells of the C.albicans ∆cbf1 
mutants indeed contained anucleate large buds (between 7 and 9% of all cells, see Table 6). In 
addition, the ∆cbf1 mutants also produced aberrantly large cells with anucleate small or 
nucleate large buds. This result suggested that deletion of CaCBF1 may have caused a defect 
in chromosome segregation, which may be responsible for the production of morphologically 
aberrant cells. However, the aberrant cell morphology could also be due to some other 
functional defect of the ∆cbf1 mutants. Therefore, additional experiments were carried out to 
address a possible role of CaCBF1 in chromosome segregation in C.albicans. 
 
Table 6.  
Frequency of aberrant cells in C.albicans ∆cbf1 mutants and control strains.  
The symbols in columns 4-6 indicate unusually large cells with small buds, unusually large cells with a large bud 
after or during nuclear division, and unusually large cells with a large anucleate bud, respectively. The number 
of cells exhibiting these different aberrant morphologies is given for each strain along with the total number of 
counted cells. 
Strain Genotype Total no. of 
cells counted 
   
 URA3     
SC5314 CBF1/CBF1 277 0 0 0 
CBF1M5A ∆cbf1/∆cbf1 315 1 39 23 
CBF1M5B ∆cbf1/∆cbf1 243 5 32 19 
CBF1MK1A ∆cbf1/∆cbf1 + CBF1 277 1 0 0 
CBF1MK1B ∆cbf1/∆cbf1 + CBF1 292 0 3 1 
      
 ura3     
CAI4 CBF1/CBF1 287 0 0 0 
CBF1M4A ∆cbf1/∆cbf1 221 1 32 18 
CBF1M4B ∆cbf1/∆cbf1 214 5 36 19 
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ScCbf1p is involved in centromere function and hence S.cerevisiae cbf1 null mutants 
are hypersensitive to microtubule disrupting drugs like thiabendazole (Cai and Davis, 1990). 
It was found that the deletion of CaCBF1 did not cause hypersensitivity to thiabendazole in 
C.albicans. At thiabendazole concentrations that reduced growth of the wild-type strain, the 
∆cbf1 mutants were still able to grow, and the growth difference compared with the wild-type 
and complemented strains was similar to that observed on plates without the drug (Fig. 44). 
This phenotypic difference between S.cerevisiae and C.albicans ∆cbf1 mutants indirectly 
argued against a role of CaCbf1p in centromere function in C.albicans. Therefore, it was tried 
to directly assess a possible role of CaCBF1 in chromosome stability in C.albicans.  
 
 
 
 
 
 
 
 
 
Fig. 44. Deletion of CaCBF1 does not cause hypersusceptibility to thiabendazole in C.albicans. The indicated 
strains were grown to stationary phase in YPD medium, and serial 10-fold dilutions were spotted onto YPD 
plates or YPD plates containing 100 µg/ml thiabendazole and grown for 2 days at 30°C. 
 
 
               S.cerevisiae ∆cbf1 mutants also show an increased rate of centromeric plasmid loss, 
which facilitates detection of defects in chromosome stability. However, since there are no 
centromeric plasmids available for C.albicans, plasmid stability in the C.albicans ∆cbf1 
mutants could not be investigated as for S.cerevisiae. To assess an effect of CaCBF1 deletion 
on chromosome stability, the genomic hybridization pattern of wild-type strains and ∆cbf1 
mutants with the C.albicans-specific repetitive DNA element CARE-2 was analyzed. This 
DNA element is present on most, if not all C.albicans chromosomes (Lasker et al., 1992). 
Loss of chromosomes should therefore result in the disappearance or a decrease in the relative 
signal strength of some hybridizing bands. Three individual colonies of each analyzed strain 
were picked from an SD agar plate and separately grown for 48 hours at 30°C in YPD liquid 
medium. The cultures were then diluted 10-2 in fresh YPD medium and again grown for 
48 hours at 30°C. This procedure was repeated several times. After seven passages (about 50 
generations) suitable dilutions of the cultures were spread onto YPD agar plates. One colony 
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SC5314 (WT)
CBF1M5A (∆cbf1)
CBF1M5B (∆cbf1)
CBF1MK1A (∆cbf1+ CBF1 )
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from each culture was then used for isolation of genomic DNA and Southern hybridization 
with the C.albicans-specific repetitive DNA element CARE-2 as described previously (Franz 
et al., 1998). The CARE-2 hybridization patterns of all strains were identical (Fig. 45), 
demonstrating that none of the clones had suffered a detectable chromosome loss. 
 
 
 
 
 
 
 
 
Fig. 45. CARE-2 hybridization 
pattern of C.albicans ∆cbf1 mutants 
and control strains. Three 
independent colonies of each strain 
were grown for approximately 50 
generations in YPD liquid medium 
at 30°C. Genomic DNA of each 
clone was isolated, digested with 
EcoRI, and analyzed by Southern 
hybridization with the CARE-2 
probe. The banding pattern is 
identical for all clones. Differences 
in signal strength between 
individual lanes are due to slightly 
unequal loading.  
SC5314, wild-type; CBF1M5A/B, 
∆cbf1; CBF1MK1A/B,  ∆cbf1 + 
CaCBF1. 
 
 
 
 
 
 
 
 
 
Since chromosome loss might still be a relatively rare event even if it is enhanced in 
∆cbf1 mutants, an additional approach was used to detect a low frequency loss of a specific 
chromosome. For this purpose, one of the two alleles of ADE2 gene, which is located on 
chromosome 3 (http://alces.med.umn.edu/bin/genelist?genes), was disrupted in the parental 
strain CAI4 and in the ∆cbf1 mutants (Fig. 46A and B). Individual colonies of the strains in 
which the other ADE2 allele was inactivated were taken from an SD agar plate and grown to 
stationary phase in YPD medium at 30°C. Appropriate dilutions were spread on SD agar 
plates and the frequency of red ade2 colonies was monitored after 7 days of incubation at 
SC5314        CBF1M5A    CBF1M5B   CBF1MK1A  CBF1MK1B
1    2    3    1    2    3    1    2    3    1    2    3    1   2    3
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30°C. Cells that have lost the chromosome 3 homolog containing the intact ADE2 allele 
become auxotrophic for adenine and can be detected as red colonies on plates containing 
limited amounts of adenine (Barton and Gull, 1992). Red ade2 colonies were detected at 
similar frequencies in all the strains (see Table 7). Such ade2 mutants can be generated in 
different ways: inactivation of the intact ADE2 allele due to point mutations, loss of the intact 
ADE2 allele by mitotic recombination or gene conversion, or loss of the chromosome 3 
homolog containing the intact ADE2 allele, as outlined above. To differentiate between these 
possibilities, several red ade2 clones from wild-type and ∆cbf1 parent strains were analyzed 
by Southern hybridization (Fig. 47).  
 
 
A. 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
Fig. 46. Inactivation of one of the ADE2 alleles in strain CAI4 and ∆cbf1 mutants by insertion of the URA3 
marker. (A) Structure of the deletion cassette from plasmid pADE2M2 (top) and genomic structure of the ADE2 
locus in the parental strains (bottom). The ADE2 coding region is represented by the white arrow, and the 
upstream and downstream sequences by the solid lines. The probe used for Southern hybridization analysis of 
the mutants is indicated by the thick bar. Only relevant restriction sites are given. Bg, BglII; EI, EcoRI; K, KpnI; 
P, PstI; ScI, SacI. (B) Southern hybridization of EcoRI-digested genomic DNA of the parental strains CAI4 
(wild-type, lane 1) and CBF1M4A/B (∆cbf1, lanes 4 and 7) and their ADE2/ade2::URA3 derivatives (lanes 2, 3, 
5, 6, 8, 9) with an ADE2-specific probe. The sizes of the hybridizing fragments (in kb) are given on the left side 
of the blot and their identities are indicated on the right. 
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Table 7.  
Frequency of ade2 cells in wild-type and ∆cbf1 mutants.  
                                                                                                                                                                                                                 
Strain Relevant Genotype Exp. no.a Total no. of 
colonies 
No. of red 
ade2 colonies 
b 
Frequency of 
red ade2 
colonies 
1 28,730 2 (1) 7.0 x 10-5 
2 17,650 0 - 
3 82,400 2 2.4 x 10-5 
ADE2M1A CBF1/CBF1 
ADE2/ade2::URA3 
4 93,800 3 3.2 x 10-5 
      
1 16,570 0 - 
2 16,210 0 - 
3 88,800 1 (1) 1.1 x 10-5 
ADE2M1B CBF1/CBF1 
ADE2/ade2::URA3 
4 82,400 2 2.4 x 10-5 
      
1 19,090 0 - 
2 28,910 1 (2) 3.4 x 10-5 
3 95,200 4 4.2 x 10-5 
ADE2∆cbfM1A1 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 
4 74,400 3 4.0 x 10-5 
      
1 28,730 3 1.0 x 10-4 
2 15,310 0 - 
3 67,200 2 3.0 x 10-5 
ADE2∆cbfM1A2 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 
4 75,200 3 4.0 x 10-5 
      
1 27,740 3 1.1 x 10-4 
2 15,490 0 - 
3 88,000 2 2.3 x 10-5 
ADE2∆cbfM1B1 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 
4 69,600 3 4.3 x 10-5 
      
1 19,810 1 5.0 x 10-5 
2 17,650 0 - 
3 90,400 2 (1) 2.2 x 10-5 
ADE2∆cbfM1B2 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 
4 77,600 2 2.6 x 10-5 
a Experiments no. 1 and 2 were performed on the same day, using two independent colonies of each strain. 
Experiments no. 3 and 4 were performed on a separate occasion and a higher no. of cells from each colony was 
plated. 
b The first no. indicates the no. of red colonies, i.e. the no. of cells that had lost the ADE2 gene before plating. 
The no. in parenthesis gives the no. of sectored colonies, i.e. those cases in which the ADE2 gene was lost during 
growth of the progeny colony. 
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Hybridization with an ADE2 probe demonstrated that all analyzed clones had lost the 
fragment containing the intact ADE2 allele and retained the fragment containing the disrupted 
copy, excluding the possibility that they were generated by a simple point mutation (Fig. 47A, 
lanes 4-16). The blot was then rehybridized with a fragment from the YMR211 gene, which is 
also located on chromosome 3 but on a different contig (http://www-
sequence.stanford.edu/group/candida/) and is therefore not closely linked to the ADE2 gene 
(Fig. 47B), and with a fragment from the ACT1 gene, which is located on chromosome 1 
(http://alces.med.umn.edu/bin/genelist?genes) (Fig. 47C). The YMR211 and ACT1 probes 
produced signals of comparable strength in the parental strains (Fig. 47B and C, lanes 1-3). In 
contrast, in several of the red ade2 clones the YMR211 signal was clearly reduced in 
comparison to the ACT1 signal (e.g. lanes 4 and 16), indicating that these clones had lost one 
of the chromosome 3 homologs. In other red ade2 clones the ACT1 and YMR211 signals were 
comparable, as in their parents (e.g. lanes 5 and 15). These clones might have lost the intact 
ADE2 copy by mitotic recombination, but there are also other possible explanations (see 
section 5.2.2). Altogether, these experiments provide evidence that deletion of the CaCBF1 
gene does not result in an increased chromosome 3 loss. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.47. Analysis of red ade2 colonies by Southern hybridization. EcoRI digested genomic DNA of the parental 
strains (lanes 1-3) and red ade2 derivatives (lanes 4-16)  was hybridized with probes specific for ADE2 (A), 
YMR211 (B), or ACT1 (C). The sizes of the hybridizing fragments (in kb) are given on the left side of the blots 
and their identities are indicated on the right. 
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4.2.2.5. Phenotype of ∆cbf1 mutants at the non-permissive temperature 
The inability of the ∆cbf1 mutants to grow at 42°C suggested that CaCbf1p might have 
a more important function at the higher as opposed to lower temperatures. Therefore, whether 
the morphological defect of the mutants was aggravated at the non-permissive temperature 
was examined. However, it was found that morphologically abnormal cells appeared with 
comparable frequencies at 30°C and 42°C (compare the data in Table 8 with those in Table 
6), demonstrating that the temperature-sensitivity of the ∆cbf1 mutants was not due to an 
increased number of cells with defects in morphology. A few very small, anucleate cells were 
observed when the strains were incubated at 42°C, but their frequency (0.5 to 2.5 %) was 
comparable in ∆cbf1 mutants and control strains. 
 
Table 8.  
Frequency of aberrant cells in C.albicans ∆cbf1 mutants and control strains at 42°C 
The symbols in columns 4-6 indicate unusually large cells without or with small buds, unusually large cells with 
a large bud after or during nuclear division, and unusually large cells with a large anucleate bud, respectively. 
The number of cells exhibiting these different aberrant morphologies is given for each strain along with the total 
number of counted cells. 
Strain Genotype Total no. of 
cells counted 
   
 URA3     
SC5314 CBF1/CBF1 263 0 0 0 
CBF1M5A ∆cbf1/∆cbf1 280 9 43 26 
CBF1M5B ∆cbf1/∆cbf1 256 10 30 16 
CBF1MK1A ∆cbf1/∆cbf1 + CBF1 276 1 4 0 
CBF1MK1B ∆cbf1/∆cbf1 + CBF1 259 1 2 0 
      
 ura3     
CAI4 CBF1/CBF1 271 0 1 0 
CBF1M4A ∆cbf1/∆cbf1 260 8 28 18 
CBF1M4B ∆cbf1/∆cbf1 248 8 31 15 
 
 
Whether ∆cbf1 mutants might exhibit an increased rate of chromosome loss at 42°C, 
the strains were first grown to mid log phase at 30°C and then transferred to a 42°C water 
bath and incubated for 24 hours. Appropriate dilutions were spread on SD agar plates and the 
frequency of red ade2 colonies was monitored after 7 days of incubation at 30°C. As shown 
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in Table 9, red ade2 mutants arose with similar frequency in ∆cbf1 mutants and control strains 
also at the elevated temperature, demonstrating that the temperature sensitivity of the ∆cbf1 
mutants was not caused by an increased chromosome loss at 42°C. 
 
Table 9.  
 
Frequency of ade2 cells in wild-type and ∆cbf1 mutants at 42°C 
 
Strain Relevant Genotype Exp. no.a Total no. of 
colonies 
No. of red 
ade2 colonies 
b 
Frequency of 
red ade2 
colonies 
1 31,720 3 (4) 9.4 x 10-5 ADE2M1A CBF1/CBF1 
ADE2/ade2::URA3 2 28,090 2 (4) 7.1 x 10-5 
1 20,670 1 (1) 4.8 x 10-5 ADE2M1B CBF1/CBF1 
ADE2/ade2::URA3 2 26,500 2 (1) 7.5 x 10-5 
1 21,660 1 4.6 x 10-5 ADE2∆cbfM1A1 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 2 17,290 1 5.8 x 10-5 
1 25,760 2 7.8 x 10-5 ADE2∆cbfM1A2 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 2 22,400 1 4.5 x 10-5 
1 36,550 3 (3) 8.2 x 10-5 ADE2∆cbfM1B1 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 2 22,110 2 (2) 9.0 x 10-5 
1 27,160 2 (3) 7.4 x 10-5 ADE2∆cbfM1B2 ∆cbf1::FRT/∆cbf1::FRT 
ADE2/ade2::URA3 2 21,840 2 9.1 x 10-5 
a Experiments no. 1 and 2 were performed using two independent colonies of each strain. 
b The first no. indicates the no. of red colonies, i.e. the no. of cells that had lost the ADE2 gene before plating. 
The no. in parenthesis gives the no. of sectored colonies, i.e. those cases in which the ADE2 gene was lost during 
growth of the progeny colony. 
 
 
Finally, it was examined whether the temperature sensitivity of the ∆cbf1 mutants 
reflected an inability to grow or cell killing. Since CaCbf1p might function during active 
growth, cell survival was determined in one set experiments during incubation in rich medium 
YPD at 42°C (see section 3.7). As shown in Fig. 48A, a moderate killing of the ∆cbf1 mutants 
was detected after 24 hours of incubation at 42°C, since the number of viable cells was 
reduced to about 15%. In contrast, the cell numbers of wild-type and control strains had 
slightly increased during that time. This difference could be explained if a proportion of the 
cell population of both mutants as well as wild-type and control strains is killed at 42°C, but 
in contrast to the former the latter strains can overcome the reduction in cell number by 
growing fast enough. To confirm this assumption, survival of the strains at 42°C was also 
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tested in PBS, which does not support growth, instead of YPD medium. As shown in Fig. 
48B, in this case the number of viable cells decreased in all strains and was only 2 to 3 fold 
higher in wild-type and control strains than in the ∆cbf1 mutants, presumably due to some 
residual growth in the former after transfer from rich medium to PBS. From these 
experiments it is obvious that the temperature sensitivity of the ∆cbf1 mutants is caused by 
their slow growth rate, which does not allow them to overcome the rate of cell killing at 42°C, 
instead of a specific function of CaCbf1p at the elevated temperature. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 48. Survival of C.albicans ∆cbf1 mutants and control strains at 42°C. Strains were grown at 30°C in YPD 
medium to log phase and then incubated for 24 h at 42°C either in YPD medium (A) or in PBS (B). The bars 
indicate the percent survival of the cells at 42°C (see section 3.7). The following strains were used: 1, SC5314; 
2, CBF1M5A; 3, CBF1M5B; 4, CBF1MK1A; 5, CBF1MK1B; 6, CAI4; 7, CBF1M4A; 8, CBF1M4B 
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4.2.3. YIL19 
 
ORF YIL19 encodes a protein of 328 amino acids of unknown function in C.albicans. 
The homolog of this ORF in S.cerevisiae has been very recently designated as FAF1 in SGD 
(Saccharomyces Genome Database). Whole genome analysis of S.cerevisiae had shown 
before that this ORF is essential for cell viability. Recently Shirai et al. (2004) and 
Karkusiewicz et al. (2004) independently have shown that this gene in S.cerevisiae is 
involved in the processing of 18S rRNA, and depletion of YIL019w (FAF1) gene product 
affect 40S ribosomal subunit biogenesis, resulting from a decrease in the production of 18S 
rRNA. 
Biogenesis of ribosomes is one of the major metabolic processes of the cell and 
appears to be conserved throughout eukaryotes. In S.cerevisiae this process is very well 
characterised and its genome contains 100-200 copies of rDNA. Each rDNA copy encodes 
two rRNA precursors, the 35S and 5S rRNA transcribed by RNA polymerases I and III, 
respectively. The 35S precursor contains the sequences for the mature 18S rRNA of the 40S 
subunit and 5.8S and 25S rRNAs of the 60S subunit. These 18S, 5.8S and 25S rRNAs in 35S 
pre-rRNA are separated by two internal transcribed spacer sequences, ITS1 and ITS2, and 
flanked by two external transcribed spacer sequences, 5´-ETS and 3´-ETS (Fig. 49).  
 
 
 
 
 
 
Fig. 49. Structure and processing sites of 35S pre-rRNA in S.cerevisiae. The processing sites are indicated by 
arrows. 
 
 
The 35S pre-rRNA is first cleaved at site A0 to generate the 33S pre-rRNA which is 
subsequently processed at sites A1 and A2. The latter cleavage results in the separation of the 
pre-rRNAs destined for the small and large ribosomal subunits. Final cleavage at the site D of 
the 20S precursor leads to mature 18S rRNA. The all steps of rRNA processing and 
maturation from 35S precursor RNA, as well as modification of rRNAs through ribose 
methylation and isomerization of uridines, are well characterized in S.cerevisiae (Kressler et 
al., 1999; Venema and Tollervey 1999). Concominant with its synthesis and processing, 
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rRNA assembles with the ribosomal proteins and this assembly requires also transient 
association with a number of proteins which are not present in mature ribosomes. Many 
proteins are predicted to be associated with the pre-ribosomes, however the precise roles of 
these proteins remain undefined (Huh et al., 2003). 
 
 
 
4.2.3.1.  In silico characterization of Yil19 protein 
 
ORF 6.3009 has been annotated at the Stanford Genome Technology Center 
(http://www-sequence.stanford.edu/group/candida/) as YIL19 based on its similarity to the 
previously uncharacterized ORF YIL019 in S.cerevisiae. The encoded protein is 328 amino 
acids long. ClustalW (http://www.ebi.ac.uk/clustalw/#) analysis of the total Yil19p sequences of 
different ascomycetes like S.cerevisiae, Schizosachharomyces pombe, Neurospora crassa 
found that all these proteins share well conserved regions (Fig. 50A). Analysis by the PSORT 
program showed the presence of the classical type of nuclear localization signals (NLS), pat4 
which is composed of 4 basic amino acids ‘RKRR’, starting at amino acid 325 and, pat7 
which is a pattern starting with P and followed within 3 residues by a basic segment 
containing 3 K/R residues out of 4, starting at amino acid 191 (Fig. 50A), in C.albicans. On 
the other hand these nuclear localization signals are absent in S.cerevisiae, but there is a 
bipartite NLS, located at the C terminal part of the protein, starting at the 279th amino acid. 
This nuclear localization signal is important for the proper functioning of the protein in 
S.cerevisiae (Karkusiewicz et al., 2004). Another interesting feature is that this gene is 
clustered with the HIS6 gene in the genome of all these ascomycetes. Moreover in C.albicans 
and S.cerevisiae the gene for the subunit 3 of RNA polymerase II is preserved in this cluster 
(Fig. 50B) (Karkusiewicz et al., 2004). It was found by microarray experiments in 
S.cerevisiae that the pair YIL019-HIS6 is co-regulated in the cell-cycle, during diauxic shift 
and sporulation (Kruglyak and Tang, 2000). Although polycistronic transcription units are not 
evident in eukaryotes, clustering and co-expression of neighbouring genes are common 
(Fukuoka et al., 2004; Overbeek et al., 1999). 
 
 
 
 
  Results 
 
 104
A.  
C.albicans            -----------------------------------------------------MSEDDEY   7 
S.cerevisiae          ----------------------------------------------------MTLDDDDY   8 
Sz. pombe             ----------------------------------------------------------MS   2 
N.crassa              MPSATLLGKRKSIAAQPEAKKKKRVAEDLEVKRKKQKLAKKEEKPVKKANEEEEEEQQDI  60 
                                                                             
 
C.albicans            IKALEIQRRNFEAQFGSIEDMGFEDKSKTQVELEDEDERSSQDSPDQS------------  55 
S.cerevisiae          IKQMELQRKAFESQFGSLESMGFEDKTKNIRTEVDTRDSSGDEIDNSD------------  56 
Sz.pombe              ENALLALQRHFEDQFGHIEGLQPVSAKPSETAFNSDASEKEQSPTTSN------------  50 
N.crassa              SDALSVFQRAFEARFKPIASAPATTTTTKAEKSKSTKNKTRKAQEDGDGVGDNLDEDQIL 120 
                       . :   :: ** :*  : .      . .     .  . . .     .             
 
C.albicans            SGEDEEDSKFDEIDSDSNEEEMDFLGDDEEQDDIPK--PKVFKLNDSSNTPLPVVSKQDR 113 
S.cerevisiae          HGSDFKDGTIESSNS-SDEDSGNETAEENNQDSKPKTQPKVIRFNGPSDVYVPPS-KKTQ 114 
Sz.pombe              EEEDAISDMEDKEDVSFGSKILRVSHQEVEKPTLSATVGRVSFLKKMPKLEDEEE----- 105 
N.crassa              EDDDAVDSGSEDDSSGLEDEEDYSGSDSEEEEKDDEDAPKVMVVDYSKDPSKVDTSKMSK 180 
                        .*  ..  :. .    ..      :. ::        :*  ..   .            
 
C.albicans            KLLKSGRA-PTLLEISKKEKLAAKQQSKQQSAKSKAEDEENLANDLKLQRLLKESHILAN 172 
S.cerevisiae          KLLRSG---KTLTQINKKLESTEAKEEKED----ETLEAENLQNDLELQQFLRESHLLSA 167 
Sz.pombe              ------------ILAKKREEQKLRKRSRQNDDGSDDDEVENLKNDLELQKLLRESHLLHE 153 
N.crassa              KELKAYLSSKPPNAILDSNSQTNGTKAKKDKDGEGEDSAAFLANDLALQRLIAESHILSA 240 
                                      .  .     . :::       .   * *** **::: ***:*   
 
C.albicans            T------LEYSGADLTLQTIDFDDP----------TGKARRRALDSRIRELASTNSRTGG 216 
S.cerevisiae          FNNGGSGSTNSGVSLTLQSMGGGNDDGIVYQDDQVIGKARSRTLEMRLNRLSRVNGHQDK 227 
Sz.pombe              ATSR-------------------------------TGQVQLVAEGKIRHKVVQQHIAQLG 282  
N.crassa              AGGNASHYLSSAAAETDKN----------------TRAFAEGRIRKKTTDMRMQALGAKG 284 
                                                                        :          
 
C.albicans            LPKKLEKMPMAMRKGMIKKRDERIKKYEQDARDAGIVLSKVRKGELRDLDAGRGSTSSSD 276 
S.cerevisiae          IN-KLEKVPMHIRRGMIDKHVKRIKKYEQEAAEGGIVLSKVKKGQFRKIESTYKKDIERR 286 
Sz.pombe              GKKETEKMPMAARRGMKKKQKHIEKVIENEARESGTVLAKKRK----------------- 325 
N.crassa              SVLEQEKMPMNMRKGIKKASETYEQKRRREARENGIILEKASGKG--------------- 329 
                         : **:**  *:*: .      :  ..:* : * :* *                     
 
 
 
 
C.albicans            RLGTGKKIDKR---IRDRGLKINGIGRSTRNGLVISQGEIDRVNRGGKKG-----FRKRR 328 
S.cerevisiae          IGGSIKARDKEKATKRERGLKISSVGRSTRNGLIVSKRDIARISGGERSGKFNGKKKSRR 346 
Sz.pombe              --------ERKQFKKGFRPVTFSAPGKLVGGTLLLPKSMIPK------------------ 359 
N.crassa              ------KGTVKKRSGGDRPVDMPGIGKMRGAQLTISSREIRSMENSGPVGRGGRGMGGKA 383 
                                .      * : : . *:     * :..  *                     
 
C.albicans            -------- 
S.cerevisiae          -------- 
Sz.pombe              -------- 
N.crassa              KGGHRKRR 391 
 
 
 
B. 
 
 
 
 
 
 
Fig. 50. Comparison of amino acid sequence and genomic organization of Yil19. (A) Clustal W 
(http://www.ebi.ac.uk/clustalw/#) analysis of  Yil19 from C.albicans, S.cerevisiae, Sz. pombe and N.crassa. 
Identical and similar amino acids are indicated by asterisks and colons, respectively. Amino acids positions are 
indicated on the right. The NLS of the C.albicans protein is shown in red and that of S.cerevisiae in blue. (B) 
Gene clustering around the YIL19 gene in four ascomycetes. The gene not coloured is not homologous to other 
Rpb3 proteins (adapted from Karkusiewicz et al., 2004). 
RPB3 HIS6 YIL19
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4.2.3.2. YIL19 is an essential gene in C.albicans 
For targeted gene deletion of the two YIL19 wild-type alleles the URA3-flipping 
strategy was used (see section 4.1.3). The ura3-negative strain CAI4 was transformed with 
the plasmid pYIL19M2 in which almost all of the YIL19 coding sequence had been replaced 
by the URA3 flipper (see section 3.2 and Fig. 51). In strain CAI4, the two alleles of YIL19 
(arbitrarily designated as YIL19-1 and YIL19-2) can be distinguished by a SalI restriction site 
polymorphism. From two transformants in which the deletion cassette has been integrated in 
either of the two possible YIL19 alleles (strains YIL19M1A and YIL19M1B, Fig. 52, lanes 2 
and 3), the URA3 flipper was excised by FLP-mediated recombination, resulting in strains 
YIL19M2A and YIL19M2B (Fig. 52, lanes 4 and 5). When those two strains were again 
transformed with the same deletion cassette from plasmid pYIL19M2, all analysed 
transformants from both parent strains showed integration into the already inactivated YIL19 
allele (data not shown). The absence of allelic integration bias in the first allele transformation 
and the failure to delete the second allele in either of the two parent strains provided evidence 
that this gene might be an essential gene in C.albicans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 51. Structure of the deletion cassette from plasmid pYIL19M2 (top) and genomic structure of the YIL19 
locus in the parental strain CAI4 (bottom). The YIL19 coding region is represented by the white arrow, and the 
upstream and downstream sequences by the solid lines. The 34 bp FRT sites (black arrows) are not drawn to 
scale. The probe used for Southern hybridization analysis of the mutants is indicated by the thick bar. Only 
relevant restriction sites are given. Bg, BglII; K, KpnI; P, PstI; ScI, SacI; Xh, XhoI; Sl, SalI. The downstream 
SalI restriction site shown in parenthesis is present only in the YIL19-2 allele. 
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Fig. 52. Southern hybridization of SalI-digested genomic DNA of the parental strain CAI4 and mutant 
derivatives with a YIL19-specific probe shown in Fig. 51. The sizes of the hybridizing fragments (in kb) are 
given on the left side of the blot and their identities are indicated on the right. 
 
 
 
 
4.2.3.3. Construction of conditional yil19 deletion mutant 
To construct the conditional yil19 mutants the inducible gene deletion (Michel et al., 
2002), was used. A copy of the YIL19 gene including its own regulatory sequences to ensure 
proper expression, and the dominant selection marker MPAR were flanked by direct repeats of 
the FRT site (pYIL19D1) and integrated into ACT1 locus of the heterozygous mutants 
YIL19M2A and YIL19M2B (Fig. 53). Excision of the MPAR marker along with the cloned 
copy the gene by the expression of FLP gene allowed the screening for the loss of the extra 
copy of YIL19 gene. The cassette was targeted to the ACT1 locus as efficient excision of the 
MPAR marker from this genomic site had been achieved in previous experiments, and 
disruption of one ACT1 allele did not cause the alteration of growth of C.albicans (Staib et 
al., 1999; 2000). Southern analysis showed the correct integration of FRT-YIL19-MPAR-FRT 
cassette into one of the ACT1 allele, resulting the strains YIL19M3A and YIL19M3B (Fig. 52 
and Fig. 54, lanes 6 and 7). 
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Fig. 53. Integration of the FRT-YIL19-MPAR-FRT cassette from pYIL19D1(top) into one of the genomic ACT1 
alleles (bottom). The ACT1 coding region is indicated by grey arrow. The 34 bp FRT sites (black arrows) are not 
drawn to scale. The probe used for Southern hybridization analysis of the mutants is indicated by the thick bar. 
Only relevant restriction sites are given. EI, EcoRI; ScI, SacI. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 54. Southern hybridization of EcoRI-digested genomic DNA of the parental strain CAI4 and mutant 
derivatives with ACT1-specific probe shown in Fig. 53. The sizes of the hybridizing fragments (in kb) are given 
on the left side of the blot and their identities are indicated on the right. 
 
 
 
When strains YIL19M3A and YIL19M3B were transformed with the deletion cassette 
from pYIL19M2, integration was successfully targeted to the remaining wild-type YIL19 
allele, generating strains YIL19M4A and YIL19M4B (Fig. 52, lanes 8 and 9). The URA3 
flipper was then excised from these strains by FLP-mediated recombination, generating the 
strains YIL19M5A and YIL19M5B, both of which retained the deletable additional copy of 
the YIL19 gene (Fig. 52, lanes 10 and 11). 
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Fig. 55. Integration of the SAP2-1P-ecaFLP fusion (top) from pSFL213 or the URA3 marker (bottom) from 
plasmid pSFL28 into the SAP2 locus (middle). The SAP2 coding region is indicated by the pink arrow. The 
upstream ClaI restriction site shown in parenthesis is present only in the SAP2-1 allele into which the fragments 
were inserted. Only the relevant restriction sites are shown, C, ClaI; ScI, SacI; X, XbaI. 
 
 
 
The SAP2-1P-ecaFLP fusion from plasmid pSFL213 was integrated into the SAP2-1 
allele of strains YIL19M5A and YIL19M5B generating the strains YIL19M6A and 
YIL19M6B, respectively (Fig. 55, top and Fig. 56, lanes 12 and 13). In these strains induction 
of the SAP2 promoter results in expression of the ecaFLP gene and allow efficient deletion of 
the YIL19 copy integrated at ACT1 locus. Two types of control strains were also constructed. 
Integration of the SAP2-1P-ecaFLP fusion into the SAP2-1 allele in YIL19M3A and 
YIL19M3B generated the strains YIL19M7A and YIL19M7B, respectively (Fig. 56, lanes 14 
and 15), which carried the additional YIL19 copy in a heterozygous background, ensuring that 
one of the wild-type YIL19 alleles remains after deletion of the MPAR-YIL19 cassette. The 
strains YIL19M8A and YIL19M8B (Fig. 56, lanes 16 and 17) were obtained by integrating 
only the URA3 selection marker rather than the SAP2-1P-ecaFLP fusion (Fig. 55, bottom) 
into YIL19M5A and YIL19M5B. Those latter strains would be unable to delete the ACT1-
integrated YIL19 copy under SAP2-inducing conditions. 
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Fig. 56. Southern hybridization of ClaI-digested genomic DNA of the parental strain CAI4 and mutant 
derivatives with  the SAP2-specific probe shown in Fig. 55. The sizes of the hybridizing fragments (in kb) are 
given on the left side of the blot and their identities are indicated on the right. 
 
 
 
4.2.3.4. YIL19 deletion is lethal in C.albicans 
To determine the effect of YIL19 deletion in C.albicans strains YIL19M6A and 
YIl19M6B, in which the original YIL19 alleles were inactivated, were grown for 16 hours in 
YCB-BSA medium. The SAP2 promoter is repressed in commonly used laboratory media, 
such as YPD, and can be induced in media containing a protein as the sole nitrogen source, 
such as YCB-BSA; this induction occurs after several hours of growth when low-molecular-
weight nitrogen sources are exhausted (Staib et al., 1999). Wild-type strain SC5314, the 
strains YIL19M7A and YIL19M7B which retained one of the wild-type YIL19 allele in 
addition to the deletable copy, and strains YIL19M8A and YIL19M8B which contained only 
the deletable YIL19 copy but not the ecaFLP gene were included as controls. All the strains 
had reached the same optical density (O.D600 between 28 and 30) and by microscopic 
appearance, the cells of all strains looked like wild-type (Fig. 57). 
To determine the colony forming units (cfu), the cultures from all these strains were 
diluted and plated on YPD as well as MPA indicator plates. The cultures of the control strains 
YIL19M7A/B or YIL19M8A/B were shown to contain ~4×108 ml-1 viable cells, which is 
comparable to the no of viable cells from the culture of the wild-type strain SC5314 (~6× 108 
ml-1). The colonies from the wild-type and strains YIL19M7A/B were MPA sensitive whereas 
the colonies from YIL19M8A/B were MPA resistant, which indicates the efficient deletion of 
YIL19- MPAR from YIL19M7A/B. In contrast, the cultures of strains YIL19M6A/B produced 
only ~2× 105 cfu ml-1, and these were MPA resistant, indicating that <0.1% of the cells had 
escaped FLP-mediated excision of the YIL19-MPAR cassette and that all other cells were 
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unable to generate viable colonies. These results demonstrate that YIL19 is an essential gene 
in C.albicans and the FLP-mediated gene deletion effectively generated an almost pure 
population of yil19 null mutants. 
  
 
 
 
 
 
 
 
 
 
Fig. 57. Phase contrast micrographs of the cells. A single colony of each strain was inoculated into 10 ml of 
YCB-BSA medium and grown for 16 hours at 30°C. The strain pairs YIL19M6A/B, YIL19M7A/B and 
YIL19M8A/B looked identical, and only one of them is shown. 
 
 
 
To assess the effect of YIL19 deletion on vegetative growth and cell morphology, the 
cells were diluted in fresh YPD medium after 16 hours growth in YCB-BSA. Comparisons of 
the growth of the population of null mutants in liquid YPD medium at 30°C along with wild-
type strain SC5314 and control strains YIL19M8A/B showed that the YIL19M6A/B strains 
were impaired in growth. The control strains, which contain a single copy of YIL19 gene, 
grew slightly slower than the wild-type strain (Fig. 58). When the cells were observed by 
microscope, it was found that the cells of YIL19M6A/B were slightly bigger than those of the 
wild-type and control strains (Fig. 59). To determine whether YIL19 deletion affected hyphae 
formation in C.albicans, the YCB-BSA cultures of the mutant and control strains were diluted 
10-2 into fresh RPMI+10% serum and incubated for 8 hours at 37°C. It was found that both 
mutant and control strains were able to elongate the cells equally well and there was no effect 
of deletion of this gene on the development of hyphae (Fig. 60). 
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Fig. 58. Effect of YIL19 deletion 
on vegetative growth of 
C.albicans. The YCB-BSA 
cultures shown in Fig. 57 were 
diluted 10-2 into fresh YPD 
medium and grown for 8 hours at 
30°C. Growth was followed by 
measuring the increase in optical 
density over time. 
 
 
 
 
 
  
Fig. 59. Morphologies of 
C.albicans cells grown in YPD 
after deletion of YIL19. The 
YCB-BSA cultures shown in Fig. 
57 were diluted 10-2 into fresh 
YPD and the cells were analysed 
by phase-contrast microscopy 
after 8 hours growth at 30°C. The 
strain pairs YIL19M6A/B and 
YIL19M8A/B looked identical, 
and only one of them is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 60. The YCB-BSA cultures shown in Fig. 57 were diluted 10-2 into RPMI 1640 with 10% serum and the 
cells were analysed by phase-contrast microscopy after 8 hours growth at 37°C. The strain pairs YIL19M6A/B 
and YIL19M8A/B looked identical, and only one of them is shown. 
 
 
 
4.2.3.5. YIL19 depleted cells are impaired in the maturation of 18S rRNA 
Yil19p (Faf1p) of S.cerevisiae has very recently been shown to be involved in 18S 
rRNA maturation and is also essential in this organism (Shirai et al., 2004; Karkusiewicz et 
al., 2004). The similarity of YIL19 in C.albicans and S.cerevisiae and the essentiality in both 
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organisms, suggested that Yil19p might function in rRNA processing also in C.albicans. To 
test this hypothesis, the steady state level of rRNA was examined by Northern blotting. After 
16 hours induction in YCB-BSA (see section 4.2.3.4), cells of the wild-type strain SC5314, 
the yil19 null mutants YIL19M6A/B, and the control strains YIL19M8A/B, were grown in 
YPD medium at 30°C for 8 hours. Total RNA was prepared and equal amounts of RNA were 
electrophoresed and blotted on a nylon membrane. Visualization of RNA by methylene blue 
staining of the blot indicated that the level of 18S rRNA was reduced in the mutant cells, 
whereas the level of 25S rRNA was comparable to the wild-type and the control strains (Fig. 
61). To determine whether the reduced level of 18S rRNA resulted from a defect in rRNA 
processing, the Northern blot was hybridised with probes specific to the ITS regions of the 
35S pre-rRNA transcript. Northern hybridization with the probe specific for the ITS1 region 
(oligo ITS1.3) showed the accumulation of two bands in the mutants positioned between the 
25S and 18S rRNAs (Fig. 62B, left). Moreover, there was a slight increase in the amount of 
35S pre-rRNA in the mutant cells, confirming the inhibition of the processing of rRNA (Fig. 
62B, left). The control strains YIL19M8A and YIL19M8B, which retain one YIL19 copy, also 
showed the accumulation of one precursor rRNA band, which might be due to a gene dosage 
effect. Hybridization with the probe ITS 2.1, specific for the precursor containing 5.8S and 
25S rRNA showed a similar level of  the 7S intermediate in the wild-type, control and mutant 
cells, indicating that the processing steps leading to the 5.8S were not disturbed in the mutant 
cells (Fig. 62B, right).  All these data together showed that YIL19, like its counterpart in 
S.cerevisiae also had a role in the processing of 18S rRNA in C.albicans. 
 
 
 
 
 
 
 
Fig. 61. Methylene blue stained blot of total RNA 
extracted from the wild-type strain (SC5314) and, the 
homozygous (YIL19M6A/B) and heterozygous 
(YIL19M8A/B) mutants of YIL19.  
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Fig. 62 (A) Structure of 35S pre-rRNA and positions of oligonucleotide probes. (B) Autoradiographs of the blot 
shown in Fig. 61 hybridized with oligonucleotide probes indicated on the top. Positions of different pre-rRNAs 
and mature rRNAs are indicated. 
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5. Discussion 
 
 
5.1. Nitrogen starvation induced filamentous growth and ammonium transporters 
 
In its natural habitat C.albicans encounters a wide variety of nitrogen sources. 
However, not all nitrogen sources support growth equally well. Good nitrogen sources result 
in a relatively higher growth rate than poor nitrogen sources. Moreover, nutrient limitation is 
a stress situation for the cells. When C.albicans cells are grown in the presence of limiting 
nutritional sources, their morphological behaviour changes and they start to grow in a 
filamentous form to seek nutrients in their surroundings. The present work showed that 
limiting concentrations of any nitrogen source induce filamentous growth in C.albicans and 
that nitrogen starvation induced filamentation was suppressed by sufficient amount of a 
preferred nitrogen source, like ammonium.  Limjindaporn et al. (2003) reported that 
filamentation in C.albicans is not under nitrogen repression, but they used glutamine at high 
concentration rather than ammonium. In the present study it was observed that, when 
relatively high concentrations (10 mM) of glutamine were used as sole nitrogen source, 
filamentation was induced, although filaments started to emerge after 5 days of incubation 
and that filamentous growth was repressed only in presence of very high concentrations of 
ammonium (100 mM). Although glutamine is a preferred nitrogen source, high concentrations 
may have caused an imbalance in nitrogen metabolism, that resulted in filamentous growth. 
Repression of filamentation by ammonium was not extended to the other filament inducing 
conditions, like the presence of serum, which indicates that the repression of filamentation by 
ammonium occurs only when the response is due to nitrogen starvation and not in case of the 
other environmental conditions which also causes filamentation in this opportunistic 
pathogen. Moreover, nitrogen starvation induced filamentation was observed only in solid 
media and not in liquid media. When the colonies grow on a solid surface, they initially use 
up the locally available nitrogen and then for further growth they need to scavenge the 
nutrients from the other parts of the plate and need to elongate the cells, which is done 
through the formation of filaments. It is also important to keep in mind that initially on the 
plate smooth colonies are formed and after 3 days of incubation filaments start to come up 
from the borders of the colonies.  
Ammonium, either taken up directly from the external medium or derived from amino 
acids, is often considered as a preferred source of nitrogen in microorganisms (ter Schure et 
al., 2000). Ammonium uptake by S.cerevisiae involves at least three ammonium permeases, 
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Mep1p, Mep2p and Mep3p (Marini et al., 1994; 1997), which belong to a multigene family, 
the so-called Mep/Amt family (Marini et al., 1994; Ninnemann et al., 1994). This study 
showed that C.albicans possesses two genes, CaMEP1 and CaMEP2, encoding ammonium 
permeases that allow growth when low concentrations of ammonium are the sole nitrogen 
source.  CaMEP1 is more similar to ScMEP1 than to ScMEP3 in that it allowed normal 
growth and ammonium uptake when it was the only MEP gene present, as has been 
demonstrated for ScMEP1, whereas S.cerevisiae cells expressing only MEP3 exhibit reduced 
ammonium uptake and reduced growth under limiting ammonium conditions (Lorenz and 
Heitman, 1998a; Marini et al., 1997). The C.albicans genome sequence contains a third gene 
(ORF 6.7259) which shows homology to ammonium permeases. However, deletion of 
CaMEP1 and CaMEP2 rendered C.albicans incapable of growing at low ammonium 
concentration, and hence, the studies were focused on only these two genes. Although ORF 
6.7259 may act as an ammonium permease, CaMep1p and CaMep2p seem to be the major 
ammonium transporters in C.albicans. It is possible that the encoded protein of the ORF 
6.7259 is involved in ammonium uptake at higher ammonium concentration (76 mM), which 
would explain that the deletion of CaMEP1 and CaMEP2 did not affect growth at higher 
ammonium concentrations. But the entry of ammonium into the cell through simple diffusion 
at higher concentrations can not be ruled out. However, expression of either CaMep1p or 
CaMep2p alone resulted in specific ammonium transport activity, demonstrating these 
proteins are indeed ammonium transporters.  
Although ammonium permeases from various other organisms can rescue the 
ammonium uptake defect of S.cerevisiae ∆mep1 ∆mep2 ∆mep3 triple mutants, only some of 
them are able to restore pseudohyphal growth. Therefore, it is assumed that a certain subclass 
of ammonium permeases possesses structural features which are required for morphogenesis 
and which are absent from the other ammonium permeases that have only a transporter 
function (Smith et al., 2003). CaMep2p was found to be required for filamentation in 
response to nitrogen starvation in C.albicans. Although the main physiological function of 
Mep proteins is to scavenge the ammonium from the medium for use as a nitrogen source, 
CaMep2p but not CaMep1p, is required for filamentation. The specific function of CaMep2p 
in nitrogen starvation induced filamentous growth of C.albicans is similar to the role of its 
counterpart ScMep2p in pseudohyphal growth of S.cerevisiae under limiting ammonium 
conditions (Lorenz and Heitman, 1998a), but an important difference between CaMEP2 and 
ScMEP2 is that the former is required for filamentous growth under nitrogen starvation 
conditions in general, whereas the latter plays a role only under limiting ammonium 
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conditions, but not when other limiting nitrogen sources induce pseudohyphal growth (Lorenz 
and Heitman, 1998a). Moreover, growth and ammonium import were found to be normal in 
∆mep2 mutant, indicating that the filamentation defect of these mutants is not due to growth 
impairment. Interestingly, when arginine was used as a limiting source of nitrogen, 
filamentation was found not to be dependent on CaMep2p. At higher concentrations (10 mM) 
arginine was found to inhibit the growth of C.albicans (data not shown) and the induction of 
filamentous growth by arginine may therefore represent a different type of stress response. 
When other conditions, like serum, agar embedding, or any other liquid filament induction 
medium was used, filamentation was not dependent on CaMep2p. In these conditions the 
filamentation induction pathways seem to be activated in different ways.  
One can envisage different models to explain the requirement for CaMEP2 in 
filamentous growth of C.albicans when nitrogen sources other than ammonium are limiting. 
One possibility is that the role of CaMep2p in filamentous growth is not that of an ammonium 
sensor, which is in contrast to the suggested role of Mep2p in S.cerevisiae. Evidently, 
CaMep2p is not the primary sensor of nitrogen starvation, since expression of CaMEP2 itself 
was induced under these conditions. It is likely that C.albicans senses limiting concentrations 
of nitrogen metabolites within the cell, for example with the help of Gln3p, a putative 
glutamine sensor, or Gat1p, a putative glutamate sensor (Magasanik and Kaiser, 2002). These 
GATA transcription factors may then induce expression of CaMEP2 and CaMEP1, which 
contain GATA binding sites in their upstream regions. CaMEP2 expression was induced 
irrespective of the nature of the limiting nitrogen source in the growth medium, indicating that 
C.albicans tries to obtain the preferred nitrogen source ammonium even when amino acids are 
available as nitrogen source and the simple presence of CaMep2p would then induce the 
yeast-hyphal switch also in the absence of ammonium. The second model implies that 
CaMep2p signals filamentous growth in the presence of limiting nitrogen sources other than 
ammonium because intracellular ammonium leakes out of the cells which is then transported 
back into the cell by CaMep2p. In this model signaling would depend on ammonium 
recognition/transport by CaMep2p, in concordance with a role of CaMep2p as an ammonium 
sensor. There is some evidence that ammonia secretion may facilitate intercolony 
communication in yeast (Palkova et al., 1997). 
What makes the CaMep2 permease specific for the regulation of filamentation? The 
results of the present study demonstrate that the specific role of CaMep2p in filamentous 
growth of C.albicans is due at least in part to its higher expression as compared with 
CaMep1p. Lowering the expression level of CaMEP2 abolished its ability to induce 
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filamentous growth, and artificially increasing the expression level of CaMEP1 conferred on 
it the ability to induce a weak filamentation. The elevated expression of CaMEP2 seems to be 
caused both by increased promoter activity and by increased mRNA stability. Higher amounts 
of mRNA and a stronger fluorescence of the cells were observed when CaMEP2- or 
CaMEP1-GFP fusions were expressed from the CaMEP2 promoter than from the CaMEP1 
promoter, indicating that the former is induced more strongly than the latter in response to 
nitrogen starvation. In addition, regardless of the promoter used, CaMEP2-GFP mRNA levels 
were always higher than CaMEP1-GFP mRNA levels expressed from the same promoter, 
indicating that the sequences within the CaMEP1 and CaMEP2 coding regions determine the 
stability of the respective mRNAs and result in increased CaMEP2 transcript levels. Together 
these mechanisms ensure that much higher amounts of CaMep2p than of CaMep1p are 
present in the cytoplasmic membrane, as judged from the signals obtained with the GFP-
tagged proteins. Since the same expression levels for CaMep1p as for CaMep2p were not 
achieved, even when expressing CaMEP1 from the strong ADH1 promoter, it is possible that 
the specific role of CaMep2p in filamentous growth of C.albicans relies solely on its higher 
expression as compared with CaMep1p. However, it is likely that CaMep2p has also evolved 
structural features that made it a more efficient signaling protein instead of an efficient 
ammonium transporter.  
The results obtained with C-terminally truncated proteins clearly demonstrate that the 
C-terminal cytoplasmic tail of CaMep2p is dispensable for ammonium transport but essential 
for the induction of filamentous growth, and therefore, has a specific signaling function. At 
first sight, this result came as a surprise since it has been reported that the C-terminal 
cytoplasmic domain of ScMep2p is not required for its ability to induce pseudohyphal growth 
in response to ammonium starvation in S.cerevisiae (Lorenz and Heitman, 1998a). However, 
from the alignment of the sequences of the ammonium transporters from C.albicans and 
S.cerevisiae it became clear that the C-terminal deletion of ScMep2p described by Lorenz and 
Heitman did not completely remove the cytoplasmic tail and correspond almost exactly to the 
∆C440 truncation in CaMep2p described in the present study, which retained its capacity to 
induce filamentous growth. Interesting observation made in this study was that the deletion of 
the distal half of the CaMep2p C-terminal domain in fact resulted in a hyperfilamentous 
growth under low ammonium conditions, without affecting the growth at low ammonium 
concentrations and ammonium uptake. This raises the possibility that the extreme C-terminal 
part of CaMep2p functions as an autoinhibitory domain that might interact with the signaling 
domain to prevent filamentous growth under certain conditions. But, the Northern data 
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suggested that the deletion of this region increases the transcript stability and possibly this 
deletion results in an increase of the amount of protein which might then cause 
hyperfilamentation. This provides another evidence that the expression level of CaMEP2 
plays a major role for its signaling function. In contrast, further deletions close to the last 
predicted trans-membrane domain resulted in a protein that allowed wild-type growth under 
low ammonium conditions and also ammonium uptake like the full length protein, 
demonstrating that it was functional as a permease, but it lost its capacity to induce 
filamentous growth, although the deletion of this region increased the stability of the 
transcript. This result provides evidence that the C-terminal cytoplasmic domain of CaMep2p 
(and possibly also of ScMep2p) has a role in signaling. Surprisingly, the region involved in 
signaling comprises the part of the C-terminal region in which CaMep2p has the highest 
similarity to CaMep1p and also other Mep proteins that do not induce morphogenesis. 
Furthermore, the substitution of the C-terminal cytoplasmic tail for the corresponding region 
in CaMEP1 did not confer signaling activity to the latter protein, which suggests that there is 
some other region in CaMep2p which needs to interact with the cytoplasmic region to 
transmit the signal and that region is different in CaMep1p and CaMep2p. Additional 
experiments to identify the regions which interact with the C-terminal region were not 
successfull because of the failure to make the functional hybrids of CaMep2p and CaMep1p 
when the fusion points were not in the C-terminal cytoplasmic region (data not shown).  
When CaMep2p is involved in signaling for morphogenesis, then what are the 
downstream regulators? The pseudohyphal growth defect of Scmep2 mutants could not be 
rescued by activation of the MAP kinase cascade with a dominant active STE11 allele, but 
addition of exogenous cAMP or dominant active GPA2 or RAS1 alleles overcame the defect 
(Lorenz and Heitman, 1998a). Several components of the MAP kinase pathway and the 
cAMP-dependent signaling pathway have been shown to be required for filamentous growth 
of C.albicans under low ammonium conditions (Bahn and Sundstrom, 2001; Csank et al., 
1998; Rocha et al., 2001; Sanchez-Martinez and Perez-Martin, 2002). It was therefore 
reasonable to assume that CaMep2p might induce filamentous growth by activating one of 
these pathways. The ability of an artificially activated component of a signaling pathway to 
bypass the requirement for another component is often taken as evidence that the artificially 
activated component is located downstream of the defective component in the same signaling 
pathway. It was observed in this study that the dominant active alleles of GPA2 or RAS1, or 
the addition of exogenous cAMP rescued the filamentation defect of ∆mep2 mutants, 
indicating that CaMep2p acts upstream of GPA2 and RAS1. The Ras1p is known to act 
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upstream of the MAP kinase and the cAMP pathway to regulate filamentation, and the Gα 
protein, Gpa2p is also involved in the regulation of filamentous growth upstream of cAMP 
pathway. However, since different signaling pathways can induce filamentous growth in 
response to environmental conditions in C.albicans it is also possible that artificial activation 
of one pathway bypasses the normal requirement of a parallel pathway, as has been suggested 
for S.cerevisiae (Gagiano et al., 1999; Lorenz and Heitman, 1998b). Therefore, another 
approach using the hyperactive CaMep2∆C440 allele, was taken to gain information about how 
CaMep2p induces filamentous growth in C.albicans. Assuming that CaMep2p is a sensor that 
is localized at the head of a signaling pathway, the ability of the hyperactive CaMep2∆C440 
allele to bypass a defect in a downstream component of one of the pathways would indicate 
that CaMep2p is able to signal through another pathway. The hyperactive CaMep2∆C440 
allele induced filamentous growth in mutants deleted for transcription factors of either the 
MAP kinase or the cAMP pathway, but not in mutants defective for both pathways, 
suggesting that in wild-type cells CaMep2p activates both the MAP kinase pathway and the 
cAMP pathway to induce the switch from yeast to filamentous growth. Although other 
explanations are possible, the results are consistent with a model in which CaMep2p, directly 
or indirectly, activates Ras1p to induce filamention, since the CaMep2∆C440 allele could not 
rescue the filamentation defect of ras1 mutant. Ras1p in turn may then activate both the MAP 
kinase pathway and the cAMP pathway. But it is also possible that Ras1p is required only for 
the activation of the cAMP pathway, and the resulting adenylyl cyclase activity then enables 
components of the MAP kinase pathway to become fully active (Rocha et al., 2001). The 
latter hypothesis is supported from the observation that the hyperactive CaMep2∆C440 allele 
was unable to induce filamentation in cdc35 mutants whereas the addition of cAMP restored 
the filamentous growth of ∆mep2 mutants. Gpa2p, which is also required for filamentous 
growth under these conditions, may be activated by additional signals through the putative 
sugar sensor Gpr1p (Miwa et al., 2004) and then contribute to the activation of one or both 
signaling pathways. 
 Since nitrogen starvation is sensed before the expression of the ammonium permeases 
is induced, the question arises why C.albicans has integrated an ammonium transporter into 
the signaling pathways that regulate filamentous growth instead of directly inducing 
morphogenesis under these conditions. A possible explanation is that such a regulatory circuit 
allows C.albicans to fine-tune morphogenetic development in response to the availability of 
the preferred nitrogen source ammonium. Except at very high ammonium concentrations, 
ammonium permeases are required to take up sufficient ammonium to allow growth at an 
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optimal rate. Therefore, at intermediate extracellular ammonium concentrations the activity of 
the transporters creates intracellular conditions in which C.albicans prefers to grow as 
budding yeast and, consequently, signaling by CaMep2p must be blocked. An attractive 
hypothesis is that the signaling activity of CaMep2p depends on its transport activity. When 
no or low concentrations of ammonium are available, CaMep2p would not be involved in 
ammonium transport most of the time and be able to activate the signaling pathways, resulting 
in filamentous growth. At higher ammonium concentrations CaMep2p would increasingly 
become engaged in transport, and this status might block the signaling activity of the C-
terminal cytoplasmic tail. The results of this study indicate that CaMep2p is a less efficient 
ammonium transporter than CaMep1p, and needs to be expressed at much higher levels to 
allow sufficient ammonium uptake and growth when ammonium concentrations are limiting. 
These features, a high number of CaMep2p molecules in the cell membrane and inefficient 
ammonium transport, may be requirements for CaMep2p to regulate morphogenesis in 
response to ammonium availability. It is noteworthy that this model contrasts with the one 
proposed for the function of ScMep2p as an ammonium sensor in S.cerevisiae in that the 
signaling activity of CaMep2p is inhibited by ammonium.  
One must assume an additional level of regulation in the presence of moderate 
ammonium concentrations, conditions in which CaMEP2 is still expressed but no filamentous 
growth occurs. Under these conditions CaMep2p signaling seems to be blocked by other 
regulatory mechanisms, for example the sensing of sufficient intracellular nitrogen sources. 
But, it can also not be ruled out that at moderate ammonium concentration CaMEP2 
expression is not as high as in low concentration as suggested by the fluorescence level of 
GFP fusion protein. Further support for the control of gene expression in C.albicans by 
sufficiently high intracellular concentrations of ammonium (or its assimilation products) also 
comes from the observation that the dominant active allele of GPA2 or RAS1, or the addition 
of exogenous cAMP did not induce filaments at moderate ammonium concentration (10 mM). 
This is in contrast to the regulation of morphogenesis in S.cerevisiae where such conditions 
have been reported not only to bypass the requirement for ScMep2p but also to induce 
pseudohyphal growth even at high ammonium concentrations (Lorenz and Heitman, 1998a). 
The mechanism how ammonium represses filamentation in C.albicans at this level and how 
this repression is overcome by other environmental signals, like serum, remains unknown. 
However, it is intriguing that C.albicans has installed a regulatory circuit in which an 
inhibitor of filamentous growth is taken up into the cell by the same transporter that is 
essential for the induction of morphogenesis in response to nitrogen starvation. 
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However, the main regulation of filamentation by CaMep2p is by the regulation of its 
expression. Studies of the regulation of expression will provide more insights into the 
filament formation pathways at low nitrogen conditions. The S.cerevisiae mutant strains 
deleted for GLN3, URE2, or NPR1, which control ScMep2p levels, also display a 
pseudohyphal growth defect even when other nitrogen sources like glutamine or proline are 
limiting, and it was suggested that these regulatory proteins have additional targets that are 
critical for the regulation of dimorphism (Lorenz and Heitman, 1998a). ScMEP2 expression in 
S.cerevisiae requires at least the presence of a functional GATA factor, Gln3p or Gat1p 
(Marini et al., 1997). Promoters of CaMEP1 and CaMEP2 contain several binding sites of 
GATA factors. C.albicans GAT1 has recently been characterized and GAT1 deletion did not 
affect the filamentation in low nitrogen medium (Limjindaporn et al., 2003). Since CaMep2p 
is required for filamentation under these conditions, gat1 mutants should have filamentation 
defect if CaMEP2 expression is controlled by Gat1p. The presence of several GATA factors 
suggests that other factors than Gat1p are involved in the expression of this ammonium 
permease. It is possible that the expression of CaMEP2 may only require Gln3p, like in the 
S.cerevisiae ScMEP1 and ScMEP3 expression, which require only Gln3p and not Gat1p 
(Marini et al., 1997). This hypothesis can be addressed by the construction of gln3 mutants in 
C.albicans and studying the expression of the ammonium permeases in those deletion strains. 
However, this study proposes how the difference in the expression of these two ammonium 
permeases controls filament formation, a virulence factor of C.albicans, and opens a new 
direction towards the understanding of the correlation of nitrogen regulation, filament 
formation and virulence in C.albicans. 
 
 
 
5.2. Analysis of putative essential genes in C.albicans 
 
With the significant increase of fungal infections it has become essential to understand 
the biology of virulence factors, as their inactivation is likely to block the progression of 
disease. Although some virulence factors might be good targets for antifungal drug 
development, most are not shared among all fungal pathogens, and thus drugs that target these 
factors are likely to have a rather narrow spectrum. To develop new therapies and treatments 
for fungal infections, identification and characterization of essential genes which are 
conserved among most fungal pathogens and show significant divergence in higher 
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eukaryotes, are favoured by most pharmaceutical companies. For the development of new 
antifungal agents, a detailed knowledge about the consequences of loss of gene function will 
help to design inhibitors as well as screening systems to test them. Therefore, in an attempt to 
identify potential antifungal targets, the knowledge obtained from functional genomic 
analyses was used and C.albicans homologs of three genes which show no or low homologies 
to higher eukaryotes and are essential in other fungi were selected in collaboration with an 
industrial partner. The selected genes were then characterized by analysing the deletion 
mutants of these genes in C.albicans. 
 
 
5.2.1. Repressor/Activator Protein 1 
  
 CaRap1p is different from Rap1p of S.cerevisiae and other yeasts like C.glabrata,  
K.lactis or S.castelli. CaRap1p is truncated at its C-terminal region which is involved in 
transcriptional activation and silencing in ScRap1p. In contrast, all other published yeast Rap1 
proteins contain all three regions described for ScRap1p, although similarity is highest in the 
essential DNA binding domain (Larson et al., 1994; Haw et al., 2001; Wahlin and Cohn 
2002). Since CaRap1p shows similarity to the central DNA binding region of ScRap1p, it was 
interesting to check whether it could complement conditional rap1 mutants of S.cerevisiae. 
The inability of CaRap1p to complement might not be surprising, because KlRap1p which 
was also cloned on the basis of its similarity to the DNA binding domain and is more similar 
to ScRap1p than CaRap1p was unable to complement the growth defect of a temperature-
sensitive rap1 mutant (Larson et al., 1994). However the possibility remains that CaRAP1 
was not functionally expressed in the heterologous host, for example because of the non-
standard codon usage of C.albicans or the inability of CaRAP1 promoter to function in 
S.cerevisiae. Importantly, this study showed that CaRAP1 is not an essential gene in 
C.albicans and that its deletion did not negatively affect the growth of the cells under most 
conditions. It is important to keep in mind the CaRap1p in C.albicans is much shorter than 
ScRap1p and this difference may explain the finding that CaRAP1 is not essential in 
C.albicans. The essential functions of ScRap1p may reside in other proteins in C.albicans 
which were not identified by homology searches. Recently Uemura et al. (2004) have shown 
that CaRap1p is able to bind in vitro to the RPG-box present in the S.cerevisiae ENO1 
promoter and suggests a possible involvement of CaRap1p in the regulation of glycolytic 
genes in C.albicans (Uemura et al., 2004). It seems that some functions of ScRap1p are 
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retained in CaRap1p but there is a loss of the major functions of this protein. Therefore, 
CaRap1p does not seem to be useful as a target for the development of drugs against the 
pathogenic yeast C.albicans. 
The most obvious phenotype of rap1 deletion mutants was the formation of 
pseuodohyphae under conditions that normally promote yeast form growth. However, 
although the percentage of pseudohyphal cells was 100-fold enhanced in ∆rap1 mutants as 
compared with the wild type strains, the majority of the cells still grew as budding yeasts. In 
contrast, mutation of the gene FKH2  causes the majority of the cells to grow as pseudohyphal 
cells in yeast form promoting growth medium (Bensen et al., 2002). Mutants with deletions of 
other morphogenesis regulators, like TUP1, NRG1, or RFG1, grow also predominantly or 
exclusively in a filamentous form (Braun and Johnson, 1997; Braun et al., 2001; Kadosh and 
Johnson, 2001; Khalaf and Zitomer, 2001; Murad et al., 2001). It seems possible that the 
DNA binding domain of CaRAP1 does play some role in the efficient repression of 
pseudohyphal growth under yeast growth conditions, but does not play a major role in 
morphogenesis. 
 
 
 
5.2.2. Centromere Binding Factor 1 
 
  A previous study has demonstrated that CBF1 from C.albicans complements the 
known defects of an S.cerevisiae ∆cbf1 mutant, i.e. slow growth, methionine auxotrophy, and 
plasmid instability (Eck et al., 2001). Since the roles of Cbf1p as a centromere binding protein 
and as a transcription factor in S.cerevisiae are separable (Foreman and Davis, 1993; 
McKenzie et al., 1993), these results suggested that CaCbf1p has retained both activities and 
has the same functions in C.albicans as its counterpart in S.cerevisiae. 
Analyses of the ∆cbf1 mutants in this study demonstrated that deletion of CaCBF1 in 
C.albicans indeed results in a slow growth phenotype and auxotrophy for sulphur amino 
acids, as in S.cerevisiae. Interestingly, the sequence TCACGTG is present within 350 bp from 
the start codon of all the genes of the sulphate assimilation pathway in C.albicans, MET3, 
MET10, MET14, MET16, and MET25 (MET15) (http://www-
sequence.stanford.edu/group/candida/). Therefore, as in S.cerevisiae, by binding to this 
sequence CaCbf1p may allow transcriptional activation of these genes also in C.albicans, 
explaining the inability of the ∆cbf1 mutants to assimilate sulphate from the medium. 
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A possible role of CaCBF1 in the fidelity of chromosome segregation in C.albicans 
was also investigated in this study. The morphological abnormalities observed in the ∆cbf1 
mutants indicated such a possibility, since many cells were unusually large and frequently 
contained large buds without nuclei. Generation of enlarged cells with large, anucleate buds 
has recently been described for conditional C.albicans mutants depleted for the essential 
centromere protein Cse4p and may be a consequence of a block in nuclear division due to 
inefficient chromosome segregation (Sanyal and Carbon, 2002). However, the C.albicans 
∆cbf1 mutants did not exhibit increased susceptibility to the microtubule destabilizing agent 
thiabendazole, a phenotype described for S.cerevisiae ∆cbf1 mutants, which argued against a 
role of CaCbf1p in centromere function in C.albicans, and the aberrantly large cells might be 
due to some other defect of the ∆cbf1 mutants. 
Increased chromosome instability in C.albicans spindle assembly checkpoint mutants 
has recently been detected by measuring the frequency of mutant cells that are able to grow 
on sorbose (Bai et al., 2002). Such sorbose utilizing mutants arise after loss of one of the 
chromosome 5 homologs (Janbon et al., 1998), so that a higher frequency of sorbose utilizing 
cells can be taken as indication for increased chromosome instability. Since sorbose utilizing 
mutants appear as visible colonies after six and more days of growth on sorbose plates, this 
approach was found unreliable for the analysis of the C.albicans ∆cbf1 mutants because of 
their slow growth phenotype. To directly observe an effect of CaCBF1 deletion on 
chromosome stability, the CARE-2 hybridization pattern of individual clones of mutants and 
control strains which were isolated after growth in rich medium for many generations was 
analyzed. Because CARE-2 is present on most or even all C.albicans chromosomes, there was 
a high probability that loss of one homolog of any chromosome would result in an alteration 
in the hybridization pattern. The failure to detect increased chromosome instability by this 
approach provided some evidence that CaCBF1 does not have a major role in centromere 
function in C.albicans. However, it was possible that chromosome loss occurs with increased 
frequency in ∆cbf1 mutants but still remains a relatively rare event, since deletion of CBF1 in 
S.cerevisiae increases chromosome loss only about 10-fold (Baker and Masison, 1990; Cai 
and Davis, 1990). In addition, if cells that have lost one or more chromosomes exhibit 
reduced fitness they might be overgrown by other cells, such that the clones with an unaltered 
genome were selected for analysis. To detect a possible moderate increase in chromosome 
loss in ∆cbf1 mutants the frequency of loss of the ADE2 containing chromosome 3 in 
heterozygous ADE2/ade2 mutants was determined. Adenine-auxotrophic clones were 
detected at comparable frequencies in both wild-type and ∆cbf1 mutants, and Southern 
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hybridization with an ADE2-specific probe demonstrated that all red ade2 clones had lost the 
DNA fragment containing the intact ADE2 allele. Some of these clones also exhibited a 
reduced hybridization signal with another, unlinked, chromosome 3-specific probe, indicating 
that they had lost one of the chromosome 3 homologs. In other clones the intensity of signals 
with chromosome 3-specific probes and the chromosome 1-specific ACT1 probe were 
comparable, and they might have lost the ADE2 gene by mitotic recombination. However, it 
is likely that these clones also arose by loss of the ADE2 containing chromosome 3 homolog 
and subsequent reduplication of the remaining chromosome 3 by a second missegregation 
event, as has been described previously by Barton and Gull (1992). These authors reported 
that aneuploid ade2 mutants, which were obtained after chromosome loss in an ADE2/ade2 
heterozygous strain, were unstable and frequently regained a second copy of the chromosome. 
The aneuploid ade2 mutants formed smaller colonies than their parental strains, but returned 
to normal colony size after chromosome reduplication, and it was suggested that it was the 
loss of the respective chromosome, and not the adenine auxotrophy, that caused the reduced 
growth. Interestingly, the red ade2 clones derived from ∆cbf1 mutant and control strains also 
formed smaller colonies than their ADE2/ade2 heterozygous parents (data not shown). After 
restreaking they formed larger colonies with high frequency, although these large red colonies 
were still slightly smaller than those of the prototrophic parental strains, indicating that 
adenine auxotropy reduces the growth rate even on supplemented medium in the strain 
background used in this study. Therefore, C.albicans does not seem to tolerate aneuploidy for 
chromosome 3 well and chromosome loss may not always be detectable after passage of the 
ade2 clones. The fact that all red ade2 clones derived from the ∆cbf1 mutant and control 
strains initially formed smaller colonies than those of the prototropic parental strains suggests 
that they resulted from chromosome 3 loss instead of mitotic recombination, the frequency of 
which has been reported to be one order of magnitude lower (10-5 to 10-6) (Fonzi and Irwin, 
1993) than the frequency of chromosome loss observed in the present study (10-4 to 10-5), 
although the former depends on the relative location of a marker with respect to the 
centromere. In the ∆cbf1 background no growth difference between ade2 clones and their 
ADE2 parents was observed, indicating that the slow growth phenotype caused by deletion of 
CaCBF1 masks any growth defect resulting from the loss of one chromosome 3 homolog or 
from adenine auxotrophy. The failure to detect an increased frequency of red ade2 mutants in 
the ∆cbf1 mutants suggests that CaCbf1p is not required for maintenance of this chromosome. 
Together with the results from the other experiments in this study it can be concluded that 
CaCbf1p does not have a major role in chromosome segregation in C.albicans. 
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The temperature sensitivity of ∆cbf1 mutants apparently was not caused by a specific 
requirement of CaCbf1p at 42°C as opposed to lower temperature. At 42°C there is a certain 
degree of killing of C.albicans cells. Wild-type cells are nevertheless able to grow at this 
temperature since the rate of growth exceeds the rate of cell killing, at least in rich medium. 
This is not the case in the slowly growing ∆cbf1 mutants, resulting in their failure to grow at 
higher temperature. An augmentation of the morphological defect of the ∆cbf1 mutants by the 
higher temperature was also not detected, since the frequency of morphologically abnormal 
cells was similar at 30°C and 42°C. In addition, there was no increased chromosome 3 loss in 
the ∆cbf1 mutants at 42°C, demonstrating that CaCbf1p is not required for chromosome 
stability at the non-permissive temperature. 
Recently Sanyal et al. (2004) have characterized C.albicans centromeres and found 
that they are completely different from those of S.cerevisiae point centromeres and also from 
the regional centromeres found in Schizosaccharomyces pombe and higher eukaryotes. 
Moreover, centromeres of each chromosome of C.albicans contain a different and unique 
centromeric DNA sequence, a centromeric property previously unobserved in other 
organisms. None of these centromeric DNA sequences in any chromosome contain the 
binding sites for CaCbf1p, suggesting that CaCbf1p acts only as a transcription factor and 
have no role in centromere binding in C.albicans. Nevertheless, the results of the analysis of 
CaCbf1p in C.albicans demonstrate that a functional CaCbf1p is important for efficient 
growth of this pathogen and may therefore represent an attractive target for the development 
of antifungal drugs. 
 
 
5.2.3. YIL19: An essential gene in Candida albicans 
 
The Yil19p is essential for cell viability and is required for the proper processing of 
18S rRNA in S.cerevisiae. This gene product has been found in S.cerevisiae to interact with a 
multifunctional protein, Krr1p, which is associated with the 90S pre-ribosomes (Karkusiewicz 
et al., 2004) and also with Ebp2p, the yeast homolog of human Epstein-Barr virus nuclear 
antigen 1-binding protein 2, essential for the biogenesis of the 60S ribosomal subunit (Shirai 
et al., 2004). This gene was selected as a putative target for antifungal drug development. In 
an attempt to analyse the function of this gene, mutants were constructed. Inability to delete 
both wild-type alleles of this gene suggested that this gene has an essential function in 
C.albicans, too. Moreover, when an ectopic YIL19 allele was deleted by FLP-mediated gene 
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excision, the cells became nonviable. Microscopic examination of the mutants after deletion 
of this gene showed that the cells became enlarged in comparison to the wild type and control 
strains. However, it is unlikely that YIL19 is required for cell elongation, because the mutants 
were able to form filaments in the presence of hyphal inducer, serum. Northern blot analysis 
suggested that YIL19 is required for 18S rRNA maturation. Lower levels of mature 18S rRNA 
in the mutant strains was accompanied by the accumulation of intermediate RNA products 
and also the pre-rRNA transcript. The exact processing site of rRNA is still not known in 
C.albicans although it is well characterized in S.cerevisiae. The mutants accumulated RNAs 
with a size between that of the 18S and 25S rRNAs, possibly representing 23S and 20S 
rRNA. The accumulation of the 23S rRNA product indicates that rRNA was cleaved at the A3 
site without being cleaved at A0, A1, and A2 sites (Venema and Tollervey, 1999; Lee and 
Baserga, 1999). The slightly increased amount of 35S rRNA in the mutant cells also confirms 
the inhibition of cleavage at site A0. An exact knowledge of rRNA maturation steps in 
C.albicans and further characterization of the Yil19p will provide detailed information about 
how this protein works in the processing of 18S rRNA. The involvement of this gene in rRNA 
maturation provides a possible explanation for the increased cell size of the mutants. 
Systematic determination of cell size distributions for the complete set of ~6000 S.cerevisiae 
gene deletion strains have identified a complex network that governs critical cell size, and 
ribosome biogenesis has been found to be intimately linked with cell size (Jorgensen et al., 
2002). Since, YIL19 is essential for viability in C.albicans and the observation that the 
presence of Yil19p is limited to ascomycetes and not present in higher eukaryotes, it might be 
a good target for the development of antifungal drugs. 
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Appendix 
 
 
A.1. Construction of plasmids 
 
 
A.1.1. Plasmids used to study ammonium transporters 
 
A.1.1.1. Plasmids used for CaMEP1 and CaMEP2 deletion  
 
pMEP1M1 (8.6 kb): 3´-fragment of CaMEP1 was amplified from the chromosomal DNA of CAI4 using the 
primers MEP13 (+ 1569 to + 1597 in the + strand) and MEP14 (+ 2137 to + 2112 in the – strand). The BglII and 
SacI sites were introduced at position + 1577 in the primer MEP13 and at position + 2126 in the primer MEP14, 
respectively. The MEP13 primer also contains a PstI site at position + 1584. The PCR product was then digested 
with BglII-SacI and ligated into the BglII-SacI digested plasmid pYMR211M2 (Bader T, unpublished data), to 
replace the 3´-fragment of YMR211 by 3´-CaMEP1. 
 
pMEP1M2 (8.2 kb): 5´-fragment of CaMEP1 was amplified from the chromosomal DNA of CAI4 using the 
primers MEP11 (- 620 to - 594 in the + strand) and MEP12 (+ 13 to - 13 in the – strand). The KpnI and XhoI 
sites were introduced at position - 608 in the primer MEP11 and at position - 3 in the primer MEP12, 
respectively. The PCR product was then digested with KpnI-XhoI and ligated into the KpnI-XhoI digested 
plasmid pMEP1M1. The resulting plasmid thus contains the URA3 flipper flanked by the 5´ and 3´ of CaMEP1. 
The 5.3 kb KpnI-SacI digested fragment [5´MEP1-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´MEP1] from this 
plasmid was used to generate the CaMEP1 deletion strains. 
 
pMEP1M3 (6.2 kb): 5´-fragment of CaMEP1 was amplified from the chromosomal DNA of CAI4 using the 
primers MEP15 (- 647 to - 622 in the + strand) and MEP17 (+ 23 to - 4 in the – strand). The XhoI and BglII sites 
were introduced at position - 640 in the MEP15 and at position + 9 in the primer MEP17, respectively. The PCR 
product was then digested with XhoI-BglII and ligated into the XhoI-BglII digested plasmid pSAP2-1K (Staib et 
al., 2002). 
 
pMEP1M4 (5.8 kb): 3´-fragment of CaMEP1 was amplified from the chromosomal DNA of CAI4 using the 
primers MEP13 (+ 1569 to + 1597 in the + strand) and MEP14 (+ 2137 to + 2112 in the – strand). The PstI and 
SacI sites were introduced at position + 1584 in the primer MEP13 and at position + 2126 in the primer MEP14, 
respectively. The MEP13 primer also contains a BglII site at position + 1577. The PCR product was then 
digested with PstI-SacI and ligated into the PstI-SacI digested plasmid pMEP1M3. The 2.9 kb KpnI-SacI 
digested fragment [5´MEP1-ACT1T-URA3-3´MEP1] from this plasmid was used to generate the uridine-
prototrophic CaMEP1 deletion strains. 
 
pMEP2M1 (8.3 kb): 5´-fragment of CaMEP2 was amplified from the chromosomal DNA of SC5314 using the 
primers MEP3 (- 619 to - 586 in the + strand) and MEP4 (+ 47 to + 19 in the – strand). The KpnI and XhoI sites 
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were introduced at position - 608 in the primer MEP3 and at position + 32 in the primer MEP4, respectively. The 
PCR product was then digested with KpnI-XhoI and ligated into the KpnI-XhoI digested plasmid pCBF1M1. 
  
pMEP2M2 (8.1 kb): 3´-fragment of CaMEP2 was amplified from the chromosomal DNA of SC5314 using the 
primers MEP5 (+ 1345 to + 1372 in the + strand) and MEP6 (+ 1779 to + 1751 in the – strand). The BglII and 
SacI sites were introduced at position + 1354 in the primer MEP5 and at position + 1769 in the primer MEP6, 
respectively. The PCR product was then digested with BglII-SacI and ligated into the BglII-SacI digested 
plasmid pMEP2M1. The resulting plasmid thus contains the URA3 flipper flanked by 5´and 3´of CaMEP2. The 
5.2 kb KpnI-SacI digested fragment [5´MEP2-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´MEP2] from this 
plasmid was used to generate the CaMEP2 deletion strains. 
 
pMEP2M3 (5.6 kb): 3´-fragment of CaMEP2 was amplified from the chromosomal DNA of SC5314 using the 
primers MEP8 (+ 1345 to + 1372 in the + strand) and MEP6 (+ 1779 to + 1751 in the – strand). The PstI and 
SacI sites were introduced at position + 1362 in the primer MEP8 and at position + 1769 in the primer MEP6, 
respectively. The PCR product was then digested with PstI-SacI and ligated into the PstI-SacI digested plasmid 
pCBF1M4. 
 
pMEP2M4 (5.7 kb): 5´-fragment of CaMEP2 was amplified from the chromosomal DNA of SC5314 using the 
primers MEP3 (- 619 to - 586 in the + strand) and MEP7 (+ 47 to + 19 in the – strand). The KpnI and BglII sites 
were introduced at position - 608 in the MEP3 and at position + 28 in the primer MEP7, respectively. The PCR 
product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid pMEP2M3. The 2.8 
kb KpnI-SacI digested fragment [5´MEP2-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the 
uridine-prototrophic CaMEP2 deletion strains. 
 
 
A.1.1.2. Plasmids containing lacZ reporter gene fusions 
 
pLACZ2 (6.0 kb): A fragment containing the N-terminal region of the Streptococcus thermophilus lacZ ORF 
was amplified from the plasmid pAU36 (Uhl and Johnson, 2001) with the primers LACZ1 (+ 1 to + 22 in the + 
strand) and LACZ2 (+ 1230 to + 1209 in the – strand). A XhoI site was introduced in the LACZ1 primer.  The 
PCR product was then digested at XhoI and at internal ClaI sites (position + 1196) and ligated together with a 
2.1 kb ClaI-BamHI fragment from the plasmid pAU36 containing the remainder of the lacZ ORF into the XhoI-
BamHI digested plasmid pBluescript (Stratagene, Heidelberg, Germany). 
 
pLACZ3 (6.4 kb): A fragment containing the ACT1 terminator region (ACT1T) was amplified using the primers 
ACT16 (+ 1784 to + 1811 in the + strand) and ACT19 (+ 2180 to + 2156 in the – strand) from the plasmid 
pSAP2-7 (Staib et al., 2000). The BglII and SacII sites were introduced into the ACT16 and ACT19, 
respectively. The PCR product was then digested with BglII-SacII and ligated into the BamHI-SacII digested 
plasmid pLACZ2. 
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pLACZ4 (7.4 kb): A 1.1 kb ACT1 promoter fragment was PCR amplified using the primers UNI (5´-
GTAAAACGACGGCCAGT-3´) and ACT20 (- 10 to - 35 in the – strand) from the plasmid pGFP31 
(Morschhäuser et al., 1998). The ACT20 primer contains a SalI site. The BamHI-SalI digested PCR product was 
ligated together with a 3.5 kb XhoI-SacII fragment from the plasmid pLACZ3 containing lacZ-ACT1T, into the 
BamHI-SacII digested plasmid pGFP31 (Morschhäuser et al., 1998). The 4.5 kb BamHI-SacII fragment 
[ACT1P-lacZ-ACT1T] from this plasmid was used to generate the strain CALACZ1. 
 
pMEP1LACZ2 (8.9 kb):  The 2.9 kb KpnI-BamHI fragment containing MEP2P-lacZ from the plasmid 
pMEP2LACZ1 was ligated into the KpnI-BglII digested plasmid pMEP1M4. 
 
pMEP1LACZ3 (8.9 kb): The KpnI-XhoI fragment containing the CaMEP1 promoter from the plasmid 
pMEP1M2 was ligated into the KpnI-XhoI digested plasmid pMEP1LACZ2 and generateed a plasmid in which 
the lacZ gene is under the control of CaMEP1 promoter. A 6.0 kb KpnI-SacI fragment [MEP1P-lacZ-ACT1T-
URA3-3´MEP1] from this plasmid was used to generate the strains CLACZ1A and CLACZ1B. 
 
pMEP2LACZ1 (6.6 kb): A fragment containing the CaMEP2 promoter was amplified with the primers MEP3 (- 
619 to - 586 in the + strand) and MEP24 (+ 8 to - 22 in the – strand) from the plasmid pMEP2K1. The KpnI and 
XhoI sites were introduced at position - 608 in the primer MEP3 and at position - 5 in the primer MEP24. The 
PCR product was then digested with KpnI-XhoI and ligated into the KpnI-XhoI digested plasmid pLACZ2. 
 
pMEP2LACZ2 (8.8 kb): The 3.7 kb KpnI-BamHI fragment containing MEP2P-lacZ from the plasmid 
pMEP2LACZ1 was ligated into the KpnI-BglII digested plasmid pMEP2M4 generating a plasmid in which the 
the lacZ gene is under the control of CaMEP2 promoter. A 5.9 kb KpnI-SacI fragment [MEP2P-lacZ-ACT1T-
URA3-3´MEP2] from this plasmid was used to generate the strains CLACZ2A and CLACZ2B. 
 
 
A.1.1.3. Plasmids containing CaMEP1 and CaMEP2 under different promoters 
 
 
pMEP1K1 (7.5 kb): A fragment containing the CaMEP1 promoter and coding region was amplified from the 
chromosomal DNA of CAI4 using the primers MEP16 (+ 1629 to + 1604 in the - strand) and MEP18 (- 618 to - 
592 in the + strand). The BglII and XhoI sites were introduced at position + 1616 in the primer MEP16 and at 
position - 608 in the primer MEP18, respectively. The PCR product was then digested with XhoI-BglII and 
ligated into the XhoI-BglII digested plasmid pMEP1M4. The resulting plasmid contains the full length CaMEP1 
gene. A 4.6 kb XhoI-SacI fragment [MEP1P-MEP1-ACT1T-URA3-3´MEP1] from this plasmid was used to 
reintroduce CaMEP1 into the ∆mep1 mutants and ∆mep1 ∆mep2 double mutants to generate the strains 
MEP1MK1A, MEP1MK1B, MEP12MK1A, and MEP12MK1B. 
 
 pMEP1K2 (7.3 kb): A fragment containing the CaMEP1 coding region was amplified from the plasmid 
pMEP1K1 using the primers MEP16 (+ 1629 to + 1604 in the - strand) and MEP27 (- 14 to + 16 in the + strand). 
The BglII and XhoI sites were introduced at position + 1616 in the primer MEP16 and at position - 7 in the 
primer MEP27, respectively. The PCR product was then digested with XhoI and ApaI (located at position + 519) 
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and ligated together with the 2.5 kb ApaI-NdeI fragment [3´MEP1-ACT1T-5´URA3] from plasmid pMEP1K1 
into the XhoI-NdeI digested plasmid pMEP2LACZ2. The resulting plasmid thus contains the full length 
CaMEP1 gene under the control of CaMEP2 promoter. A 4.4 kb SacI-partial KpnI fragment [MEP2P-MEP1-
ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains MEP12MK3A, and MEP12MK3B. 
  
pMEP1E2 (7.8 kb): The 2.7 kb XhoI-EcoRI fragment [MEP1-ACT1T-5´URA3] from the plasmid pMEP1K2 
was ligated into the SalI-EcoRI digested plasmid pADH1G2 (Kusch et al., 2004). The resulting plasmid contains 
the full length CaMEP1 gene under the control of ADH1 promoter. A 4.9 kb XhoI-SacI fragment [ADH1P-
MEP1-ACT1T-URA3-3´ADH1] from this plasmid was used to generate the strains MEP12ME1A, and 
MEP12ME1B. 
  
pMEP2K1 (7.15 kb): A fragment containing the CaMEP2 promoter and coding region was amplified from the 
chromosomal DNA of SC5314 using the primers MEP3 (- 619 to - 586 in the + strand) and MEP9 (+ 1522 to + 
1494 in the - strand). The BglII and KpnI sites were introduced at position + 1507 in the primer MEP9 and at 
position - 608 in the primer MEP3, respectively. The PCR product was then digested with KpnI-BglII and ligated 
into the KpnI-BglII digested plasmid pMEP2M3. The resulting plasmid contains the full length CaMEP2 gene. 
A 4.25 kb KpnI-SacI fragment [MEP2P-MEP2-ACT1T-URA3-3´MEP2] from this plasmid was used to 
reintroduce CaMEP2 into the ∆mep2 mutants and ∆mep1 ∆mep2 double mutants to generate the strains 
MEP2MK1A, MEP2MK1B, MEP12MK2A, and MEP12MK2B. This 4.25 kb KpnI-SacI fragment was also 
transformed into CAI4 and different signaling mutants to generate the control strains (see section 3.3). 
 
pMEP2K2 (7.3 kb): A fragment containing the CaMEP2 coding region was amplified from the plasmid 
pMEP2K1 using the primers MEP21 (- 13 to + 20 in the + strand) and MEP9 (+ 1522 to + 1494 in the - strand). 
The BglII and XhoI sites were introduced at position + 1507 in the primer MEP9 and at position - 7 in the primer 
MEP21, respectively. The 0.4 kb XhoI-EcoRV fragment containing the N-terminus of CaMep2p from the PCR 
product was ligated together with 2.25 kb EcoRV-EcoRI fragment [3´MEP2-ACT1T-5´URA3] from the plasmid 
pMEP2K1 into the XhoI-EcoRI digested pMEP1LACZ3. The resulting plasmid thus contains the full length 
CaMEP2 gene under the control of CaMEP1 promoter. A 4.4 kb KpnI-SacI fragment [MEP1P-MEP2-ACT1T-
URA3-3´MEP1] from this plasmid was used to generate the strains MEP12MK4A, and MEP12MK4B. 
 
pMEP2E2 (7.7 kb): A fragment containing the CaMEP2 coding region was amplified from the plasmid 
pMEP2K1 using the primers MEP21 (- 13 to + 20 in the + strand) and MEP9 (+ 1522 to + 1494 in the - strand). 
The BglII and XhoI sites were introduced at position + 1507 in MEP9 and at position - 7 in primer MEP21, 
respectively. The PCR product was then digested with XhoI-BglII and ligated together with the 1.0 kb BamHI-
EcoRI fragment [ACT1T-5´URA3] from the plasmid pYPR127E2 (Kusch et al., 2004) into the SalI-EcoRI 
digested pADH1G2 (Kusch et al., 2004). The resulting plasmid contains the full length CaMEP2 gene under the 
control of ADH1 promoter. A 4.8 kb KpnI-SacI fragment [ADH1P-MEP2-ACT1T-URA3-3´ADH1] from this 
plasmid was used to generate the strains MEP12ME2A, and MEP12ME2B. 
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A.1.1.4. Plasmids containing the GFP-tagged CaMEP1 and CaMEP2 genes 
 
 
pMEP1G1 (8.2 kb): A fragment containing the CaMEP1 coding region was amplified from the plasmid 
pMEP1K1 using the primers MEP37 (+ 1615 to + 1587 in the - strand) and MEP27 (- 14 to + 16 in the + strand). 
The BamHI site was introduced in the primer MEP37 at position + 1603 replacing the CaMEP1 stop codon and 
XhoI site at position - 7 in the primer MEP27. The PCR product was then digested with BamHI and SalI (located 
at position + 957) and ligated together with the 1.7 kb BamHI-EcoRI fragment [GFP -ACT1T-5´URA3] from the 
plasmid pMEP2G2 into the SalI-EcoRI digested plasmid pMEP1K1. The resulting plasmid contains the full 
length CaMEP1-GFP fusion under the control of CaMEP1 promoter. This fusion results into a CaMep1-GFP 
fusion protein with two amino acids (Gly-Ser) in between the two proteins. A 5.3 kb XhoI-SacI fragment 
[MEP1P-MEP1-GFP-ACT1T-URA3-3´MEP1] from this plasmid was used to generate the strains CMEP1GA, 
CMEP1GB, MEP12MG1A, and MEP12MG1B. 
 
pMEP1G2 (8.0 kb): The 2.8 kb ApaI-EcoRI fragment [3´MEP1-GFP-ACT1T-5´URA3] from the plasmid 
pMEP1G1 was ligated into the ApaI-EcoRI digested plasmid pMEP1K2. The resulting plasmid thus contains the 
CaMEP1-GFP fusion under the control of the CaMEP2 prmoter. A 5.1 kb SacI-partial KpnI fragment [MEP2P-
MEP1-GFP-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains CMEP1G2A, 
CMEP1G2B, MEP12MG3A, and MEP12MG3B. 
 
pMEP1G3 (8.5 kb): The 2.8 kb ClaI-EcoRI fragment [3´MEP1-GFP-ACT1T-5´URA3] from the plasmid 
pMEP1G1 was ligated into the ClaI-EcoRI digested plasmid pMEP1E2. The resulting plasmid thus contains the 
CaMEP1-GFP fusion under the control of ADH1 prmoter. A 5.5 kb XbaI-SacI fragment [ADH1P-MEP1-GFP-
ACT1T-URA3-3´ADH1] from this plasmid was used to generate the strains CMEP1EGA, CMEP1EGB, 
MEP12MEG1A, and MEP12MEG1B. 
 
pMEP2G1 (7.8 kb):  A fragment containing the CaMEP2 coding region was amplified from the plasmid 
pMEP2K1 using the primers MEP21 (- 13 to + 20 in the + strand) and MEP32 (+ 1454 to + 1426 in the - strand). 
The BamHI site was introduced in the primer MEP32 at position + 1441 replacing the CaMEP2 stop codon and 
XhoI site at position - 7 in the primer MEP21. The PCR product was then digested at an internal SalI site and at 
the BamHI site introduced in the MEP32 primer and ligated together with 1.5 kb KpnI-SalI fragment from the 
plasmid pMEP2K1 into the KpnI-BamHI digested pOP4G1 (Park Yang-Nim, unpublished data). The resulting 
plasmid thus contains the full length CaMEP2-GFP fusion. This fusion results into a CaMep2-GFP fusion 
protein with two amino acids (Gly-Ser) in between the two proteins.  
 
pMEP2G2 (7.8 kb):  The 1.3 kb EcoRI-SacI fragment containing 3´URA3-3´MEP2 from the plasmid pMEP2K1 
was ligated into the EcoRI-SacI digested plasmid pMEP2G1. A 4.9 kb KpnI-SacI fragment [MEP2P-MEP2-
GFP-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains CMEP2GA, CMEP2GB, 
MEP12MG2A, and MEP12MG2B. 
 
pMEP2G4 (8.4 kb): The 1.3 kb BamHI-PstI fragment containing ADH1P-5´MEP2 from the plasmid pMEP2E2 
was ligated along with the 2.1 kb PstI-EcoRI fragment containing 3´MEP2-GFP-ACT1T-5´URA3 from the 
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plasmid pMEP2G1 into the BamHI-EcoRI digested plasmid pMEP2E2. The resulting plasmid thus contains the 
CaMEP2-GFP fusion under the control of ADH1 prmoter. A 5.5 kb XbaI-SacI fragment [ADH1P-MEP2-GFP-
ACT1T-URA3-3´ADH1] from this plasmid was used to generate the strains CMEP2EGA, CMEP2EGB, 
MEP12MEG2A, and MEP12MEG2B. 
 
pMEP2G5 (8.0 kb): The 2.9 kb EcoRV-EcoRI fragment containing 3´MEP2-GFP-ACT1T-URA3 from the 
plasmid pMEP2G4 was ligated into the EcoRV-EcoRI digested plasmid pMEP2K2. The resulting plasmid thus 
contains the CaMEP2-GFP fusion under the control of CaMEP1 prmoter. A 5.1 kb KpnI-SacI fragment 
[MEP1P-MEP2-GFP-ACT1T-URA3-3´MEP1] from this plasmid was used to generate the strains CMEP2G1A, 
CMEP2G1B, MEP12MG5A, and MEP12MG5B. 
 
 
A.1.1.5. Plasmids containing the truncation of CaMEP1 and CaMEP2 genes 
 
 
pMEP1∆C1 (6.8 kb): A fragment containing the CaMEP1 promoter and coding region was amplified from the 
plasmid pMEP1K1 using the primers MEP20 (+ 1224 to + 1193 in the - strand) which introduces stop codon (+ 
1212 to + 1215) behind Ile404 and MEP18 (- 618 to - 592 in the + strand). The BglII and XhoI sites were 
introduced at position + 1219 in the primer MEP20 and at position - 608 in the primer MEP18, respectively. The 
PCR product was then digested with XhoI-BglII and ligated into the XhoI-BglII digested plasmid pMEP1K1. The 
resulting plasmid contains the C-terminally truncated CaMEP1∆C404 gene. A 3.9 kb KpnI-SacI fragment 
[MEP1P-MEP1∆C404-ACT1T-URA3-3´MEP1] from this plasmid was used to generate the strains 
MEP12MK1A∆C1, and MEP12MK1B∆C1. 
 
pMEP1∆C2 (6.9 kb): A fragment containing the CaMEP1 promoter and coding region was amplified from the 
plasmid pMEP1K1 using the primers MEP23 (+ 1327 to + 1294 in the - strand) which introduces stop codon (+ 
1315 to + 1317) behind Val438 and MEP18 (- 618 to - 592 in the + strand). The BglII and XhoI sites were 
introduced at position + 1320 in the primer MEP23 and at position - 608 in the primer MEP18, respectively. The 
PCR product was then digested with XhoI-BglII and ligated into the XhoI-BglII digested plasmid pMEP1K1. The 
resulting plasmid contains the C-terminally truncated CaMEP1∆C438 gene. A 4.0 kb KpnI-SacI fragment 
[MEP1P-MEP1∆C438-ACT1T-URA3-3´MEP1] from this plasmid was used to generate the strains 
MEP12MK1A∆C2, and MEP12MK1B∆C2. 
 
pMEP2∆C1 (6.8 kb): A fragment containing the CaMEP2 promoter and coding region was amplified from the 
plasmid pMEP2K1 using the primers MEP19 (+ 1232 to + 1199 in the - strand) which introduces stop codon (+ 
1219 to + 1221) behind Met406 and MEP3 (- 619 to - 586 in the + strand). The BglII and KpnI sites were 
introduced at position + 1226 in the primer MEP19 and at position - 608 in the primer MEP3, respectively. The 
PCR product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid pMEP2K1. 
The resulting plasmid contains the C-terminally truncated CaMEP2∆C406 gene. A 3.9 kb KpnI-SacI fragment 
[MEP2P-MEP2∆C406-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains 
MEP12MK2A∆C1, and MEP12MK2B∆C1. 
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pMEP2∆C2 (6.8 kb): A fragment containing the CaMEP2 promoter and coding region was amplified from the 
plasmid pMEP2K1 using the primers MEP22 (+ 1335 to + 1301 in the - strand) which introduces stop codon (+ 
1321 to + 1323) behind Asp440 and MEP3 (- 619 to - 586 in the + strand). The BglII and KpnI sites were 
introduced at position + 1327 in the primer MEP22 and at position - 608 in the primer MEP3, respectively. The 
PCR product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid pMEP2K1. 
The resulting plasmid contains the C-terminally truncated CaMEP2∆C440 gene. A 4.0 kb KpnI-SacI fragment 
[MEP2P-MEP2∆C440-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains 
MEP12MK2A∆C2, and MEP12MK2B∆C2. This 4.0 kb KpnI-SacI fragment was also transformed into CAI4 
and different signalling mutants to replace one of the wild type CAMEP2 allele by the truncated allele (see 
section 3.3). 
 
pMEP2∆C3 (6.9 kb): A fragment containing the CaMEP2 promoter and coding region was amplified from the 
plasmid pMEP2K1 using the primers MEP25 (+ 1287 to + 1257 in the - strand) which introduces stop codon (+ 
1270 to + 1272) behind Leu423 and MEP3 (- 619 to - 586 in the + strand). The BglII and KpnI sites were 
introduced at position + 1280 in the primer MEP25 and at position - 608 in the primer MEP3, respectively. The 
PCR product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid pMEP2K1. 
The resulting plasmid contains the C-terminally truncated CaMEP2∆C423 gene. A 4.0 kb KpnI-SacI fragment 
[MEP2P-MEP2∆C423-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains 
MEP12MK2A∆C3, and MEP12MK2B∆C3. 
 
pMEP2∆C4 (6.8 kb): A fragment containing the CaMEP2 promoter and coding region was amplified from the 
plasmid pMEP2K1 using the primers MEP26 (+ 1253 to + 1227 in the - strand) which introduces stop codon (+ 
1240 to + 1242) behind Arg413 and MEP3 (- 619 to - 586 in the + strand). The BglII and KpnI sites were 
introduced at position + 1247 in the primer MEP26 and at position - 608 in the primer MEP3, respectively. The 
PCR product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid pMEP2K1. 
The resulting plasmid contains the C-terminally truncated CaMEP2∆C413 gene. A 3.9 kb KpnI-SacI fragment 
[MEP2P-MEP2∆C413-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains 
MEP12MK2A∆C4, and MEP12MK2B∆C4. 
 
 
A.1.1.6. Plasmids containing the MEP hybrids 
 
 
pMEP12H2 (7.4 kb): The C-terminal part of CaMEP2 was amplified using the primers MEP35 and MEP9 (+ 
1522 to + 1494 in the – strand, with an introduced BglII site at position + 1507). Primer MEP35 consists of 
CaMEP1 sequences from positions + 1233 to + 1248 including the ClaI site at position + 1241 followed by the 
CaMEP2 sequences from positions + 1255 to + 1276. The PCR product was digested with ClaI-BglII and ligated 
into the ClaI-BglII digested plasmid pMEP1K1. This results into a plasmid containing the CaMEP1-CaMEP2 
hybrid gene expressed from the CaMEP1 promoter and encodes a protein  in which the first 416 amino acids of 
CaMep1p are fused to the last 62 amino acids of CaMep2p (amino acids 419-480). A 4.5 kb KpnI-SacI fragment 
[MEP1P-MEP11-416-MEP2419-480-ACT1T-URA3-3´MEP1] from this plasmid was used to generate the strains 
MEP12MK12AH2A, and MEP12MK12H2B. 
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pMEP12H3 (7.1 kb): The 1.6 kb XbaI-BglII fragment containing the CaMEP1-CaMEP2 hybrid gene from the 
plasmid pMEP12H2 was ligated into the XbaI-BglII digested plasmid pMEP1K2. This results into a plasmid 
containing the CaMEP1-CaMEP2 hybrid gene expressed from the CaMEP2 promoter and encodes a protein  in 
which the first 416 amino acids of CaMep1p are fused to the last 62 amino acids of CaMep2p (amino acids 419-
480). A 4.2 kb KpnI-SacI fragment [MEP2P-MEP11-416-MEP2419-480-ACT1T-URA3-3´MEP2] from this plasmid 
was used to generate the strains MEP12MK12H3A, and MEP12MK12H3B. 
 
pMEP12H4 (7.0 kb): A fragment containing the CaMEP1-CaMEP2 hybrid gene was amplified using the 
primers MEP27 (- 14 to + 16 in the + strand of CaMEP1 sequence) and MEP22 (+ 1335 to + 1301 in the – 
strand of CaMEP2 sequence) which introduces stop codon (+ 1321 to + 1323) behind Asp440. A BglII site was 
introduced at position + 1327 in MEP22. The PCR product was then digested with SalI (located at position + 957 
in CaMEP1 sequence) and BglII and ligated together with the 2.3 kb BglII-SacI fragment containing [ACT1T-
URA3-3´MEP2] into the SalI-SacI digested plasmid pMEP12H3. This resulted into a plasmid containing the 
CaMEP1-CaMEP2 hybrid gene expressed from the CaMEP2 promoter and encodes a protein in which the first 
416 amino acids of CaMep1p are fused to the amino acids 419-440 of CaMep2p. A 4.1 kb KpnI-SacI fragment 
[MEP2P-MEP11-416-MEP2419-440-ACT1T-URA3-3´MEP2] from this plasmid was used to generate the strains 
MEP12MK12H4A, and MEP12MK12H4B. 
 
pMEP21H2 (7.2 kb): A fragment containing the CaMEP2 promoter and a portion of the coding region from the 
N-terminal part of CaMEP2 was amplified from the plasmid pMEP2K1 using the primers MEP3 (- 619 to - 586 
in the + strand) and MEP33p (+ 1254 to + 1234 in the – strand). The KpnI site was introduced at position - 608 
in the primer MEP3. A C-terminal part of CaMEP1 was also amplified using the primers MEP34p (+ 1249 to + 
1270 in the + strand) and MEP16 (+ 1629 to + 1604 in the – strand). The BglII site was introduced at position + 
1616 behind the stop codon in the primer MEP16. The MEP33p and MEP34p primers are phosphorylated at 
their 5´ends. The CaMEP2 and CaMEP1 fragments were then digested at the KpnI and BglII sites, respectively, 
fused at their blunt ends and ligated into the KpnI-BglII digested plasmid pMEP1K2. The resulting plasmid 
contains the CaMEP2-CaMEP1 hybrid gene expressed from the CaMEP2 promoter and encodes a protein in 
which the first 418 amino acids of CaMep2p are fused to the last 118 amino acids of CaMep1p (amino acids 417 
to 534). A 4.3 kb SacI-partial KpnI digested fragment [MEP2P-MEP21-418-MEP1417-534-ACT1T-URA3-3´MEP2] 
from this plasmid was used to generate the strains MEP12MK21H2A and MEP12MK12H2B. 
 
 
A.1.1.7. Plasmids containing the dominant active RAS1G13V and GPA2Q354L alleles 
 
 
pRAS1E1 (6.9 kb): A fragment containing the ACT1 promoter was amplified from the genomic DNA of 
SC5314 using the primers ACT31 (- 501 to - 475 in the + strand) and ACT20 (- 10 to - 35 in the – strand). The 
ACT31 and ACT20 primers contain XbaI and SalI sites, respectively. The RAS1 ORF was then amplified from 
the genomic DNA of SC5314 with the primers RAS1 (- 12 to + 47 in the + strand) and RAS2 (+ 886 to + 856 in 
the – strand). The RAS1 primer contains a SalI site at position - 7 (in front of the start codon) and substitutes a 
valine specific GTT codon for the original glycine specific GGT codon at positions + 37 to + 39, whereas the 
RAS2 primer introduces a BglII site at position + 876, behind the stop codon. The ACT1 upstream fragment and 
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the RAS1G13V fragments were digested with XbaI-SalI and SalI-BglII, respectively, and were ligated together into 
the XbaI-BglII digested plasmid pSAP2-1K (Staib et al., 2002). The resulting plasmid thus contains the 
dominant active RAS1G13V under the control of ACT1 promoter. A 4.0 kb fragment [ACT1P-RAS1G13V-ACT1T-
URA3-3´ACT1] from this plasmid was used to generate the strains RAS1E1A, RAS1E1B, MEP2MRAS1E1A 
and MEP2MRAS1E1B. 
 
pGPA2 (6.9 kb): A fragment containing the N-terminal part of GPA2 ORF was amplified using the primer 
GPA1 (- 12 to + 18 in the + strand) which introduces SalI site in front of the start codon (at position - 7) and the 
5´-phosphorylated primer GPA2 (+ 1056 to + 1027 in the - strand), from the genomic DNA of CAI4. The 
remainder of GPA2 ORF was amplified with the 5´-phosphorylated primer GPA3 (+ 1057 to + 1086 in the + 
strand) which substitutes the leucine specific TTA codon for the original glutamine specific CAA codon at 
positions + 1060 to + 1062, and primer GPA4 (+ 1518 to + 1584 in the – strand) which introduces a BglII site at 
position + 1508, from the genomic DNA of CAI4. The PCR products were digested with SalI and BglII, 
respectively, fused at their blunt ends and ligated into the SalI-BglII digested pCBF1M4. 
 
pGPA2E1 (7.5 kb): The 1.5 kb SalI-BglII fragment from pGPA2 and the 1.0 kb BglII-EcoRI digested fragment 
containing ACT1T-5´URA3 from the plasmid pRAS1E1 were ligated together into the SalI-EcoRI digested 
pRAS1E1. The resulting plasmid thus contains the dominant active GPA2Q354L under the control of ACT1 
promoter. A 4.6 kb fragment [ACT1P-GPA2Q354L-ACT1T-URA3-3´ACT1] from this plasmid was used to generate 
the strains GPA2E1A, GPA2E1B, MEP2MGPA2E1A and MEP2MGPA2E1B. 
 
 
 
A.1.2. Plasmids used to study C.albicans Repressor/activator protein 1 (CaRap1p) 
 
pRAP1M1 (8.7 kb): 3´-fragment of CaRAP1 was amplified from the chromosomal DNA of SC5314 using the 
primers RAP3 (+ 1251 to + 1277 in the + strand) and RAP7 (+ 1890 to + 1861 in the – strand). The BamHI and 
SacII sites were introduced at position + 1260 in the primer RAP3 and at position + 1883 in the primer RAP7, 
respectively. The PCR product was then digested with BamHI-SacII and ligated into the BglII-SacII digested 
plasmid pYMR211M2 (Bader T, unpublished data), to replace the 3´-fragment of YMR211 by 3´-CaRAP1. 
  
pRAP1M2 (8.2 kb): 5´-fragment of CaRAP1 was amplified from the chromosomal DNA of SC5314 using the 
primers RAP5 (- 463 to - 436 in the + strand) and RAP6 (+ 37 to + 10 in the – strand). The KpnI and XhoI sites 
were introduced at position - 448 in the primer RAP5 and at position + 20 in the primer RAP6, respectively. The 
PCR product was then digested with KpnI-XhoI and ligated into KpnI-XhoI digested pRAP1M1. The resulting 
plasmid thus contains the URA3 flipper flanked by 5´and 3´of CaRAP1. The 5.3 kb KpnI-SacI digested fragment 
[5´RAP1-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´RAP1] from this plasmid was used to generate the CaRAP1 
deletion strains. 
 
pRAP1M3 (5.9 kb): 3´-fragment of CaRAP1 was amplified from the chromosomal DNA of SC5314 using the 
primers RAP9 (+ 1156 to + 1188 in the + strand) and RAP10 (+ 1897 to + 1869 in the – strand). The PstI and 
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SacI sites were introduced at position + 1172 in the primer RAP9 and at position + 1885 in the primer RAP10, 
respectively. The PCR product was then digested with PstI-SacI and ligated into the PstI-SacI digested 
pCBF1M4. 
 
pRAP1M4 (5.8 kb): 5´-fragment of CaRAP1 was amplified from the chromosomal DNA of SC5314 using the 
primers RAP5 (- 463 to - 436 in the + strand) and RAP8 (+ 20 to - 10 in the – strand). The KpnI and BamHI sites 
were introduced at position - 448 in the primer RAP5 and at position + 6 in the primer RAP8, respectively. The 
PCR product was then digested with KpnI-BamHI and ligated into KpnI-BglII digested plasmid pRAP1M3. The 
2.9 kb KpnI-SacI digested fragment [5´RAP1-ACT1T-URA3-3´RAP1] from this plasmid was used to generate the 
uridine-prototrophic CaRAP1 deletion strains. 
 
pRAP1K1 (7.1 kb): A fragment containing the CaRAP1 promoter and coding region was amplified from the 
chromosomal DNA of SC5314 using the primers RAP5 (- 463 to - 436 in the + strand) and RAP11 (+ 1369 to + 
1343 in the – strand). The KpnI and BamHI sites were introduced at position - 448 in the primer RAP5 and at 
position + 1354 in the primer RAP11, respectively. The PCR product was then digested with KpnI-BamHI and 
ligated into the KpnI-BamHI digested plasmid pRAP1M3. The resulting plasmid contains full length CaRAP1 
gene. A 4.2 kb KpnI-SacI fragment [RAP1P-RAP1-ACT1T-URA3-3´RAP1] from this plasmid was used to 
reintroduce CaRAP1 into rap1 null mutants. 
 
pRSRAP1 (7.8 kb): A 2.3 kb KpnI-SalI fragment containing the RAP1 promoter, coding region and ACT1 
terminator sequence from the plasmid pRAP1K1 was ligated into the KpnI-SalI digested yeast 2µ plasmid 
pRS426. 
 
 
 
A.1.3. Plasmids used to study C.albicans Centromere binding protein 1 (CaCbf1p) 
 
pCBF1M1 (8.6 kb): 3´-fragment of CaCBF1 was amplified from the chromosomal DNA of SC5314 using the 
primers CBF3 (+ 657 to + 682 in the + strand) and CBF4 (+ 1249 to + 1218 in the – strand). The BglII and SacI 
sites were introduced at position + 665 in the primer CBF3 and at position + 1236 in the primer CBF4, 
respectively. The PCR product was then digested with BglII-SacI and ligated into the BglII-SacI digested 
plasmid pYMR211M2 (Bader T, unpublished data), to replace the 3´-fragment of YMR211 by 3´-CaCBF1. 
 
 pCBF1M2 (8.2 kb): 5´-fragment of CaCBF1 was amplified from the chromosomal DNA of SC5314 using the 
primers CBF1 (- 588 to - 563 in the + strand) and CBF2 (+ 4 to - 24 in the – strand). The KpnI and XhoI sites 
were introduced at position - 577 in the primer CBF1 and at position - 11 in the primer CBF2, respectively. The 
PCR product was then digested with KpnI-XhoI and ligated into the KpnI-XhoI digested plasmid pCBF1M1. The 
resulting plasmid thus contains the URA3 flipper flanked by the 5´and 3´of CaCBF1. The 5.3 kb KpnI-SacI 
digested fragment [5´CBF1-FRT-SAP2P-caFLP-ACT1T-URA3-FRT-3´CBF1] from this plasmid was used to 
generate the CaCBF1 deletion strains. 
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pCBF1M3 (6.1 kb): 5´-fragment of CaCBF1 was amplified from the chromosomal DNA of SC5314 using the 
primers CBF1 (- 588 to - 563 in the + strand) and CBF6 (+ 4 to - 24 in the – strand). The KpnI and BglII sites 
were introduced at position - 577 in the primer CBF1 and at position - 15 in the primer CBF6, respectively. The 
PCR product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid pSAP2-1K 
(Staib et al., 2002). 
 
pCBF1M4 (5.8 kb): 3´-fragment of CaCBF1 was amplified from the chromosomal DNA of SC5314 using the 
primers CBF5 (+ 657 to + 682 in the + strand) and CBF4 (+ 1249 to + 1218 in the – strand). The PstI and SacI 
sites were introduced at position + 672 in the primer CBF5 and at position + 1236 in the primer CBF4, 
respectively. The PCR product was then digested with PstI-SacI and ligated into the PstI-SacI digested plasmid 
pCBF1M3. The 2.9 kb KpnI-SacI digested fragment [5´CBF1-ACT1T-URA3-3´CBF1] from this plasmid was 
used to generate the uridine-prototrophic CaCBF1 deletion strains. 
 
pCBF1K1 (6.5 kb): A fragment containing the CaCBF1 promoter and coding region was amplified from the 
chromosomal DNA of SC5314 using the primers CBF1 (- 588 to - 563 in the + strand) and CBF7 (+ 689 to + 
661 in the – strand). The KpnI and BglII sites were introduced at position - 577 in the primer CBF1 and at 
position + 672 in the primer CBF7, respectively. The PCR product was then digested with KpnI-BglII and 
ligated into the KpnI-BglII digested plasmid pCBF1M4. The resulting plasmid thus contains the full length 
CaCBF1 gene. A 3.6 kb KpnI-SacI fragment [CBF1P-CBF1-ACT1T-URA3-3´CBF1] from this plasmid was used 
to reintroduce CaCBF1 into cbf1 null mutants. 
 
pADE2M1 (5.67 kb): 5´-fragment of ADE2 was amplified from the chromosomal DNA of CAI4 using the 
primers ADE3 (+ 13 to + 37 in the + strand) and ADE4 (+ 484 to + 456 in the – strand). The KpnI and BglII sites 
were introduced at position + 23 in the primer ADE3 and at position + 469 in the primer ADE4, respectively. 
The PCR product was then digested with KpnI-BglII and ligated into the KpnI-BglII digested plasmid 
pCBF1M4. 
 
pADE2M2 (5.36 kb): 3´-fragment of ADE2 was amplified from the chromosomal DNA of CAI4 using the 
primers ADE5 (+ 1314 to + 1340 in the + strand) and ADE6 (+ 1690 to + 1669 in the – strand). PstI and SacI 
sites were introduced at position + 1326 in the primer ADE5 and at position + 1679 in the primer ADE6, 
respectively. The PCR product was then digested with PstI-SacI and ligated into the PstI-SacI digested plasmid 
pADE2M1. The 2.46 kb KpnI-SacI digested fragment [5´ADE2-ACT1T-URA3-3´ADE2] from this plasmid was 
used to generate the ADE2/ade2 heterozygous mutant strains. 
 
 
 
A.1.4. Plasmids used to study C.albicans YIL19 
 
pYIL19M1 (8.0 kb): 5´-fragment of YIL19 was amplified from the chromosomal DNA of CAI4 using the 
primers YIL1 (- 532 to - 509 in the + strand) and YIL2 (+ 13 to - 10 in the – strand). The KpnI and XhoI sites 
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were introduced at position - 519 in the primer YIL1 and at position - 1 in the primer YIL2, respectively. The 
PCR product was then digested with KpnI-XhoI and ligated into the KpnI-XhoI digested plasmid pMEP1M1. 
 
pYIL19M2 (8.0 kb): 3´-fragment of YIL19 was amplified from the chromosomal DNA of CAI4 using the 
primers YIL3 (+ 977 to + 999 in the + strand) and YIL4 (+ 1384 to + 1359 in the – strand). The BglII and SacI 
sites were introduced at position + 982 in the primer YIL3 and at position + 1373 in the primer YIL4, 
respectively. The PCR product was then digested with BglII-SacI and ligated into the BglII-SacI digested 
plasmid pYIL19M1. The resulting plasmid thus contains the URA3 flipper flanked by the 5´and 3´of YIL19.  
 
pYIL19 (5.6 kb): The YIL19 gene was PCR amplified from the chromosomal DNA of CAI4 using the primers 
YIL5 (- 1180 to - 1153 in the + strand) and YIL 6 (+ 1495 to + 1469 in the – strand). The XhoI and HindIII sites 
were introduced at position - 1171 in the primer YIL5 and at position + 1484 in the YIL6, respectively. The PCR 
product was then digested with XhoI-HindIII and ligated into the XhoI-HindIII digested plasmid pBluescript KS 
II (Stratagene, Heidelberg, Germany). 
 
pYIL19D1 (10.1 kb): The 1.2 kb BamHI-SalI fragment containing ACT1P-FRT fragment from pAFI3 (Staib et 
al., 1999), the 2.8 kb XhoI-HindIII YIL19-fragment from pYIL19, and the 2.9 kb HindIII-PstI MPAR-fragment 
from pAFI3 (Staib et al., 1999) were ligated together into the 3.8 kb BamHI-PstI digested vector pAFI3 (Staib et 
al., 1999).  
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A.2. Lee´s medium 
  
For 1000 ml of medium followings were mixed in distilled water: 
Dextrose:                                             12.5 g 
NaCl      :                                                 5.0 g 
Ammonium sulphate:                              5.0 g 
K2HPO4:                                                  2.5 g 
L-Leucine:                                 1.3 g 
L-Lysine:                                 1.0 g 
L-Alanine:                                 0.5 g 
L-Phenylalanine:                                 0.5 g 
L-Proline:                                 0.5 g 
L-Threonine:                                 0.5 g 
L-Methionine:                                 0.1 g 
L-Ornithine:                                 0.07 g 
L-Arginine:                                 0.07 g 
pH adjusted to 6.7-6.8 
d-Biotin:                                 1.0 mg 
After autoclaving, it was cooled to < 65°C and the followings were added: 
100 µM Zinc-Sulphate:                                 1.0 ml 
MgSO4,7H2O (20 g/L):                               10.0 ml 
To make the agar plates of Lee´s medium 2% agar was used. 
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A.3. Abbreviations  
 
A:                         Absorbance 
bp:                        base pair  
caFLP:                 C.albicans adapted FLP (recombinase) gene 
cfu:   colony forming units 
Ci:   Courie 
cm:    centimeter 
CSM:    Complete Supplement Medium 
DEPC:    Diethyl pyrocarbonate 
DNA:    Deoxyribonucleic acid  
dNTPs:    deoxy nucleoside phosphates 
DTT:    Dithiothreitol 
ecaFLP:   ‘enhanced’ C.albicans adapted FLP (recombinase) gene  
EDTA:    Ethylediaminetetraacetate  
FRT:    FLP recognition site  
g:    gram 
GFP:    Green fluorescent protein 
h:    hour 
IAA:    Isopropyl alcohol 
kb:    kilobasepair  
kD:   kilo Dalton 
Kv:    Kilovolt  
lacZ:    β-galactosidase gene 
LB:    Luria-Bertani 
M:    Molar 
ml:    milliliter  
mM:    millimolar  
mRNA:   messenger Ribonucleic acid  
ng:    nanogram 
nm:   nanometer 
MPAR :    Mycophenolic acid resistance gene 
OD:    Optical density 
P, 5´and 3´:   Promoter, 5´ and 3´ regions of any gene, respectively  
PBS:    Phosphate-buffered saline  
PNK:    Polynucleotide kinase  
RNA:    Ribonucleic acid  
RNase A:   Ribonuclease A  
rpm:    rotation per minute 
RT:    Room temperature  
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rRNA:   ribosomal Ribonucleic acid 
SD:    Synthetic Dextrose  
SDS:    Sodium dodecyl sulphate 
u:    unit 
URA3:    Oritidine-5´phosphate decarboxylase  
v:    volume 
w:   weight 
WT:   Wild-type  
YCB:    Yeast Carbon Base  
YNB:    Yeast Nitrogen Base  
µ:    micro.   
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